UNITED STATES SURGICAL CORP
S-3, 1994-04-27
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: UJB FINANCIAL CORP /NJ/, S-4/A, 1994-04-27
Next: UNITED STATES SURGICAL CORP, 10-Q, 1994-04-27



<PAGE>   1
 
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL 27, 1994
 
                                           REGISTRATION STATEMENT NO.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
 
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                            ------------------------
 
                                    FORM S-3
                             REGISTRATION STATEMENT
                                     UNDER
                           THE SECURITIES ACT OF 1933
                            ------------------------
                       UNITED STATES SURGICAL CORPORATION
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
 
          DELAWARE                                          13-2518270
 (STATE OR OTHER JURISDICTION OF                            (I.R.S. EMPLOYER
 INCORPORATION OR ORGANIZATION)                           IDENTIFICATION NO.)
 
                 150 GLOVER AVENUE, NORWALK, CONNECTICUT 06856
                                 (203) 845-1000
  (ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE, OF
                   REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES)
                            ------------------------
                              DONALD F. CRANE, JR.
                               SENIOR SEC COUNSEL
                       UNITED STATES SURGICAL CORPORATION
                               150 GLOVER AVENUE
                           NORWALK, CONNECTICUT 06856
                                 (203) 845-1000
 (NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE,
                             OF AGENT FOR SERVICE)
                            ------------------------
 
    APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: from time
to time after the Registration Statement becomes effective.
                            ------------------------
 
    If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box.  / /
 
    If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box.  /X/
 
                        CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION> 
- ---------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------
                                                                                                        AMOUNT OF   
TITLE OF EACH CLASS OF                            AMOUNT TO BE     AGGREGATE PRICE     AGGREGATE      REGISTRATION   
SECURITIES BEING REGISTERED                        REGISTERED         PER UNIT      OFFERING PRICE        FEE  
- ---------------------------------------------------------------------------------------------------------------------
<S>                                              <C>                   <C>           <C>                 <C>
Depositary Shares, each representing one-
  fiftieth of a share of DECS, Series A
  Convertible Preferred Stock, par value $5
  per share(1)................................   8,870,000 Shares      $22.55        $200,018,500        $68,972
- ---------------------------------------------------------------------------------------------------------------------
DECS, Series A Convertible Preferred Stock,
  par value $1 per share......................         (2)               (2)              (2)              N/A
- ---------------------------------------------------------------------------------------------------------------------
Common Stock, par value $.10 per share........         (3)               (3)              (3)              N/A
- ---------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------
</TABLE>
(1) 8,870,000 Depositary Shares, offered for resale hereunder, issued on March
    28, 1994, at $22.55 per share.
 
(2) One-fiftieth of the number of Depositary Shares registered hereby. DECS are
    represented by the Depository Shares and no additional registration fee is
    required.
 
(3) Up to 8,870,000 shares issuable upon, or in connection with, the conversion
    or redemption of the Depository Shares, as to which no additional
    registration fee is required.
                            ------------------------
 
    THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF
THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE SECURITIES AND EXCHANGE COMMISSION, ACTING
PURSUANT TO SAID SECTION 8(A), MAY DETERMINE.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>   2
 
INFORMATION CONTAINED HEREIN IS SUBJECT TO COMPLETION OR AMENDMENT. A
REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH
THE SECURITIES AND EXCHANGE COMMISSION. THESE SECURITIES MAY NOT BE SOLD NOR
MAY OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION
STATEMENT BECOMES EFFECTIVE. THIS PROSPECTUS SHALL NOT CONSTITUTE AN OFFER
TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE
OF THESE SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE
WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE
SECURITIES LAWS OF ANY SUCH STATE. 
                                                                         


 
SUBJECT TO COMPLETION. APRIL 27, 1994
 
PROSPECTUS
 
                                                                   [LOGO]
8,870,000 SHARES
UNITED STATES SURGICAL CORPORATION
$2.20 DEPOSITARY SHARES
EACH REPRESENTING A ONE-FIFTIETH INTEREST IN A SHARE OF
SERIES A CONVERTIBLE PREFERRED STOCK
(DIVIDEND ENHANCED CONVERTIBLE STOCK(SM) -- DECS(SM))
 
COMMON STOCK
 
This Prospectus relates to the resale of 8,870,000 of $2.20 Depositary Shares
(the "Depositary Shares"), each representing a one-fiftieth interest in a share
of Series A Convertible Preferred Stock, par value $5 per share ("DECS"), of
United States Surgical Corporation (the "Company"), of the DECS, and of up to
8,870,000 shares of Common Stock issuable upon redemption or conversion of the
Depositary Shares (collectively, the "Resale Securities") by the holders named
herein of the Resale Securities (each, a "Selling Stockholder" and collectively,
the "Selling Stockholders").
 
The Depositary Shares were issued in a transaction exempt from registration
under the Securities Act of 1933, as amended (the "Securities Act") by the
Company on March 28, 1994. See "Issuance of Resale Securities to Selling
Stockholders".
 
The Selling Stockholders directly, through agents designated from time to time,
or through dealers or underwriters to be designated, may sell the Resale
Securities from time to time on terms determined at the time of sale. See "Plan
of Distribution." The Company will not receive any of the proceeds from the sale
of the Resale Securities by the Selling Stockholders.
 
Upon any sale of the Resale Securities offered hereby, Selling Stockholders and
participating agents, brokers and dealers may be deemed to be underwriters as
that term is defined in the Securities Act. The Company, however, understands
that the Selling Stockholders do not admit that they are underwriters within the
meaning of the Securities Act.
 
The Company will pay the expenses of registration of the Resale Securities,
except for underwriters' discounts or commissions, if any.
 
Dividends on the Depositary Shares are cumulative at the annual rate of $2.20
per share (being one-fiftieth of the annual dividend rate of $110.00 for each
share of DECS), payable quarterly in arrears, commencing July 1, 1994. Each
Depositary Share has a liquidation preference (being one-fiftieth of the
liquidation preference of each share of DECS) equal to the sum of (i) $22.55 and
(ii) one-fiftieth of the amount of accrued and unpaid dividends on each share of
DECS.
 
At any time after April 1, 1997 (subject to certain limitations), the Depositary
Shares may be redeemed by the Company for an amount of Common Stock of the
Company, par value $.10 per share (the "Common Stock"), equal to $20.50,
together with an additional cash dividend as set forth herein. On April 1, 1998
(the "Mandatory Conversion Date"), each Depositary Share still outstanding will
automatically convert into one share of Common Stock, subject to adjustment in
certain events. Prior to any such redemption by the Company, each Depositary
Share may be converted at any time at the option of the holder into 0.953 of a
share of Common Stock (equivalent to 47.65 shares of Common Stock for each share
of DECS).
 
For a detailed description of the terms of DECS and the Depositary Shares, see
"Description of DECS" and "Description of Depositary Shares".
 
This Prospectus may not be used to consummate sales of the Resale Securities
unless, if resold through underwriters, dealers, or agents, accompanied by a
Prospectus Supplement which names such underwriters, dealers or agents and
describes the arrangements therewith.
The Common Stock will be listed for trading on the New York Stock Exchange under
the symbol USS. Neither the Depositary Shares nor the DECS are listed for
trading on any exchange or approved for trading with other market centers. The
Depositary Shares are eligible for trading in the Private Offerings, Resales and
Trading through Automatic Linkage ("Portal") Market.
 
PROSPECTIVE INVESTORS SHOULD CAREFULLY CONSIDER MATTERS DISCUSSED UNDER
"INVESTMENT CONSIDERATIONS".
 
                            ------------------------
 
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND
EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE COMMISSION
   OR ANY STATE SECURITIES COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY
      OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
                              CRIMINAL OFFENSE.
 
                            ------------------------
 
The date of this Prospectus is            , 1994.
<PAGE>   3
 
                             AVAILABLE INFORMATION
 
     The Company is subject to the informational requirements of the Securities
Exchange Act of 1934 (the "Exchange Act"), and in accordance therewith files
reports, proxy statements and other information with the Commission. Such
reports, proxy statements and other information can be inspected and copied at
the public reference facilities maintained by the Commission at Room 1024,
Judiciary Plaza, 450 Fifth Street, N.W., Washington, D.C., and at the
Commission's regional offices in New York (75 Park Place, New York, New York
10007) and in Chicago (Northwestern Atrium Center, Suite 1400, 500 West Madison
Street, Chicago, Illinois 60661). Copies of such materials can be obtained at
prescribed rates by writing to the Securities and Exchange Commission, Public
Reference Section, Judiciary Plaza, 450 Fifth Street, N.W., Washington, D.C.
20549. Such materials also can be inspected at the office of the New York Stock
Exchange (20 Broad Street, New York, New York 10005).
 
                INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
 
     The following documents heretofore filed with the Commission by the Company
(File No. 1-9776) are incorporated by reference in their entirety in this
Offering Memorandum:
 
          1. The Company's Annual Report on Form 10-K for the year ended
             December 31, 1993.
 
          2. The Company's Proxy Statement for the Annual Meeting to be held May
             18, 1994.
 
          3. The description of the Company's Common Stock, $.10 par value
             ("Common Stock") contained in the Company's Registration Statement
             on Form 8-B, dated August 3, 1990.
 
     All documents filed by the Company pursuant to Section 13(a), 13(c), 14 or
15(d) of the Exchange Act after the date of this Prospectus and prior to the
termination of the offering of the Securities shall be deemed to be incorporated
by reference in this Prospectus and to be a part of this Prospectus from the
date of filing of such documents. Any statement contained in a document
incorporated or deemed to be incorporated by reference in this Prospectus shall
be deemed to be modified or superseded for purposes of this Prospectus to the
extent that a statement contained herein or in any other subsequently filed
document which also is or is deemed to be incorporated by reference in this
Prospectus modifies or supersedes such statement. Any statement so modified or
superseded shall not be deemed, except as so modified or superseded, to
constitute a part of this Prospectus.
 
     The Company hereby undertakes to provide without charge to each person to
whom this Prospectus is delivered, upon the request of such person, a copy of
any or all of the documents referred to above, other than exhibits to such
documents unless such exhibits are specifically incorporated by reference herein
or in any incorporated document. Requests should be directed to United States
Surgical Corporation, Marianne Scipione, Vice President, Corporate
Communications, 150 Glover Avenue, Norwalk, Connecticut 06856 (telephone number:
(203) 845-1000).
 
                                        2
<PAGE>   4
 
                                  THE COMPANY
 
     United States Surgical Corporation (the "Company") is a Delaware
corporation primarily engaged in developing, manufacturing and marketing a
proprietary line of technologically advanced surgical wound management products
to hospitals throughout the world. (Prior to reincorporating in Delaware in
1990, the Company was a New York corporation which was organized in 1975 and was
the successor to a Maryland corporation activated in 1964.) The Company
currently operates domestically and internationally through subsidiaries,
branches and distributors. Except where the context otherwise requires, the term
Company includes the Company's divisions, subsidiaries, branches and
predecessors.
 
     The Company is the leading manufacturer and marketer of innovative
mechanical products for the wound closure market. Its principal products include
a series of surgical stapling instruments (both disposable and reusable),
disposable surgical clip appliers and presterilized disposable loading units for
use with stapling instruments. The Company's stapling instruments are an
alternative to manual suturing techniques and enable surgeons to reduce blood
loss, tissue trauma and operating time while joining internal tissue,
reconstructing or sealing off organs, removing diseased tissue, occluding blood
vessels and closing skin, either with titanium, stainless steel, or absorbable
POLYSURGICLIP(R) copolymer clips. Surgical stapling also makes possible several
surgical procedures which cannot be achieved with surgical needles and suturing
materials.
 
     The Company is also the leading manufacturer and marketer of specialized
wound management products designed for use in the rapidly growing field of
minimally invasive surgery. This surgical technique, also referred to as
endoscopic or laparoscopic surgery, requires incisions of up to one-half inch
and generally provides patients with significant reductions in post-operative
hospital stays, pain, recuperative time and hospital costs. Applications for
minimally invasive surgery include cholecystectomy (gallbladder removal),
hysterectomy, hernia repair, and various forms of bowel, stomach, gynecologic
and thoracic surgery. The Company's products in this area include a variety of
specialized surgical clip appliers and staplers, trocars (which provide entry
ports to the body for laparoscopic surgery) and a line of laparoscopic
instruments which allow surgeons to cut, clamp, retract or otherwise manipulate
tissue during laparoscopic procedures.
 
     Disposable instruments reduce the user's capital investment, eliminate the
cleaning, maintenance, sterilizing and repair required for reusable instruments,
and provide the surgeon with a new sterile instrument for each procedure,
offering more efficacious and safer practice for both patients and operating
room personnel.
 
     The Company also manufactures and markets a line of sutures, which was
introduced in 1991. The Company believes that sutures, which represent a major
portion of the wound closure market, are a natural complement to its other wound
management products. This market is currently dominated by other manufacturers.
The Company continued to expand its sutures line to enable it to compete
effectively with the full range of suture products currently offered in the
marketplace.
 
     The Company's executive offices are located at 150 Glover Avenue, Norwalk,
Connecticut 06856, and its telephone number is (203) 845-1000.
 
                                        3
<PAGE>   5
 
               SUMMARY DESCRIPTION OF DECS AND DEPOSITARY SHARES
 
SECURITIES......................   Depositary Shares, each such share
                                   representing a one-fiftieth interest in a
                                   share of DECS and entitling the holder to
                                   that proportion of all the rights,
                                   preferences, and privileges of a share of
                                   DECS (including dividend, voting, conversion,
                                   and liquidation rights and preferences)
                                   represented thereby, are offered hereby. The
                                   Depositary Shares mandatorily convert into
                                   shares of Common Stock on April 1, 1998 (the
                                   "Mandatory Conversion Date"), and the Company
                                   has the option to redeem the shares of DECS
                                   (and the related Depositary Shares), in whole
                                   or in part, on or after April 1, 1997 (the
                                   "Initial Redemption Date") and prior to the
                                   Mandatory Conversion Date, at the DECS Call
                                   Price (as defined herein) payable in shares
                                   of Common Stock, provided that the Current
                                   Market Price (as defined herein) of the
                                   Common Stock is greater than a defined amount
                                   described herein. In addition, the Depositary
                                   Shares are convertible at the option of the
                                   holder at any time prior to the Mandatory
                                   Conversion Date as set forth below.
 
DIVIDENDS.......................   Annual cumulative dividends accrue at a rate
                                   of $2.20 with respect to each Depositary
                                   Share (equivalent to a rate of $110.00 per
                                   annum for each share of DECS), from the date
                                   of initial issuance, payable quarterly in
                                   arrears on each January 1, April 1, July 1
                                   and October 1, commencing July 1, 1994. See
                                   "Description of DECS -- Dividends" and
                                   "Description of Depositary Shares -- 
                                   Dividends and Other Distributions".
 
MANDATORY CONVERSION............   On the Mandatory Conversion Date, unless
                                   previously redeemed or converted, each
                                   outstanding Depositary Share will mandatorily
                                   convert into (i) one share of Common Stock,
                                   subject to adjustment in certain events, and
                                   (ii) the right to receive cash in an amount
                                   equal to all accrued and unpaid dividends
                                   (other than previously declared dividends
                                   payable to a holder of record as of a prior
                                   date) with respect to such Depositary Share.
                                   See "Description of DECS -- Mandatory
                                   Conversion of DECS" and "Description of
                                   Depositary Shares -- Conversion and Call
                                   Provisions". The value of the Common Stock
                                   that may be received by holders of Depositary
                                   Shares upon their mandatory conversion may be
                                   more or less than the amount paid for the
                                   Depositary Shares offered hereby due to
                                   market fluctuations in the price of the
                                   Common Stock.
 
OPTIONAL REDEMPTION.............   Shares of DECS (and the related Depositary
                                   Shares) are not redeemable either (i) prior
                                   to the Initial Redemption Date or (ii) at any
                                   time on or after the Initial Redemption Date
                                   when the Current Market Price of the Common
                                   Stock is less than or equal to the sum of (x)
                                   the DECS Call Price and (y) the Additional
                                   Dividend (as defined herein) per Depositary
                                   Share. Subject to the foregoing, at any time
 
                                        4
<PAGE>   6
 
                                   and from time to time on or after the Initial
                                   Redemption Date, and ending immediately prior
                                   to the Mandatory Conversion Date, the Company
                                   may redeem any or all of the outstanding
                                   shares of DECS (and thereby the related
                                   Depositary Shares). Upon any such redemption,
                                   each holder of Depositary Shares will
                                   receive, in exchange for each Depositary
                                   Share so redeemed, an amount of Common Stock
                                   having an aggregate Current Market Price on
                                   the applicable date of determination equal to
                                   the closing price ($20.50) of the Common
                                   Stock on the New York Stock Exchange (the
                                   "NYSE") on the date of this Offering
                                   Memorandum (the "DECS Call Price"). Each
                                   holder of Depositary Shares will also receive
                                   an additional cash dividend (the "Additional
                                   Dividend") upon redemption by the Company in
                                   an amount initially equal to $0.55 for each
                                   share of Depository Shares, declining ratably
                                   after the Initial Redemption Date to $0 one
                                   month prior to the Mandatory Conversion Date,
                                   as set forth herein. See "Description of
                                   DECS -- Optional Redemption" and "Description
                                   of Depositary Shares -- Conversion and Call
                                   Provisions". The number of shares of Common
                                   Stock to be delivered upon redemption will be
                                   determined by dividing the DECS Call Price by
                                   the Current Market Price of the Common Stock
                                   prior to the announcement of the redemption,
                                   and the market price of the Common Stock may
                                   vary between the date of such determination
                                   and the subsequent delivery of such shares.
 
CONVERSION AT THE OPTION OF THE
  HOLDER........................   At any time prior to the Mandatory Conversion
                                   Date, unless previously redeemed, each
                                   Depositary Share is convertible at the option
                                   of the holder thereof into 0.953 of a share
                                   of Common Stock (the "Optional Conversion
                                   Rate"), equivalent to a conversion price of
                                   $21.50 per share of Common Stock (the
                                   "Conversion Price"), subject to adjustment as
                                   described below (such Optional Conversion
                                   Rate being equivalent to 47.65 shares of
                                   Common Stock for each share of DECS). The
                                   number of shares of Common Stock a holder
                                   will receive upon redemption, and the value
                                   of the shares received upon conversion, will
                                   vary depending on the market price of the
                                   Common Stock from time to time, all as set
                                   forth herein. The right of holders to convert
                                   shares of DECS called for redemption (and the
                                   related Depositary Shares) will terminate
                                   immediately prior to the close of business on
                                   the redemption date. See "Description of
                                   DECS -- Conversion at the Option of the
                                   Holder" and "Description of Depositary
                                   Shares -- Conversion and Call Provisions".
 
ENHANCED DIVIDEND YIELD,
  LESS EQUITY APPRECIATION
  THAN COMMON STOCK.............   Dividends will accrue on the Depositary
                                   Shares at a higher rate than the rate at
                                   which dividends are currently paid on the
                                   Common Stock. The opportunity for equity
                                   apprecia-
 
                                        5
<PAGE>   7
 
                                   tion afforded by an investment in the
                                   Depositary Shares may be less than that
                                   afforded by an investment in the Common Stock
                                   to the extent the Conversion Price is higher
                                   than the purchase price and the Company may,
                                   at its option, redeem the shares of DECS (and
                                   thereby the Depositary Shares) at any time on
                                   or after April 1, 1997, and prior to the
                                   Mandatory Conversion Date, and may do so if,
                                   among other circumstances, the applicable
                                   Current Market Price of the Common Stock
                                   exceeds the DECS Call Price plus the
                                   Additional Dividend per Depositary Share. In
                                   such event, a holder of a Depositary Share
                                   will receive less than one share of Common
                                   Stock. A holder may also surrender for
                                   conversion any Depositary Shares called for
                                   redemption up to the close of business on the
                                   redemption date, and a holder that so elects
                                   to convert will receive 0.953 of a share of
                                   Common Stock per Depositary Share. The value
                                   of Common Stock received by a holder of a
                                   Depositary Share may be more or less than the
                                   per share amount paid for the Depositary
                                   Shares offered hereby, due to market
                                   fluctuations in the price of Common Stock.
                                   See "Description of DECS -- Enhanced Dividend
                                   Yield, Less Equity Appreciation than Common
                                   Stock" and "Description of Depositary
                                   Shares".
 
VOTING RIGHTS...................   The holders of shares of DECS shall have the
                                   right with the holders of Common Stock to
                                   vote in the election of Directors and upon
                                   each other matter coming before any meeting
                                   of the holders of Common Stock on the basis
                                   of 0.95 of a vote for each Depositary Share
                                   held (equivalent to 47.50 votes for each
                                   share of DECS). On such matters, the holders
                                   of shares of DECS and the holders of Common
                                   Stock will vote together as one class except
                                   as otherwise provided by law. In addition,
                                   (i) whenever dividends on the shares of DECS
                                   or any other series of the Company's
                                   preferred stock (all series of which,
                                   including the shares of DECS, hereinafter are
                                   called the "Preferred Stock") shall be in
                                   arrears and unpaid for six quarterly dividend
                                   periods, and in certain other circumstances,
                                   the holders of the shares of DECS (voting
                                   separately as a class with holders of all
                                   other series of outstanding Preferred Stock
                                   upon which the voting rights have been
                                   conferred and are exercisable) will be
                                   entitled to vote, on the basis of one vote
                                   for each share of DECS (equivalent to
                                   one-fiftieth of a vote for each Depositary
                                   Share), for the election of two Preferred
                                   Stock Directors (as defined herein) of the
                                   Company, these Directors to be in addition to
                                   the number of Directors constituting the
                                   Board of Directors immediately prior to the
                                   accrual of such right, and (ii) the holders
                                   of the shares of DECS will have voting rights
                                   with respect to certain alterations of the
                                   Company's Certificate of Incorporation and
                                   certain other matters, voting on the same
                                   basis or separately as a series. The owners
                                   of Depositary Shares will be entitled to
                                   direct the
 
                                        6
<PAGE>   8
 
                                   voting of the shares of DECS represented
                                   thereby. See "Description of DECS -- Voting
                                   Rights", "Description of Depositary
                                   Shares -- Voting of DECS" and "Description of
                                   Capital Stock -- Common Stock".
 
LIQUIDATION PREFERENCE AND
  RANKING.......................   The shares of DECS will rank prior to the
                                   Common Stock as to payment of dividends and
                                   distributions of assets upon liquidation. The
                                   liquidation preference of each share of DECS
                                   is an amount equal to the sum of (i)
                                   $1,127.50, which is fifty times the offering
                                   price to investors per share shown on the
                                   cover page of this Offering Memorandum
                                   (equivalent to a liquidation preference per
                                   Depositary Share of $22.55) and (ii) all
                                   accrued and unpaid dividends thereon. See
                                   "Description of DECS -- Dividends" and
                                   "-- Liquidation Rights" and "Description of
                                   Depositary Shares".
 
REGISTRATION RIGHTS.............   The Company has agreed to file a shelf
                                   registration statement under the Securities
                                   Act relating to resales of the Depositary
                                   Shares and the Common Stock issuable upon
                                   conversion or redemption thereof. If such
                                   registration statement is not filed or
                                   declared effective within the time periods
                                   set forth herein, the dividend rate on the
                                   Depositary Shares will be temporarily or
                                   permanently increased in the manner described
                                   herein. This Prospectus is a part of the
                                   registration statement filed pursuant to the
                                   foregoing obligation of the Company. See
                                   "Description of Depositary
                                   Shares -- Registration Rights".
 
                                        7
<PAGE>   9
 
                           INVESTMENT CONSIDERATIONS
 
LEVERAGE
 
     After giving effect to the receipt of approximately $192 million of net
proceeds from the sale of the Depositary Shares, described above in "Issuance of
Resale Securities to Selling Stockholders", the Company's consolidated
indebtedness approximates 45% of the sum of its stockholders' equity and
consolidated indebtedness. This degree of leverage increases the Company's
vulnerability to adverse general economic and health care industry conditions
and to increased competitive pressures, including pricing pressure from better
capitalized competitors.
 
RECENT LOSSES; REDUCTION IN STOCKHOLDERS' EQUITY
 
     The Company reported a net loss of approximately $138.7 million for the
fiscal year ended December 31, 1993. This loss includes the effect of a total of
approximately $138 million ($130 million after-tax) in restructuring charges
incurred during that period. The Company expects to show a loss for the first
quarter of 1994. The Company's losses have reduced its stockholders' equity.
 
RECENT DEVELOPMENTS IN THE HEALTH CARE INDUSTRY
 
     Recent developments in the health care industry have had a significant
impact on the Company's performance. Significant uncertainty exists regarding
the impact that health care reforms proposed by the Clinton Administration or
others may have on the Company and its business. The primary trend in the health
care industry is toward cost containment. The increased use of managed care,
stricter review processes instituted by insurance companies and greater
supervision of doctors' referral patterns have resulted in a market in which
payors have greater leverage. In the context of an uncertain environment
concerning health care reform, pricing has become a more important factor in
purchasing decisions by hospitals. As a result, the Company's traditional
advantage of product superiority has been adversely impacted. This environment
has also slowed the rate of acceptance of newer techniques utilizing the
Company's products because of concerns about reimbursement. There can be no
assurance that the Company will not continue to be adversely affected by these
matters.
 
JUST-IN-TIME DISTRIBUTION
 
     The Company's sales have also been affected by the shifting since early
1993 of approximately 40% of the Company's domestic product distribution toward
third-party Just-In-Time ("JIT") distribution. This new distribution system
provides hospitals with an opportunity to reduce their inventories. These
inventory reductions have taken longer than anticipated and are expected to
result in a further significant loss of sales during the first quarter of 1994
as customer inventories are brought down to the desirable levels.
 
COMPETITION
 
     The medical device industry is highly competitive, and the Company competes
with manufacturers and marketers of medical devices (including surgical stapling
instruments, minimally invasive surgery products and sutures) that have greater
financial resources than the Company, including Johnson & Johnson and its
subsidiary, Ethicon, Inc. Competition in the markets served by the Company has
in the past resulted, and may in the future result, in losses of market share
and downward pressure on product pricing. Certain of the Company's competitors,
particularly Ethicon, have engaged in deep price discounting, especially in
aggressively pursuing evaluations of their products by hospitals, as compared to
those of the Company, for trial periods of various durations. The length of
these competitive evaluations may often extend from one to six months.
Regardless of the outcome of the evaluation, the Company loses revenues during
the evaluation period. In
 
                                        8
<PAGE>   10
 
addition, increased cost consciousness due to uncertainty over health care
reform has revived competition from reusable instruments.
 
REGULATION
 
     The Company's business is subject to varying degrees of governmental
regulation in the countries in which it operates. In the United States, the
Company's products are subject to regulation as medical devices by the Food and
Drug Administration ("FDA") and other federal and state agencies. These
regulations pertain to the manufacturing, labeling, development and testing of
the Company's products as well as to the maintenance of required records. An FDA
regulation also requires prompt reporting of an event or malfunction involving a
medical device where such device caused or contributed to death or serious
injury or may do so. Federal law provides for several alternatives by which the
FDA reviews medical devices prior to their entry into the marketplace. To date
all the Company's new products have been cleared by the FDA under the most
expedited form of pre-market review. The Company, and in the Company's belief,
the rest of the industry, has generally experienced longer FDA product approval
periods in 1992 and 1993 than in prior years. Timely product approval is
important to the Company's maintaining its technological competitive advantages.
The FDA has proposed additional procedures for obtaining regulatory approvals.
However, the extent, if any, to which any such additional procedures may affect
the Company can not be determined at this time.
 
     In other countries, the degree of government regulation affecting the
Company varies considerably among countries, ranging from stringent testing and
approval procedures in certain locations to simple registration procedures (or
no procedures at all) in others. In general, the Company has not encountered
material delays or regulatory impediments in marketing its products
internationally. Should establishment of uniform regulations for the European
Community occur, the Company believes it will be subject to a single regulatory
scheme for all the participating countries, but it anticipates that the process
generally may be more rigorous than certain of the multiple formats currently in
place.
 
ABSENCE OF PUBLIC MARKET FOR DEPOSITARY SHARES
 
     There can be no assurance as to the development or liquidity of any market
for the Depositary Shares and the DECS. The Depositary Shares are eligible for
trading in the Private Offerings, Resales and Trading through Automatic Linkage
("PORTAL") Market. The Depositary Shares may be expected to trade on the over
the counter market; the DECS are not expected to be separately traded but could
also be traded in the over the counter market.
 
   RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERRED STOCK DIVIDENDS
 
     The ratio of earnings to combined fixed charges and preferred stock
dividends of the Company, computed for each of the last five fiscal years and on
a proforma basis for the latest fiscal year, is as follows.
 
<TABLE>
<CAPTION>
                                           PRO-FORMA
                                           YEAR ENDED             YEARS ENDED DECEMBER 31,
                                          DECEMBER 31,     ---------------------------------------
                                              1993         1993    1992     1991     1990     1989
                                          ------------     ---     ----     ----     ----     ----
<S>                                       <C>              <C>     <C>      <C>      <C>      <C>
Ratio of earnings to combined fixed
 charges and preferred stock
 dividends..............................       (1)         (2)     7.43     7.51     5.56     4.59
</TABLE>
 
     The pro-forma calculation of the ratio of earnings to combined fixed
charges and preferred stock dividends assumes that the Company issued Depositary
Shares for approximately $200 million and received net proceeds from the sale of
$192 million which were used to repay long-term debt as of January 1, 1993.
However, the Company has not yet applied the proceeds to long-term debt and
there can be no assurance that such repayment will be accomplished.
 
                                        9
<PAGE>   11
 
- ---------------
(1) Earnings are inadequate to cover combined fixed charges and preferred stock
    dividends. The dollar amount of the pro-forma deficiency at December 31,
    1993 was $166.7 million. If the restructuring charges of $137.6 million were
    excluded from the calculation, the dollar amount of the pro-forma deficiency
    would have been $29.1 million.
 
(2) Earnings are inadequate to cover fixed charges. The dollar amount of the
    deficiency at December 31, 1993 is $146.9 million. If the restructuring
    charges of $137.6 million were excluded from the calculation, the dollar
    amount of the deficiency would have been $9.3 million.
 
                                USE OF PROCEEDS
 
     The Company will receive no proceeds from the sale of the Resale Securities
by the Selling Stockholders.
 
             ISSUANCE OF RESALE SECURITIES TO SELLING STOCKHOLDERS
 
     On March 28, 1994 the Company issued 177,400 shares of its Series A
Convertible Preferred Stock (convertible into a maximum of 8,870,000 shares of
the Company's Common Stock), par value $5 per share, represented by 8,870,000
Depositary Shares, in an offering exempt from registration under the Securities
Act at an offering price of $22.50 per Depositary Share.
 
                              SELLING STOCKHOLDERS
 
     The following table sets forth certain information as of April   , 1994
with respect to the Selling Stockholders:
 
<TABLE>
<CAPTION>
                                                                             
                                                                             
                                                                             
                                        SHARES OF          
                                      COMMON STOCK                                SHARES OF COMMON
                                      BENEFICIALLY                               STOCK BENEFICIALLY
                                     OWNED PRIOR TO             SHARES             OWNED AFTER THE
   NAME OF SELLING STOCKHOLDER       THE OFFERING(1)       OFFERED HEREBY(2)      OFFERING(1)(2)(3)
- ---------------------------------  -------------------     -----------------     -------------------
                                   NUMBER      PERCENT                           NUMBER      PERCENT
                                   -------     -------                           -------     -------
<S>                                <C>         <C>         <C>                   <C>         <C>
</TABLE>
 
- ---------------
(1) Information with respect to beneficial ownership is based upon information
    contained in filings made with the Commission, as modified by the Company to
    reflect the issuance of the Depositary Shares in March 1994 and information
    obtained from the Selling Stockholders.
 
(2) Depositary Shares, and the maximum number of shares of Common Stock to be
    issued on redemption or conversion of the Depositary Shares, as described
    herein.
 
(3) Assumes sale of all Resale Securities offered hereby and no other purchases
    or sales of Depositary Shares or Common Stock. See "Plan of Distribution."
 
     The Company and the Selling Stockholders have agreed to indemnify each
other against certain civil liabilities under the Securities Act.
 
                              PLAN OF DISTRIBUTION
 
     The Resale Securities may be sold from time to time to purchasers directly
by any of the Selling Stockholders, including sales into the market.
Alternatively, the Selling Stockholders may from time to time offer the Resale
Securities through underwriters, dealers or agents who may receive
 
                                       10
<PAGE>   12
 
compensation in the form of underwriting discounts, concessions or commissions
from the Selling Stockholders or the purchasers of the Resale Securities. The
Selling Stockholders and any underwriters, dealers or agents that participate in
the distribution of the Resale Securities may be deemed to be underwriters. The
Company, however, understands that the Selling Stockholders do not admit that
they are underwriters within the meaning of the Securities Act. The Selling
Stockholders and any such underwriters, dealers, and agents may be entitled to
indemnification against certain liabilities, including liabilities under the
Securities Act, or be entitled to contributions as to payments they may be
required to make in respect thereof.
 
     The Company will pay all of the expenses incident to the registration of
the Resale Securities to the public, except for underwriters' discounts or
commissions, if any.
 
     If the Resale Securities are sold through underwriters, dealers, or agents,
a Prospectus Supplement will name such underwriters, dealers, or agents and
describe the arrangements therewith.
 
                                       11
<PAGE>   13
 
                              DESCRIPTION OF DECS
 
     The summary contained herein of the terms of shares of DECS, including
those terms applicable to shares of Preferred Stock, does not purport to be
complete and is subject to and qualified in its entirety by reference to all of
the provisions of the Company's Certificate of Incorporation and form of
Certificate of Designation relating to the shares of DECS (the "Certificate of
Designation"), a copy of which Certificate of Designation has been filed with
the Registration Statement of which this Prospectus is a part.
 
     Each of the Depositary Shares represents beneficial ownership of
one-fiftieth of a share of DECS and entitles the owner to that proportion of all
the rights, preferences and privileges of the share of DECS represented thereby.
See "Description of Depositary Shares".
 
DIVIDENDS
 
     Holders of record of the shares of DECS (and thereby holders of Depositary
Shares) shall be entitled to receive, when, as and if declared by the Board of
Directors out of funds legally available therefor, cash dividends from the date
of initial issuance of the shares of DECS at the rate of $110.00 per annum or
$27.50 per quarter (equivalent to a rate of $2.20 per annum or $0.55 per quarter
for each Depositary Share), payable quarterly in arrears on January 1, April 1,
July 1 and October 1 or, if any such date is not a business day, on the next
succeeding business day. The first dividend period will be from the date of
initial issuance of the shares of DECS to, but excluding, July 1, 1994, and will
be payable on such date. Dividends will cease to accrue on the shares of DECS on
the Mandatory Conversion Date or on the date of their earlier conversion or
redemption. Dividends will be payable to holders of record of shares of DECS as
they appear on the stock register of the Company on record dates not less than
15 nor more than 60 days preceding the payment date thereof, as shall be fixed
by the Board of Directors. Dividends payable on shares of DECS for any period
less than a full quarterly dividend period will be computed on the basis of a
360-day year of twelve 30-day months and the actual number of days elapsed in
any period less than one month.
 
     Dividends on shares of DECS shall accrue whether or not there are funds
legally available for the payment of such dividends and whether or not such
dividends are declared. Accrued but unpaid dividends on shares of DECS shall
cumulate as of the dividend payment date on which they first become payable, but
no interest shall accrue on accumulated but unpaid dividends on shares of DECS.
 
     The shares of DECS will rank on a parity, both as to payment of dividends
and distribution of assets upon liquidation, with any Preferred Stock issued in
the future by the Company that by its terms ranks pari passu with the shares of
DECS.
 
     As long as any shares of DECS are outstanding, no dividends (other than
dividends payable in shares of, or warrants, rights or options exercisable for
or convertible into shares of, any capital stock, including, without limitation,
the Common Stock, of the Company ranking junior to the shares of DECS as to the
payment of dividends and the distribution of assets upon liquidation
(collectively "Junior Stock") and cash in lieu of fractional shares in
connection with any such dividend) will be paid or declared in cash or
otherwise, nor will any other distribution be made (other than a distribution
payable in Junior Stock and cash in lieu of fractional shares in connection with
any such distribution), on any Junior Stock unless: (i) full dividends on
Preferred Stock that does not constitute Junior Stock ("Parity Preferred Stock")
have been paid, or declared and set aside for payment, for all dividend periods
terminating on or prior to the date of such Junior Stock dividend or
distribution payment to the extent such dividends are cumulative; (ii) dividends
in full for the current quarterly dividend period have been paid, or declared
and set aside for payment, on all Parity Preferred Stock to the extent such
dividends are cumulative; (iii) the Company has paid or set aside all amounts,
if any, then or theretofore required to be paid or set aside for all purchase,
retirement, and sinking funds, if any, for any Parity Preferred Stock; and (iv)
the Company is not in default on any of its obligations to redeem any Parity
Preferred Stock.
 
                                       12
<PAGE>   14
 
     In addition, as long as any shares of DECS are outstanding, no shares of
any Junior Stock may be purchased, redeemed or otherwise acquired by the Company
or any of its subsidiaries (except in connection with a reclassification or
exchange of any Junior Stock through the issuance of other Junior Stock (and
cash in lieu of fractional shares in connection therewith) or the purchase,
redemption or other acquisition of any Junior Stock with any Junior Stock (and
cash in lieu of fractional shares in connection therewith)) nor may any funds be
set aside or made available for any sinking fund for the purchase, redemption or
acquisition of any Junior Stock unless: (i) full dividends on Parity Preferred
Stock have been paid, or declared and set aside for payment, for all dividend
periods terminating on or prior to the date of such purchase, redemption,
acquisition, setting aside or making available to the extent such dividends are
cumulative; (ii) dividends in full for the current quarterly dividend period
have been paid, or declared and set aside for payment, on all Parity Preferred
Stock to the extent such dividends are cumulative; (iii) the Company has paid or
set aside all amounts, if any, then or theretofore required to be paid or set
aside for all purchase, retirement, and sinking funds, if any, for any Parity
Preferred Stock; and (iv) the Company is not in default on any of its
obligations to redeem any Parity Preferred Stock.
 
     Subject to the provisions described above, such dividends or other
distributions (payable in cash, property, or Junior Stock) as may be determined
by the Board of Directors may be declared and paid on shares of any Junior Stock
from time to time and Junior Stock may be purchased, redeemed or otherwise
acquired by the Company or any of its subsidiaries, and funds may be set aside
or made available for that purpose, from time to time. In the event of the
declaration and payment of any such dividends or other distributions, the
holders of such Junior Stock will be entitled, to the exclusion of holders of
the Parity Preferred Stock, to share therein according to their respective
interests.
 
     As long as any shares of DECS are outstanding, dividends or other
distributions may not be declared or paid on any Parity Preferred Stock (other
than dividends or other distributions payable in Junior Stock and cash in lieu
of fractional shares in connection therewith), and the Company may not purchase,
redeem or otherwise acquire any Parity Preferred Stock (except with any Junior
Stock and cash in lieu of fractional shares in connection therewith and except
with the right, subject to clause (b) of this paragraph and any similar
requirement of any other Preferred Stock, to receive accrued and unpaid
dividends), unless either: (a)(i) full dividends on Parity Preferred Stock have
been paid, or declared and set aside for payment, for all dividend periods
terminating on or prior to the date of such Parity Preferred Stock dividend,
distribution, redemption, purchase or acquisition payment to the extent such
dividends are cumulative; (ii) dividends in full for the current quarterly
dividend period have been paid, or declared and set aside for payment, on all
Parity Preferred Stock to the extent such dividends are cumulative; (iii) the
Company has paid or set aside all amounts, if any, then or theretofore required
to be paid or set aside for all purchase, retirement, and sinking funds, if any,
for any Parity Preferred Stock; and (iv) the Company is not in default on any of
its obligations to redeem any Parity Preferred Stock; or (b) with respect to the
declaration and payment of dividends only, any such dividends are declared and
paid pro rata so that the amounts of any dividends declared and paid per share
of DECS and each other share of Parity Preferred Stock will in all cases bear to
each other the same ratio that accrued and unpaid dividends (including any
accumulation with respect to unpaid dividends for prior dividend periods, if
such dividends are cumulative) per share of DECS and such other share of Parity
Preferred Stock bear to each other.
 
MANDATORY CONVERSION OF DECS
 
     Unless previously redeemed or voluntarily converted into Common Stock, as
hereinafter described, on the Mandatory Conversion Date each outstanding share
of DECS will mandatorily convert into (i) shares of Common Stock at the DECS
Common Equivalent Rate (as defined herein) in effect on such date and (ii) the
right to receive cash in an amount equal to all accrued and unpaid dividends on
such share of DECS (other than previously declared dividends payable to a holder
of record as of a prior date) to the Mandatory Conversion Date, whether or not
declared, out
 
                                       13
<PAGE>   15
 
of funds legally available for the payment of dividends, subject to the
requirement set forth in clause (b) in the immediately preceding paragraph and
any similar requirement of any other Preferred Stock. The "DECS Common
Equivalent Rate" is initially fifty shares of Common Stock for each share of
DECS (equivalent to one share of Common Stock for each Depositary Share (the
"Common Equivalent Rate")) and is subject to adjustment as described below.
Dividends will cease to accrue on the Mandatory Conversion Date in respect of
the shares of DECS then outstanding.
 
     Because the price of the Common Stock is subject to market fluctuations,
the value of the Common Stock that may be received by holders of shares of DECS
upon their mandatory conversion may be more or less than the amount paid for the
shares of DECS offered hereby.
 
OPTIONAL REDEMPTION
 
     Shares of DECS (and thereby the Depositary Shares) are not redeemable by
the Company either (i) prior to the Initial Redemption Date or (ii) at any time
on or after the Initial Redemption Date when the Current Market Price of the
Common Stock is less than or equal to the sum of (x) the DECS Call Price and (y)
the Additional Dividend (as defined herein) per Depositary Share. Subject to the
foregoing, at any time and from time to time until immediately prior to the
Mandatory Conversion Date, the Company will have the right to redeem, in whole
or in part, the outstanding shares of DECS (and thereby the related Depositary
Shares). Upon any such redemption, the Company will deliver to the holder
thereof, in exchange for each share of DECS subject to redemption, (i) an amount
of Common Stock having an aggregate Current Market Price equal to the DECS Call
Price (the number of shares of which is equal to the DECS Call Price divided by
the Current Market Price of the Common Stock) determined as of the date which is
two trading days prior to the Notice Date (as defined herein), multiplied by the
DECS Common Equivalent Rate, (ii) all accrued and unpaid dividends thereon and
(iii) the Additional Dividend payable thereon. Dividends will cease to accrue on
the shares of DECS on the date fixed for their redemption.
 
     The "Additional Dividend" is an additional cash dividend payable on each
share of DECS only upon redemption by the Company in an amount equal to $27.50
($0.55 per Depository Share) on or after April 1, 1997; $20.625 ($0.4125 per
Depository Share) on or after July 1, 1997; $13.75 ($0.275 per Depository Share)
on or after October 1, 1997; $6.875 ($0.1375 per Depository Share) on or after
January 1, 1998; or $0 ($0 per Depositary Share) on or after March 1, 1998. The
"Current Market Price" per share of the Common Stock on any date of
determination means the lesser of (x) the average of the closing sale prices of
the Common Stock as reported on the NYSE for the 15 consecutive trading days
ending on and including such date of determination or (y) the closing sale price
of the Common Stock as reported on the NYSE for such date of determination;
provided, however, that, with respect to any redemption of shares of DECS, if
any event that results in an adjustment of the DECS Common Equivalent Rate
occurs during the period on the first day of such 15-day period and ending on
the applicable redemption date, the Current Market Price as determined pursuant
to the foregoing will be appropriately adjusted to reflect the occurrence of
such event. The "Notice Date" with respect to any notice given by the Company in
connection with a redemption of shares of DECS means the date on which first
occurs either the public announcement of such call for redemption or the
commencement of mailing of such notice to holders of shares of DECS.
 
     If fewer than all the outstanding shares of DECS are to be called for
redemption, shares of DECS to be called will be selected by the Company from
outstanding shares of DECS not previously called by lot or pro rata (as nearly
as may be) or by any other method determined by the Board of Directors in its
sole discretion to be equitable.
 
     The Company will provide notice of any call for redemption of shares of
DECS to holders of record of the shares of DECS to be called for redemption not
less than 15 nor more than 60 days prior to the date fixed for redemption.
Accordingly, the earliest mailing of notice of any call for redemption of shares
of DECS will be February 1, 1997. Any such notice will be provided by mail,
 
                                       14
<PAGE>   16
 
sent to the holders of record of the shares of DECS to be called for redemption
at such holder's address as it appears on the stock register of the Company,
first class postage paid; provided, however, that failure to give such notice or
any defect therein shall not affect the validity of the proceeding for
redemption of any shares of DECS to be redeemed except as to a holder to whom
the Company has failed to give said notice or whose notice was defective. On and
after the redemption date, all rights of the holders of the shares of DECS
called for redemption shall terminate except the right to receive the redemption
price (unless the Company defaults on the payment of the redemption price). A
public announcement of any call for redemption will be made by the Company prior
to, or at the time of, the mailing of such notice of redemption.
 
     Each holder of shares of DECS called for redemption must surrender the
certificates evidencing such shares of DECS to the Company at the place and in
the manner designated in the notice of redemption and will thereupon be entitled
to receive certificates for shares of Common Stock and cash for any fractional
share amount.
 
     The Depositary Shares are subject to call upon substantially identical
terms and conditions (including those as to notice to the owners of Depositary
Shares) as the shares of DECS, adjusted to reflect the fact that fifty
Depositary Shares represent one share of DECS. See "Description of Depositary
Shares -- Conversion and Call Provisions".
 
CONVERSION AT THE OPTION OF THE HOLDER
 
     The shares of DECS (and thereby the Depositary Shares) are convertible, in
whole or in part, at the option of the holders thereof, at any time prior to the
Mandatory Conversion Date, unless previously redeemed, into shares of Common
Stock at a rate of 47.65 shares of Common Stock for each share of DECS (the
"DECS Optional Conversion Rate") (or a rate of 0.953 shares of Common Stock for
each Depositary Share) equivalent, for each Depositary Share, to a conversion
price of $21.50 per share of Common Stock (the "DECS Conversion Price"), subject
to adjustment as described below. The right to convert shares of DECS called for
redemption will terminate immediately prior to the close of business on any
redemption date with respect to such shares.
 
     Conversion of shares of DECS at the option of the holder may be effected by
delivering certificates evidencing such shares of DECS, together with written
notice of conversion and proper assignment of such certificates to the Company
or in blank (and, if applicable, cash payment of an amount equal to the dividend
attributable to the current quarterly dividend period payable on such shares),
to the office of any transfer agent for shares of DECS or to any other office or
agency maintained by the Company for that purpose and otherwise in accordance
with conversion procedures established by the Company. Each optional conversion
shall be deemed to have been effected immediately prior to the close of business
on the date on which the foregoing requirements shall have been satisfied. The
conversion shall be at the DECS Optional Conversion Rate in effect at such time
on such date.
 
     Holders of shares of DECS at the close of business on a record date for any
payment of declared dividends will be entitled to receive the dividend payable
on such shares of DECS on the corresponding dividend payment date
notwithstanding the optional conversion of such shares of DECS following such
record date and prior to such dividend payment date. However, shares of DECS
surrendered for optional conversion after the close of business on a record date
for any payment of declared dividends and before the opening of business on the
next succeeding dividend payment date must be accompanied by payment in cash of
an amount equal to the dividend attributable to the current quarterly dividend
period payable on such date (unless such shares of DECS are subject to
redemption on a redemption date subsequent to such record date and prior to or
on such dividend payment date). Except as provided above, upon any optional
conversion of shares of DECS, the Company will make no payment of or allowance
for unpaid dividends, whether or not in arrears, on such shares of DECS or
previously declared dividends or distributions on the shares of Common Stock
issued upon such conversion.
 
                                       15
<PAGE>   17
 
     The Depositary Shares may be voluntarily converted by the holders thereof
upon the same terms and conditions (including those as to notice) as the shares
of DECS represented by such Depositary Shares, adjusted to reflect the fact that
fifty Depositary Shares represent one share of DECS. See "Description of
Depositary Shares -- Conversion and Call Provisions".
 
ENHANCED DIVIDEND YIELD, LESS EQUITY APPRECIATION THAN COMMON STOCK
 
     Dividends will accrue on the shares of DECS (and thereby on the Depositary
Shares) at a higher rate than the rate at which dividends are currently paid on
the Common Stock. The opportunity for equity appreciation afforded by an
investment in shares of DECS is less than that afforded by an investment in the
Common Stock because the DECS Conversion Price is higher than the closing price
of Common Stock on the NYSE on the date of this Offering Memorandum and the
Company may, at its option, redeem the shares of DECS at any time on or after
the Initial Redemption Date and prior to the Mandatory Conversion Date, and may
do so, among other circumstances, if the applicable Current Market Price of the
Common Stock exceeds the DECS Call Price. In such event, a holder of a share of
DECS will receive fewer than fifty shares of Common Stock (comparable to less
than one share of Common Stock for each Depositary Share) upon such redemption.
A holder may also surrender for conversion any shares of DECS called for
redemption up to the close of business on the redemption date, and a holder that
so elects to convert will receive 47.65 shares of Common Stock per share of DECS
(or 0.953 of a share of Common Stock per Depositary Share). The value of shares
of Common Stock received by holders of shares of DECS upon mandatory conversion
may be more or less than the amount paid for the shares of DECS offered hereby,
due to market fluctuations in the price of the Common Stock.
 
     As a result of these provisions, holders of shares of DECS would be
expected to realize no equity appreciation if the market price of Common Stock
is below the DECS Conversion Price, and less than all of such appreciation if
the market price of Common Stock is above the DECS Conversion Price. Holders of
shares of DECS will realize the entire decline in equity value if the market
price of the Common Stock is less than one-fiftieth of the price paid for a
share of DECS.
 
CONVERSION ADJUSTMENTS
 
     The DECS Common Equivalent Rate and the DECS Optional Conversion Rate are
each subject to adjustment as appropriate in certain circumstances, including if
the Company shall (a) pay or make a dividend or other distribution with respect
to its Common Stock in shares of Common Stock, (b) issue by reclassification of
its shares of Common Stock any shares of Common Stock, (c) subdivide or split
its outstanding Common Stock into a greater number of shares, (d) combine its
outstanding Common Stock into a lesser number of shares, (e) issue certain
rights or warrants to all holders of its Common Stock, or (f) pay a dividend or
make a distribution to all holders of its Common Stock in the form of evidences
of its indebtedness, cash or other assets (including capital stock of the
Company other than Common Stock but excluding any cash dividends or
distributions, other than "Extraordinary Cash Distributions", and dividends
referred to in clause (a) above). In addition, the Company will be entitled (but
shall not be required) to make such upward adjustments in the DECS Common
Equivalent Rate and the DECS Optional Conversion Rate or the DECS Call Price as
the Company, in its sole discretion, shall determine to be advisable, in order
that any stock dividend, subdivision of stock, distribution of rights to
purchase stock or securities, or distribution of securities convertible into or
exchangeable for stock (or any transaction that could be treated as any of the
foregoing transactions pursuant to Section 305 of the Internal Revenue Code of
1986, as amended, or any successor provision) hereafter made by the Company to
its stockholders will not be taxable in whole or in part. "Extraordinary Cash
Distribution" means the portion of any cash dividend or cash distribution on the
Common Stock that, when added to all other cash dividends and cash distributions
on the Common Stock made during the immediately preceding 12-month period (other
than cash dividends and cash distributions for which a prior adjustment to the
DECS Common Equivalent Rate and the DECS Optional Rate was previously made)
exceeds, on a per share of Common Stock basis, 10 percent of the average daily
closing price of the Common Stock
 
                                       16
<PAGE>   18
 
over such 12-month period. All adjustments to the DECS Common Equivalent Rate
and the DECS Optional Conversion Rate will be calculated to the nearest 1/100th
of a share of Common Stock. No adjustment in the DECS Common Equivalent Rate or
the DECS Optional Conversion Rate will be required unless such adjustment would
require an increase or decrease of at least one percent in the DECS Common
Equivalent Rate, provided, however, that any adjustments which, by reason of the
foregoing, are not required to be made shall be carried forward and taken into
account in any subsequent adjustment. All adjustments will be made successively.
 
     Whenever the DECS Common Equivalent Rate and the DECS Optional Conversion
Rate are adjusted as provided in the preceding paragraph, the Company will file
with each transfer agent for the shares of DECS a certificate with respect to
such adjustment, make a prompt public announcement thereof and mail a notice to
holder of the shares of DECS providing specified information with respect to
such adjustment. At least 10 business days prior to certain specified actions
that could result in certain adjustments in the DECS Common Equivalent Rate and
the DECS Optional Conversion Rate, the Company will notify each holder of shares
of DECS concerning such proposed action.
 
ADJUSTMENT FOR CERTAIN CONSOLIDATIONS OR MERGERS
 
     In case of any consolidation or merger to which the Company is a party
(other than a merger or consolidation in which the Company is the surviving or
continuing corporation and in which each share of Common Stock outstanding
immediately prior to the merger or consolidation remains unchanged in all
material respects), or in case of any sale or transfer to another corporation of
the property of the Company as an entirety or substantially as an entirety, or
in case of any statutory exchange of securities with another corporation (other
than in connection with a merger or acquisition), each share of DECS shall,
after consummation of such transaction, be subject to (i) conversion at the
option of the holder into the kind and amount of securities, cash, or other
property receivable upon consummation of such transaction by a holder of the
number of shares of Common Stock into which such share of DECS might have been
converted immediately prior to consummation of such transaction, (ii) conversion
on the Mandatory Conversion Date into the kind and amount of securities, cash,
or other property receivable upon consummation of such transaction by a holder
of the number of shares of Common Stock into which such share of DECS would have
been converted if the conversion on the Mandatory Conversion Date had occurred
immediately prior to the date of consummation of such transaction, plus the
right, subject to the rights of other Preferred Stock, to receive cash in an
amount equal to all accrued and unpaid dividends on such share of DECS (other
than previously declared dividends payable to a holder of record as of a prior
date), and (iii) redemption on any redemption date in exchange for the kind and
amount of securities, cash, or other property receivable upon consummation of
such transaction by a holder of the number of shares of Common Stock that would
have been issuable, using the DECS Call Price in effect on such redemption date,
upon a redemption of such share of DECS immediately prior to consummation of
such transaction, assuming that, if the Notice Date for such Redemption is not
prior to such transaction, the Notice Date had been the date of such
transaction; and assuming in each case that such holder of shares of Common
Stock failed to exercise rights of election, if any, as to the kind or amount of
securities, cash, or other property receivable upon consummation of such
transaction (provided that, if the kind or amount of securities, cash or other
property receivable upon consummation of such transaction is not the same for
each non-electing share, then the kind and amount of securities, cash or other
property receivable upon consummation of such transaction for each non-electing
share shall be deemed to be the kind and amount so receivable per share by a
plurality of the non-electing shares). The kind and amount of securities into or
for which the shares of DECS shall be convertible or redeemable after
consummation of such transaction shall be subject to adjustment as described
above under the caption "Conversion Adjustments" following the date of
consummation of such transaction. The Company may not become a party to any such
transaction unless the terms thereof are consistent with the foregoing.
 
                                       17
<PAGE>   19
 
FRACTIONAL SHARES
 
     No fractional shares of Common Stock will be issued upon redemption or
conversion of shares of DECS. In lieu of any fractional share otherwise issuable
in respect of the aggregate number of shares of DECS of any holder that are
redeemed or converted on any redemption date or upon mandatory conversion or any
optional conversion, such holder shall be entitled to receive an amount in cash
equal to the same fraction of the (i) Current Market Price of the Common Stock
in the case of redemption, or (ii) Closing Price (as defined in the Certificate
of Designation) of the Common Stock determined (A) as of the fifth trading day
immediately preceding the Mandatory Conversion Date, in the case of mandatory
conversion, or (B) as of the second trading day immediately preceding the
effective date of conversion, in the case of an optional conversion by a holder.
If more than one share of DECS shall be surrendered for conversion or redemption
at one time by or for the same holder, the number of shares of Common Stock
issuable upon conversion or redemption thereof shall be computed on the basis of
the aggregate number of shares of DECS so converted or redeemed.
 
LIQUIDATION RIGHTS
 
     In the event of any voluntary or involuntary liquidation, dissolution, or
winding up of the Company, and subject to the rights of holders of any other
series of Preferred Stock, the holders of outstanding shares of DECS are
entitled to receive an amount equal to the per share price to investors of the
shares of DECS (equivalent to an amount equal to 50 times the per share price to
investors of each Depositary Share shown on the cover page of this Offering
Memorandum) plus accrued and unpaid dividends thereon, out of the assets of the
Company available for distribution to stockholders, before any distribution of
assets is made to holders of Junior Stock upon liquidation, dissolution or
winding up.
 
     If upon any voluntary or involuntary liquidation, dissolution, or winding
up of the Company, the assets of the Company are insufficient to permit the
payment of the full preferential amounts payable with respect to shares of DECS
and all other series of Parity Preferred Stock, the holders of shares of DECS
and of all other series of Parity Preferred Stock will share ratably in any
distribution of assets of the Company in proportion to the full respective
preferential amounts to which they are entitled. After payment of the full
amount of the liquidating distribution to which they are entitled, the holders
of shares of DECS will not be entitled to any further participation in any
distribution of assets by the Company. A consolidation or merger of the Company
with one or more corporations or a sale or transfer of substantially all of the
assets of the Company shall not be deemed to be a liquidation, dissolution or
winding up of the Company.
 
VOTING RIGHTS
 
     The holders of shares of DECS shall have the right with the holders of
Common Stock to vote in the election of Directors and upon each other matter
coming before any meeting of the holders of Common Stock on the basis of 47.50
votes for each share of DECS held (equivalent to 0.95 of a vote for each
Depositary Share). The holders of shares of DECS and the holders of Common Stock
will vote together as one class on such matters except as otherwise provided by
law or the Certificate of Incorporation of the Company.
 
     In the event that dividends on the shares of DECS or any other series of
Preferred Stock shall be in arrears and unpaid for six quarterly dividend
periods, or of any other series of Preferred Stock shall be entitled for any
other reason to exercise voting rights, separate from the Common Stock, to elect
any Directors of the Company ("Preferred Stock Directors"), the holders of the
shares of DECS (voting separately as a class with holders of all other series of
Preferred Stock upon which like voting rights have been conferred and are
exercisable), with each share of DECS entitled to one vote (equivalent to
one-fiftieth of a vote for each Depositary Share) on this and other matters in
which Preferred Stock votes as a group, will be entitled to vote for the
election of two Preferred Stock Directors, such Directors to be in addition to
the number of Directors constituting the Board of Directors immediately prior to
the accrual of such right. Such right, when vested, shall continue until
 
                                       18
<PAGE>   20
 
all dividends in arrears on the shares of DECS and such other series of
Preferred Stock shall have been paid in full and the right of any other series
of Preferred Stock to exercise voting rights, separate from the Common Stock, to
elect any Preferred Stock Directors shall terminate or have terminated, and,
when so paid and such termination occurs or has occurred, such right of the
holders of the shares of DECS shall cease. Upon any termination of the aforesaid
voting right, subject to the requirements of the Delaware corporation law and
the Certificate of Incorporation of the Company, such Preferred Stock Directors
shall cease to be Directors of the Company and shall resign.
 
     The Company will not, without the approval of the holders of at least
66 2/3 percent of all the shares of DECS then outstanding: (i) amend, alter, or
repeal any of the provisions of the Certificate of Incorporation or the By-laws
of the Company so as to affect adversely the powers, preferences, or rights of
the holders of the shares of DECS then outstanding or reduce the minimum time
required for any notice to which only the holders of the shares of DECS then
outstanding may be entitled (an amendment of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of or to issue, Junior
Stock, Preferred Stock ranking on parity with the shares of DECS or any stock of
any class ranking on parity with the shares of DECS shall be deemed not to
affect adversely the powers, preferences, or rights of the holders of the shares
of DECS); (ii) create any series of Preferred Stock ranking prior to the shares
of DECS as to payment of dividends or the distribution of assets upon
liquidation; (iii) authorize or create, or increase the authorized amount of,
any capital stock, or any security convertible into capital stock, of any class
ranking prior to the shares of DECS as to payment of dividends or the
distribution of assets upon liquidation; or (iv) merge or consolidate with or
into any other corporation, unless each holder of the shares of DECS immediately
preceding such merger or consolidation shall receive or continue to hold in the
resulting corporation the same number of shares, with substantially the same
rights and preferences, as correspond to the shares of DECS so held.
 
     Notwithstanding the provisions summarized in the preceding paragraph,
however, no such approval described therein of the holders of the shares of DECS
shall be required if, at or prior to the time when such amendment, alteration,
or repeal is to take effect or when the authorization, creation or increase of
any such prior or parity stock or such other stock or security is to be made, or
when such consolidation or merger is to take effect, as the case may be,
provision is made for the redemption of all shares of DECS at the time
outstanding.
 
TRANSFER AGENT AND REGISTRAR
 
     First Chicago Trust Company of New York is the transfer agent and registrar
for, and paying agent for the payment of dividends on, shares of DECS and the
Depositary Shares. First Chicago Trust Company of New York maintains a New York
drop facility.
 
MISCELLANEOUS
 
     Upon issuance, the shares of DECS will be fully paid and nonassessable.
Holders of shares of DECS have no preemptive rights. The Company shall at all
times reserve and keep available out of its authorized and unissued Common
Stock, solely for issuance upon the conversion or redemption of shares of DECS,
such number of shares of Common Stock as shall from time to time be issuable
upon the conversion or redemption of all the shares of DECS then outstanding.
Shares of DECS redeemed for, or converted into, Common Stock of the Company or
otherwise acquired by the Company shall resume the status of authorized and
unissued shares of Preferred Stock, undesignated as to series, and shall be
available for subsequent issuance.
 
                                       19
<PAGE>   21
 
                        DESCRIPTION OF DEPOSITARY SHARES
 
     The following summary of the terms and provisions of the Depositary Shares
does not purport to be complete and is subject to, and qualified in its entirety
by, the Deposit Agreement, as defined below (which contains the form of the
Depositary Receipt, as defined below).
 
     Each Depositary Share represents one-fiftieth of a share of DECS deposited
under a Deposit Agreement dated as of March 28, 1994 (the "Deposit Agreement"),
among the Company, First Chicago Trust Company of New York, as depositary
(including any successor, the "Depositary"), and the holders from time to time
of depositary receipts executed and delivered thereunder (the "Depositary
Receipts"). Subject to the terms of the Deposit Agreement, each owner of a
Depositary Share is entitled, proportionately, to all the rights, preferences
and privileges of the shares of DECS represented thereby (including dividend,
voting, conversion, and liquidation rights), and subject to all of the
limitations of the shares of DECS represented thereby, contained in the
Certificate of Designations and summarized under "Description of DECS". The
principal executive office of First Chicago Trust Company of New York is located
at 30 West Broadway, New York, New York 10007.
 
     The Depositary Shares are evidenced by Depositary Receipts. Copies of the
Deposit Agreement, the form of which has been filed with the Registration
Statement of which this Prospectus is a part, are available for inspection at
the office of the Depositary listed above.
 
EXECUTION AND DELIVERY OF DEPOSITARY RECEIPTS
 
     Following the issuance of the shares of DECS by the Company to the Initial
Purchaser, the shares of DECS were deposited by the Initial Purchaser, or on
their behalf, with the Depositary, which executed and delivered the Depositary
Receipts to the Initial Purchaser. Depositary Receipts will be executed and
delivered evidencing only whole Depositary Shares.
 
WITHDRAWAL OF DECS
 
     Upon surrender of Depositary Receipts at the Corporate Office of the
Depositary, the owner of the Depositary Shares evidenced thereby is entitled to
delivery at such office of certificates evidencing the number of shares of DECS
(but only in whole shares of DECS) represented by such Depositary Receipts. If
the Depositary Receipts delivered by the holder evidence a number of Depositary
Shares in excess of the number of Depositary Shares representing the number of
whole shares of DECS to be withdrawn, the Depositary will at the same time
deliver to such holder a new Depositary Receipt or Receipts evidencing such
excess number of Depositary Shares. The Company does not expect that there will
be any public trading market for the shares of DECS except as represented by the
Depositary Shares. See "Investment Considerations -- Restrictions on Transfer;
Absence of Public Market".
 
CONVERSION AND CALL PROVISIONS
 
     Mandatory Conversion or Call. As described under "Description of
DECS -- Mandatory Conversion of DECS" and "-- Optional Redemption", the shares
of DECS are subject to mandatory conversion into shares of Common Stock on the
Mandatory Conversion Date, and to the right of the Company to call the shares of
DECS, at the Company's option, for redemption. The Depositary Shares are subject
to mandatory conversion or call upon substantially the same terms and conditions
(including as to notice to the owners of Depositary Shares) as the shares of
DECS, except that the number of shares of Common Stock received upon mandatory
conversion or redemption of each Depositary Share will be equal to the number of
shares of Common Stock received upon mandatory conversion or redemption of each
share of DECS divided by the DECS Common Equivalent Rate.
 
                                       20
<PAGE>   22
 
     If fewer than all of the Depositary Shares are to be redeemed, the
Depositary Shares to be redeemed shall be selected by lot or pro rata or by any
other equitable method determined by the Depositary to be consistent with the
method determined by the Board of Directors with respect to the shares of DECS.
If fewer than all of the Depositary Shares evidenced by a Depositary Receipt are
called for redemption, the Depositary will deliver to the holder of such
Depositary Receipt upon its surrender to the Depositary, together with the
redemption payment, a new Depositary Receipt evidencing the Depositary shares
evidenced by such prior Depositary Receipt and not called for redemption.
 
     Conversion at the Option of the Holder. As described under "Description of
DECS -- Conversion at the Option of the Holder", the shares of DECS may be
converted, in whole or in part, into shares of Common Stock at the option of the
holders of shares of DECS at any time prior to the Mandatory Conversion Date,
unless previously redeemed. The Depositary Shares may, at the option of holders
thereof, be converted into shares of Common Stock upon the same terms and
conditions as the shares of DECS, except that the number of shares of Common
Stock received upon conversion of each Depositary Share will be equal to the
number of shares of Common Stock received upon conversion of each share of DECS
divided by the DECS Common Equivalent Rate. To effect such an optional
conversion, a holder of Depositary Shares must deliver Depositary Receipts
evidencing the Depositary Shares to be converted, together with a written notice
of conversion and a proper assignment of the Depositary Receipts to the Company
or in blank (and, if applicable, payment in cash of an amount equal to the
dividend attributable to the current quarterly dividend period payable on such
Depositary Shares), to the Depositary or its agent. Each optional conversion of
Depositary Shares shall be deemed to have been effected immediately prior to the
close of business on the date on which the foregoing requirements shall have
been satisfied. The conversion shall be at the DECS Optional Conversion Rate in
effect at such time and on such date, adjusted to reflect the fact that fifty
Depositary Shares are the equivalent of one share of DECS.
 
     No fractional share of DECS may be converted. If only a portion of the
Depositary Shares evidenced by a Depositary Receipt is to be converted, a new
Depositary Receipt or Receipts will be issued for any Depositary Shares not
converted. No fractional shares of Common Stock will be issued upon conversion
or redemption of Depositary Shares, and, if such conversion or redemption would
otherwise result in a fractional share of Common Stock being issued, an amount
will be paid in cash as described in "Description of DECS -- Fractional Shares"
or as set forth in the Deposit Agreement.
 
     After the date fixed for conversion or redemption, the Depositary Shares so
converted or called for redemption will no longer be deemed to be outstanding
and all rights of the holders of such Depositary Shares will cease, except the
right to receive the Common Stock and amounts payable on such conversion or
redemption and any money or other property to which the holders of such
Depositary Shares were entitled upon such conversion or redemption, upon
surrender to the Depositary of the Depositary Receipt or Receipts evidencing
such Depositary Shares.
 
DIVIDENDS AND OTHER DISTRIBUTIONS
 
     The Depositary will distribute all cash dividends or other cash
distributions in respect of the shares of DECS to the record holders of
Depositary Receipts in proportion, insofar as practicable, to the number of
Depositary Shares owned by such holders.
 
     In the event of a distribution other than cash in respect of the shares of
DECS, the Depositary will distribute property received by it to the record
holders of Depositary Receipts in proportion, insofar as practicable, to the
number of Depositary Shares owned by such holders, unless the Depositary
determines that it is not feasible to make such distribution, in which case the
Depositary may, with the approval of the Company, adopt such method as it deems
equitable and practicable for the purpose of effecting such distribution,
including sale (at public or private sale) of such property and distribution of
the net proceeds from such sale to such holders.
 
                                       21
<PAGE>   23
 
     The amount distributed in any of the foregoing cases will be reduced by any
amount required to be withheld by the Company or the Depositary on account of
taxes.
 
RECORD DATE
 
     Whenever (i) any cash dividend or other cash distribution shall become
payable, any distribution other than cash shall be made, or any rights,
preferences or privileges shall be offered with respect to the shares of DECS,
or (ii) the Depositary shall receive notice of any meeting at which holders of
shares of DECS are entitled to vote or of which holders of shares of DECS are
entitled to notice, or of any election on the part of the Company to call for
redemption any shares of DECS, the Depositary shall in each such instance fix a
record date (which shall be the same date as the record date for the shares of
DECS) for the determination of the holders of Depositary Receipts (x) who shall
be entitled to receive such dividend, distribution, rights, preferences or
privileges or the net proceeds of the sale thereof, (y) who shall be entitled to
give instructions for the exercise of voting rights at any such meeting or to
receive notice of such meeting, or (z) who shall be subject to such redemption,
subject to the provisions of the Deposit Agreement.
 
VOTING OF DECS
 
     Upon receipt of notice of any meeting at which holders of shares of DECS
are entitled to vote, the Depositary will mail the information contained in such
notice of meeting to the record holders of Depositary Receipts. Each record
holder of Depositary Receipts on the record date (which will be the same date as
the record date for the shares of DECS) will be entitled to instruct the
Depositary as to the exercise of the voting rights pertaining to the number of
shares of DECS represented by such holder's Depositary Shares. The Depositary
will endeavor, insofar as practicable, to vote the number of shares of DECS
represented by such Depositary Shares in accordance with such instructions, and
the Company has agreed to take all reasonable action which may be deemed
necessary by the Depositary in order to enable the Depositary to do so. The
Depositary will abstain from voting shares of DECS to the extent it does not
receive specific written voting instructions from the holders of Depositary
Receipts representing the shares of DECS.
 
AMENDMENT AND TERMINATION OF DEPOSIT AGREEMENT
 
     The form of Depositary Receipts and any provision of the Deposit Agreement
may at any time be amended by agreement between the Company and the Depositary.
However, any amendment that imposes any fees, taxes or other charges payable by
holders of Depositary Receipts (other than taxes and other governmental charges,
fees and other expenses payable by such holders as stated under "Charges of
Depositary"), or that otherwise prejudices any substantial existing right of
holders of Depositary Receipts, will not take effect as to outstanding
Depositary Receipts until the expiration of 90 days after notice of such
amendment has been mailed to the record holders of outstanding Depositary
Receipts. Every holder of Depositary Receipts at the time any such amendment
becomes effective shall be deemed to consent and agree to such amendment and to
be bound by the Deposit Agreement, as so amended. In no event may any amendment
impair the right of any owner of Depositary Shares, subject to the conditions
specified in the Deposit Agreement, upon surrender of the Depositary Receipts
evidencing such Depositary Shares to receive shares of DECS or, upon conversion
of the shares of DECS represented by the Depositary Receipts, to receive shares
of Common Stock, and in each case any money or other property represented
thereby, except in order to comply with mandatory provisions of applicable law.
 
     Whenever so directed by the Company, the Depositary will terminate the
Deposit Agreement after mailing notice of such termination to the record holders
of all Depositary Receipts then outstanding at least 30 days prior to the date
fixed in such notice for such termination. The Depositary may likewise terminate
the Deposit Agreement if at any time 45 days shall have expired after the
Depositary shall have delivered to the Company a written notice of its election
to resign and a successor depositary shall not have been appointed and accepted
its appointment. If any
 
                                       22
<PAGE>   24
 
Depositary Receipts remain outstanding after the date of termination, the
Depositary thereafter will discontinue the transfer of Depositary Receipts, will
suspend the distribution of dividends to the holders thereof, and will not give
any further notices (other than notice of such termination) or perform any
further acts under the Deposit Agreement except as provided below and except
that the Depositary will continue (i) to collect dividends on the shares of DECS
and any other distributions with respect thereto and (ii) to deliver the shares
of DECS together with such dividends and distributions and the net proceeds of
any sales of rights, preferences, privileges or other property, without
liability for interest thereon, in exchange for Depositary Receipts surrendered.
At any time after the expiration of two years from the date of termination, the
Depositary may sell the shares of DECS then held by it at public or private
sale, at such place or places and upon such terms as it deems proper and may
thereafter hold the net proceeds of any such sale, together with any money and
other property then held by it, without liability for interest thereon, for the
pro rata benefit of the holders of Depositary Receipts which have not been
surrendered. The Company does not intend to terminate the Deposit Agreement or
to permit the resignation of the Depositary without appointing a successor
depositary. In the event the Deposit Agreement is terminated and a sufficient
number of shares of DECS remain outstanding, the Company will use its best
efforts to list the shares of DECS on the NYSE (unless the holders of a majority
of the outstanding shares of DECS shall consent to the Company not effecting
such listing).
 
CHARGES OF DEPOSITARY
 
     The Company will pay all charges of the Depositary including charges in
connection with the initial deposit of the shares of DECS, the initial execution
and delivery of the Depositary Receipts, the distribution of information to the
holders of Depositary Receipts with respect to matters on which shares of DECS
are entitled to vote, withdrawals of the shares of DECS by the holders of
Depositary Receipts or redemption or conversion of the shares of DECS, except
for taxes (including transfer taxes, if any) and other governmental charges and
such other charges as are provided in the Deposit Agreement to be at the expense
of holders of Depositary Receipts or persons depositing shares of DECS.
 
GENERAL
 
     The Depositary will make available for inspection by holders of Depositary
Receipts at its Corporate Office all reports and communications from the Company
that are delivered to the Depositary and made generally available to the holders
of the shares of DECS.
 
     Neither the Depositary nor the Company will be liable if it is prevented or
delayed by law or any circumstance beyond its control from or in performing its
obligations under the Deposit Agreement.
 
FEDERAL INCOME TAX CONSEQUENCES
 
     The following is a general discussion regarding the material United States
Federal income tax consequences under existing law of the ownership and
disposition of the shares of DECS. This discussion is intended for informational
purposes only, and does not address aspects of taxation, other than Federal
income taxation, or all tax consequences that may be relevant in the particular
circumstances of each holder (some of which, such as dealers in securities,
banks, insurance companies, tax-exempt organizations and foreign persons, may be
subject to special rules). There can be no assurance that future changes in
applicable law or administrative and judicial interpretations thereof, any of
which could have a retroactive effect, will not adversely affect the tax
consequences discussed herein or that there will not be differences of opinion
as to the interpretation of applicable law. Stock having terms closely
resembling those of the shares of DECS has not been the subject of any
regulation, ruling or judicial decision currently in effect, and there can be no
assurance that the Internal Revenue Service (the "Service") will take the
positions set forth below. The Company has not and will not seek a ruling from
the Service as to any tax matters relating to the
 
                                       23
<PAGE>   25
 
shares of DECS. Persons considering the purchase of shares of DECS should
consult their tax advisors with respect to the application of the United States
Federal income tax laws to their particular situations as well as any tax
consequences arising under the laws of any state, local, or foreign taxing
jurisdiction. The following discussion relates only to shares of DECS or shares
of Common Stock received upon conversion thereof or in exchange therefor that
are held as capital assets within the meaning of Section 1221 of the Internal
Revenue Code of 1986, as amended (the "Code").
 
  Dividends
 
     Dividends paid on the shares of DECS out of the Company's current or
accumulated earnings and profits will be taxable as ordinary income and will
generally qualify for the 70 percent intercorporate dividends-received deduction
subject to the minimum holding period (generally at least 46 days) and other
applicable requirements. Under certain circumstances, a corporate holder may be
subject to the alternative minimum tax with respect to the amount of its
dividends-received deduction. As of December 31, 1993, the Company had no
accumulated earnings and profits for federal income tax purposes. There can be
no assurance that the Company's operations during the years that the DECS are
outstanding will generate the necessary amounts of income so that the
distributions with respect to the DECS will be treated as made from earnings and
profits and thereby qualify as dividends for federal income tax purposes. To the
extent the Company does not have sufficient current or accumulated earnings and
profits in the years that the DECS are outstanding, distributions made with
respect to the DECS for any such year will not constitute dividends for federal
income tax purposes and, as a result, will not be eligible for the
dividends-received deduction.
 
     Under certain circumstances, a corporation that receives an "extraordinary
dividend", as defined in Section 1059(c) of the Code, is required to reduce its
stock basis by the non-taxed portion of such dividend. Generally, quarterly
dividends not in arrears paid to an original holder of the shares of DECS will
not constitute extraordinary dividends under Section 1059(c). In addition, under
Section 1059(c), any dividend with respect to "disqualified preferred stock" is
treated as an "extraordinary dividend". For these purposes, "disqualified
preferred stock" includes stock which is preferred as to dividends if the issue
price of such stock exceeds its liquidation rights or redemption price. It is
unclear whether the shares of the DECS will be determined to constitute
disqualified preferred stock and, thus, whether dividends distributed with
respect to the DECS will constitute extraordinary dividends.
 
  Redemption Premium
 
     Under certain circumstances, Section 305(c) of the Code requires that any
excess of the redemption price of preferred stock over its issue price be
includable in income, prior to receipt, as a constructive dividend. However, it
is believed that Section 305(c) does not apply to stock with terms such as those
of the shares of DECS.
 
  Redemption or Mandatory or Optional Conversion into Common Stock
 
     Gain or loss generally will not be recognized by a holder upon the
redemption of shares of DECS for shares of Common Stock or the conversion of
shares of DECS into shares of Common Stock if no cash is received. Income may be
recognized, however, to the extent Common Stock or cash is received in payment
of accrued and unpaid dividends or as an Additional Dividend upon a redemption
or conversion. Such income would probably be characterized as dividend income
although some uncertainty exists as to the appropriate characterization of
payments in satisfaction of undeclared accrued and unpaid dividends or as an
Additional Dividend. In addition, a holder who receives cash in lieu of a
fractional share will be treated as having received such fractional share and
having exchanged it for cash in a transaction subject to Section 302 of the Code
and related provisions. Such exchange should generally result in capital gain or
loss measured by the difference
 
                                       24
<PAGE>   26
 
between the cash received for the fractional share interest and the holder's
basis in the fractional share interest.
 
     Generally, a holder's basis in the Common Stock received upon the
redemption or conversion of the shares of DECS, other than shares of Common
Stock taxed upon receipt, will equal the adjusted tax basis of the redeemed or
converted shares of DECS (exclusive of any basis allocable to a fractional share
interest) and the holding period of such Common Stock will include the holding
period of the redeemed or converted shares of DECS.
 
  Adjustment of Conversion Rate
 
     Certain adjustments to the DECS Common Equivalent Rate and the DECS
Optional Conversion Rate to reflect the Company's issuance of certain rights,
warrants, evidences of indebtedness, securities or other assets to holders of
Common Stock may result in constructive distributions taxable as dividends to
the holders of the shares of DECS which may constitute (and cause other
dividends to constitute) "extraordinary dividends" to corporate holders as
described above.
 
  Conversion of DECS After Dividend Record Date
 
     If a holder of shares of DECS exercises such holder's right to convert
shares of DECS into shares of Common Stock after a dividend record date but
before payment of the dividend, then such holder generally will be required to
pay the Company an amount equal to the portion of such dividend attributable to
the current quarterly dividend period upon conversion, which amount would
increase the basis of the Common Stock received. The holder would recognize the
dividend payment as income.
 
  Backup Withholding
 
     Certain non-corporate holders may be subject to backup withholding at a
current rate of 31 percent on dividends and certain consideration received upon
the call or conversion of the shares of DECS. Generally, backup withholding
applies only when the taxpayer fails to furnish or certify a proper Taxpayer
Identification Number or when the taxpayer is notified by the Service that the
taxpayer has failed to report payments of interest and dividends properly.
Holders should consult their tax advisors regarding their qualification for
exemption from backup withholding and the procedure for obtaining any applicable
exemption.
 
REGISTRATION RIGHTS
 
     The Company entered into a Registration Agreement (the "Registration
Agreement") dated March 28, 1994, with the Initial Purchaser of the Depositary
Shares for the benefit of the holders thereof. The following summary of certain
provisions of the Registration Agreement does not purport to be complete and is
subject to, and is qualified by reference to, all the provisions of the
Registration Agreement, a copy of which has been filed with the registration
statement of which this Prospectus is a part. Such registration statement has
been filed to satisfy the obligations of the Company described below.
 
     Pursuant to the Registration Agreement the Company agreed, for the benefit
of the holders of Depositary Shares, that it would, at its cost, (a) within 30
days after March 28, 1994, file a shelf registration statement (a "Shelf
Registration Statement") with the Commission covering resales of the Depositary
Shares and the Common Stock issuable upon conversion or redemption thereof, (b)
cause such Shelf Registration Statement to be declared effective under the
Securities Act within 90 days of March 28, 1994, and (c) maintain such Shelf
Registration Statement continuously effective under the Securities Act until
March 28, 1997 or such earlier date as of which all the Depositary Shares or the
Common Stock issuable upon conversion or redemption thereof have been sold
pursuant to such Shelf Registration Statement. If the Company fails to comply
with clause (a) above, then, at such time, the annual dividend rate will
increase by $0.057 per Depositary Share.
 
                                       25
<PAGE>   27
 
Such increase will remain in effect until the date on which such Shelf
Registration Statement is filed, on which date the annual dividend rate will
revert to the original dividend rate plus any increase in such dividend rate
pursuant to the following sentence. If the Shelf Registration Statement is not
declared effective as provided in clause (b) above, then, at such time and on
each date that would have been the successive 30th day following such time, the
annual dividend rate (which dividend rate will be the original dividend rate
plus any increase or increases in such dividend rate pursuant to the preceding
sentence and this sentence) will increase by an additional $0.057 per Depositary
Share, provided that the dividend rate will not be increased by more than $0.114
per Depositary Share pursuant to this sentence. Such increase or increases will
remain in effect until the date on which such Shelf Registration Statement is
declared effective, on which date the annual dividend rate will revert to the
original dividend rate. Pursuant to clause (c) above, however, if the Company
fails to keep the Shelf Registration Statement continuously effective for the
period specified above, then at such time as the Shelf Registration Statement is
no longer effective and on each date thereafter that is the successive 30th day
subsequent to such time and until the earlier of (i) the date that the Shelf
Registration Statement is again declared effective, (ii) March 28, 1997 or (iii)
the date as of which all the Depositary Shares or the Common Stock issuable upon
conversion or redemption thereof are sold pursuant to the Shelf Registration
Statement, the annual dividend rate will increase by an additional $0.057 per
Depositary Share, provided that the annual dividend rate will not be increased
by more than $0.114 per Depositary Share pursuant to this sentence.
 
                          DESCRIPTION OF CAPITAL STOCK
 
     The following summary of the terms and provisions of the Company's capital
stock does not purport to be complete and is subject to, and qualified in its
entirety by, the Certificate of Incorporation and By-laws of the Company, copies
of which are available from the Company upon request.
 
GENERAL
 
     The authorized capital stock of the Company consists of 250,000,000 shares
of Common Stock and 2,000,000 shares of Preferred Stock. As of February 28,
1994, 56,351,560 shares of Common Stock were issued and outstanding and held of
record by approximately 13,800 stockholders. As of March 28, 1994, there were
177,400 shares of Preferred Stock issued and outstanding.
 
     Directors of the Company hold office until the date of the annual meeting
for the election of directors following the annual meeting at which they were
elected and until their successors are elected. The By-laws provide that
directors can be removed from office at any time, with or without cause, by the
affirmative vote of the holders of a majority of the shares of capital stock
then entitled to vote at an election of directors, and vacancies on the Board of
Directors shall be filled by majority vote of the stockholders present at such
meeting, or by a majority of the directors then in office.
 
     The Company's Certificate of Incorporation provides that any action
required or permitted to be taken by stockholders of the Company shall be
effected only at an annual or special meeting of the stockholders of the
Company, and no action required to be taken or that may be taken at any annual
or special meeting of stockholders of the Company may be taken without a
meeting, except by the unanimous written consent of all stockholders entitled to
vote on such action. The Company's By-laws provide that special meetings of
stockholders shall only be called by either the Chairman of the Board, the
President or any Vice-President.
 
     The Certificate of Incorporation and the By-laws of the Company provide
that, except under certain circumstances, directors of the Company shall not be
personally liable to the Company or its stockholders for breach of fiduciary
duties as a director. That provision may not exonerate the directors from
liability under federal securities laws and has no effect on any non-monetary
remedies that may be available to the Company and its stockholders. The
Certificate of Incorpora-
 
                                       26
<PAGE>   28
 
tion and the By-laws of the Company provide for indemnification of the officers
and directors of the Company to the fullest extent permitted by applicable law.
 
COMMON STOCK
 
     Holders of Common Stock are entitled to one vote for each share held of
record on all matters on which shareholders are entitled to vote. There are no
cumulative voting rights and holders of Common Stock have no preemptive rights.
All issued and outstanding shares of Common Stock are validly issued, fully paid
and non-assessable. Holders of Common Stock are entitled to such dividends as
may be declared from time to time by the Board of Directors out of funds legally
available for that purpose. Upon dissolution, holders of Common Stock are
entitled to share pro rata in the assets of the Company remaining after payment
in full of all its liabilities and obligations, including payment of the
liquidation preference, if any, of any Preferred Stock then outstanding.
 
     The Common Stock is listed on the New York Stock Exchange, under the symbol
USS.
 
PREFERRED STOCK
 
     The Board of Directors, generally without further action by the
shareholders, is authorized to issue Preferred Stock in one or more series and
to designate as to any such series the dividend rate, redemption prices,
preferences on liquidation or dissolution, conversion rights, voting rights and
any other preferences, and relative, participating, optional or other special
rights and qualifications, limitations and restrictions. The rights of the
holders of Common Stock will be subject to, and may be adversely affected by,
the rights of the holders of any Preferred Stock that may be issued in the
future. Issuance of a new series of Preferred Stock, while providing desirable
flexibility in connection with possible acquisitions or other corporate
purposes, could have the effect of making it more difficult for a third party to
acquire, or discouraging a third party from acquiring, a majority of the
outstanding voting stock of the Company.
 
SECTION 203 OF THE DELAWARE GENERAL CORPORATION LAW
 
     Generally, Section 203 of the Delaware General Corporation Law prohibits a
publicly held Delaware corporation from engaging in any "business combination"
with any "interested stockholder" for a period of three years following the date
that such stockholder became an interested stockholder, unless (i) prior to such
date either the business combination or the transaction which resulted in the
stockholder being an interested stockholder is approved by the board of
directors of the corporation, (ii) upon consummation of the transaction which
resulted in the stockholder becoming an interested stockholder, the interested
stockholder owned at least 85% of the voting stock of the corporation
outstanding at the time the transaction commenced, excluding for purposes of
determining the number of shares outstanding those shares owned (A) by persons
who are both directors and officers and (B) certain employee stock plans, or
(iii) on or after such date the business combination is approved by the board
and authorized at an annual or special meeting of stockholders, and not by
written consent, by the affirmative vote of at least 66 2/3% of the outstanding
voting stock which is not owned by the interested stockholder. A "business
combination" includes certain mergers, consolidations, asset sales, transfers
and other transactions resulting in a financial benefit to the interested
stockholder. An "interested stockholder" is a person who, together with
affiliates and associates, owns (or within the preceding three years, did own)
15% or more of the corporation's voting stock.
 
TRANSFER AGENT
 
     First Chicago Trust Company of New York is the transfer agent and registrar
for the Company's Common Stock.
 
                                       27
<PAGE>   29
 
                                 LEGAL MATTERS
 
     The validity of the Securities offered hereby has been passed upon by
Donald F. Crane, Jr., Senior SEC Counsel for the Company.
 
                                    EXPERTS
 
     The financial statements and the related financial statement schedules
incorporated in this prospectus by reference from the Company's Annual Report in
Form 10-K for the year ended December 31, 1993 have been audited by Deloitte &
Touche, independent auditors, as stated in their report, which is incorporated
herein by reference, and have been so incorporated in reliance upon the report
of such firm given upon their authority as experts at accounting and auditing.
 
                                       28
<PAGE>   30
 
NO PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE ANY INFORMATION
OR TO MAKE ANY REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS PROSPECTUS IN
CONNECTION WITH THE OFFER MADE BY THIS PROSPECTUS, AND, IF GIVEN OR MADE, SUCH
INFORMATION OR REPRESENTATIONS MUST NOT BE RELIED UPON AS HAVING BEEN AUTHORIZED
BY THE COMPANY OR THE INITIAL PURCHASER. NEITHER THE DELIVERY OF THIS PROSPECTUS
NOR ANY SALE MADE HEREUNDER SHALL UNDER ANY CIRCUMSTANCES CREATE ANY IMPLICATION
THAT THERE HAS BEEN NO CHANGE IN THE AFFAIRS OF THE COMPANY SINCE THE DATE
HEREOF. THIS PROSPECTUS DOES NOT CONSTITUTE AN OFFER OR SOLICITATION BY ANYONE
IN ANY JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION IS NOT AUTHORIZED OR IN
WHICH THE PERSON MAKING SUCH OFFER OR SOLICITATION IS NOT QUALIFIED TO DO SO OR
TO ANYONE TO WHOM IT IS UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION.
                            ------------------------
                               TABLE OF CONTENTS
 
<TABLE>
<CAPTION>
                                        PAGE
                                        ----
<S>                                     <C>
Available Information..................   2
Incorporation of Certain Documents by
  Reference............................   2
The Company............................   3
Summary Description of DECs and
  Depositary Shares....................
Investment Considerations..............   8
Ratio of Earnings to Combined Fixed
  Charges and Preferred Stock
  Dividends............................   9
Use of Proceeds........................  10
Issuance of Resale Securities to
  Selling Stockholders.................  10
Selling Stockholders...................  10
Plan of Distribution...................  11
Description of DECS....................  12
Description of Depositary Shares.......  20
Description of Capital Stock...........  26
Legal Matters..........................  28
Experts................................  28
</TABLE>
 
   8,870,000 SHARES
 
   UNITED STATES
   SURGICAL CORPORATION
 
   $2.20 DEPOSITARY SHARES
 
   EACH REPRESENTING A ONE-FIFTIETH INTEREST
   IN A SHARE OF SERIES A CONVERTIBLE PREFERRED STOCK
   (DIVIDEND ENHANCED CONVERTIBLE STOCK(SM) -- DECS(SM))
 
   COMMON STOCK

   [LOGO]
 
   PROSPECTUS
 
   DATED               , 1994
<PAGE>   31
 
                                    PART II
 
                     INFORMATION NOT REQUIRED IN PROSPECTUS
 
ITEM 14.  OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION
 
     The estimated expenses to be incurred in connection with the issuance and
distribution of the securities covered by this Registration Statement, all of
which will be paid by the Registrant, are as follows:
 
<TABLE>
        <S>                                                               <C>
        Registration Fee................................................  $
        Printing and Engraving Expenses.................................            *
        Accounting Fees and Expenses....................................            *
        Legal Fees and Expenses.........................................            *
        Miscellaneous...................................................            *
                                                                          -----------
                  Total.................................................  $
                                                                          -----------
                                                                          -----------
</TABLE>
 
     * To be provided by amendment hereto.
 
ITEM 15.  INDEMNIFICATION OF DIRECTORS AND OFFICERS
 
     Section 145 of the Delaware General Corporation Law empowers a corporation
to indemnify its directors and officers or former directors or officers and to
purchase insurance with respect to liability arising out of their capacity or
status as directors and officers. Such law provides further that the
indemnification permitted thereunder shall not be deemed exclusive of any other
rights to which the directors and officers may be entitled under a corporation's
Certificate of Incorporation, Bylaws, any agreement or otherwise.
 
     Article Eight of the Company's Certificate of Incorporation, as amended,
provides that, to the fullest extent permitted by the Delaware General
Corporation Law, as the same exists or may hereafter be amended, a director of
the Company shall not be liable to the Company or its stockholders for monetary
damages for breach of fiduciary duty as a director. Article XI of the Company's
By-laws provides for indemnification of officers and directors to the fullest
extent provided by law.
 
     Insofar as indemnification for liabilities arising under the Securities Act
may be permitted to directors, officers or persons controlling the Company
pursuant to the foregoing provisions, the Company has been advised that in the
opinion of the Commission such indemnification is against public policy as
expressed in the Securities Act and is therefore unenforceable.
 
ITEM 16.  EXHIBITS
 
     The following is a list of all exhibits filed as a part of this
Registration Statement on Form S-3, including those incorporated herein by
reference.
 
                                      II-1
<PAGE>   32
 
<TABLE>
<CAPTION>
                                                                                   SEQUENTIALLY
EXHIBIT                                                                             NUMBERED
 NUMBER                              DESCRIPTION OF EXHIBIT                           PAGE
- --------                             ----------------------                       ------------
<S>          <C>                                                                   <C>
   4(a)      Certificate of Designations. Incorporated by reference to the Exhibits
             filed with the Company's Form 10-K Annual Report for 1993. Commission
             file no. 1-9776.
   4(b)      Registration Rights Agreement dated March 28, 1994, between the
             Company and Salomon Brothers Inc.
   4(c)      Depositary Agreement dated March 28, 1994 between the Company and
             First Chicago Trust Company
   4(d)      Form of Certificate representing Series A Convertible Preferred Stock.
   4(e)      Form of Depositary Receipt.
   5         Opinion of Donald F. Crane, Jr. as to the legality of the Securities.
  12         Statements of computation of ratios of earnings to fixed charges and
             of earnings to combined fixed charges and preferred stock dividends.
  23(a)      Consent of Deloitte & Touche, Independent Auditors, as Experts.
  23(b)      Consent of Donald F. Crane, Jr. Included in Exhibit 5 above.
  24         Powers of Attorney.
</TABLE>
 
ITEM 17.  CERTAIN UNDERTAKINGS
 
                UNDERTAKINGS TO FILE PROSPECTUSES AS AMENDMENTS
 
     The undersigned Registrant hereby undertakes: (1) to file, during any
period in which offers or sales are being made, a post-effective amendment to
this Registration Statement (i) to include any prospectus required by Section
10(a)(3) of the Securities Act of 1933, (ii) to reflect in the prospectus any
facts or events arising after the effective date of this Registration Statement
(or the most recent post-effective amendment thereof) which, individually or in
the aggregate, represent a fundamental change in the information set forth in
this Registration Statement and (iii) to include any material information with
respect to the plan of distribution not previously disclosed in this
Registration Statement or any material change to such information in this
Registration Statement, provided, however, that paragraphs (1)(i) and (1)(ii) do
not apply if the information required to be included in a post-effective
amendment by those paragraphs is contained in periodic reports filed by the
Registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange
Act of 1934 that are incorporated by reference in this Registration Statement;
(2) that for the purpose of determining any liability under the Securities Act
of 1933, as amended, each such post-effective amendment and each filing of the
Registrant's annual report pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended, (and, where applicable, each filing of the
plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of
1934, as amended) that is incorporated by reference in this Registration
Statement shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof; and (3) to remove
from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
 
     The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each filing of the
registrant's annual report pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (and, where applicable, each filing of an employee benefit
plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of
1934) that is incorporated by reference in the registration statement shall be
deemed to be a new
 
                                      II-2
<PAGE>   33
 
registration statement relating to the securities offered therein, and the
offering of such securities at the time shall be deemed to be the initial bona
fide offering thereof.
 
                   UNDERTAKING WITH REGARD TO INDEMNIFICATION
 
     Insofar as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the foregoing provisions, or otherwise, the Registrant
has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Act and is,
therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the Registrant of expenses incurred
or paid by a director, officer or controlling person of the Registrant in the
successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.
 
                                      II-3
<PAGE>   34
 
                                   SIGNATURES
 
     Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Norwalk, State of Connecticut, on April 27, 1994.
 
                                          UNITED STATES SURGICAL CORPORATION
 
                                          By /s/ THOMAS R. BREMER
                                             ----------------------------------
                                              Thomas R. Bremer
                                              Senior Vice President and General
                                             Counsel
 
     Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities and on the dates indicated.
 
<TABLE>
<CAPTION>
               SIGNATURES                                TITLE                       DATE
- ----------------------------------------  ------------------------------------  ---------------
<C>                                       <S>                                   <C>
                   *                      Chairman of the Board, President,     April   , 1994
- ----------------------------------------  Chief Executive Officer and Director
             Leon C. Hirsch               (Principal Executive Officer)

                   *                      Director                              April   , 1994
- ----------------------------------------
          John A Bogardus, Jr.

         /s/  THOMAS R. BREMER            Director                              April 27, 1994
- ----------------------------------------
            Thomas R. Bremer

                                          Director                              April   , 1994
- ----------------------------------------
             Turi Josefsen

                   *                      Director                              April   , 1994
- ----------------------------------------
            Douglas L. King

                                          Director                              April   , 1994
- ----------------------------------------
             Zanvyl Krieger

                                          Director                              April   , 1994
- ----------------------------------------
            Bruce S. Lustman

                   *                      Director                              April   , 1994
- ----------------------------------------
             William F. May
</TABLE>
 
                                      II-4
<PAGE>   35
 
<TABLE>
<CAPTION>
               SIGNATURES                                TITLE                       DATE
- ----------------------------------------  ------------------------------------  ---------------
<C>                                       <S>                                   <C>
                   *                      Director                              April   , 1994
- ----------------------------------------
           Marianne Scipione

                   *                      Director                              April   , 1994
- ----------------------------------------
           Douglas T. Tansill

                   *                      Senior Vice President, Finance and    April   , 1994
- ----------------------------------------  Chief Financial Officer (Principal
         Howard M. Rosenkrantz            Financial Officer)

         /s/  JOSEPH C. SCHERPF           Vice President and Controller         April 27, 1994
- ----------------------------------------  (Principal Accounting Officer)
           Joseph C. Scherpf
</TABLE>
 
* By Power of Attorney
 
                                      II-5
<PAGE>   36
 
                                 EXHIBIT INDEX
 
<TABLE>
<CAPTION>
EXHIBIT
 NUMBER                          DESCRIPTION                                        LOCATION
- --------                         -----------                                        --------
<S>          <C>                                                                   <C>
   4(a)      Certificate of Designations. Incorporated by reference to the Exhibits
             filed with the Company's Form 10-K Annual Report for 1993. Commission
             file no. 1-9776.
   4(b)      Registration Rights Agreement dated March 28, 1994, between the
             Company and Salomon Brothers Inc.
   4(c)      Depositary Agreement dated March 28, 1994 between the Company and
             First Chicago Trust Company
   4(d)      Form of Certificate representing Series A Convertible Preferred Stock.
   4(e)      Form of Depositary Receipt.
   5         Opinion of Donald F. Crane, Jr. as to the legality of the Securities.
  12         Statements of computation of ratios of earnings to fixed charges and
             of earnings to combined fixed charges and preferred stock dividends.
  23(a)      Consent of Deloitte & Touche, Independent Auditors, as Experts.
  23(b)      Consent of Donald F. Crane Jr. Included in Exhibit 5 above.
  24         Powers of Attorney.
</TABLE>

<PAGE>   1
                                                                    EXHIBIT 4(b)

                                                                  EXECUTION COPY





                       UNITED STATES SURGICAL CORPORATION

                          8,870,000 Depositary Shares


                             REGISTRATION AGREEMENT


                                                              New York, New York
                                                                  March 28, 1994


Salomon Brothers Inc
Seven World Trade Center
New York, New York 10048

Dear Sirs:

                 United States Surgical Corporation, a Delaware  corporation
(the "Company"), proposes to issue and sell to you (the "Purchaser"), upon the
terms set forth in a Purchase Agreement of even date herewith (the "Purchase
Agreement"), 8,870,000 of its $2.20 Depositary Shares (the "Securities"), each
representing a one-fiftieth interest in a share of Series A Convertible
Preferred Stock (the "Preferred Stock") (the "Initial Placement").  As an
inducement to you to enter into the Purchase Agreement and in satisfaction of a
condition to your obligations thereunder, the Company agrees with you (i) for
your benefit and (ii) for the benefit of the holders (including you) from time
to time (each of the foregoing a "Holder" and together the "Holders") of the
Securities or the Converted Securities (each as defined below) as follows:

                 1.  Definitions.  Capitalized terms used herein without
definition shall have their respective meanings set forth in the Purchase
Agreement.  As used in this Agreement, the following capitalized defined terms
shall have the following meanings:

                 "Act" means the Securities Act of 1933 and the rules and
regulations of the Commission promulgated thereunder.

                 "Affiliate" of any specified person means any other person
which, directly or indirectly, is in control of, is controlled by, or is under
common control with, such specified person.  For purposes of this definition,
control
<PAGE>   2
                                                                               2

of a person means the power, direct or indirect, to direct or cause the
direction of the management and policies of such person whether through
ownership of voting securities or by contract or otherwise; and the terms
"controlling" and "controlled" have meanings correlative to the foregoing.

                 "Closing Date" has the meaning set forth in the Purchase
Agreement.

                 "Commission" means the Securities and Exchange Commission.

                 "Common Stock" means the Common Stock, $.10 par value, of the
Company.

                 "Converted Securities" means Securities that have been
converted or redeemed into shares of Common Stock.

                 "Exchange Act" means the Securities Exchange Act of 1934 and
the rules and regulations of the Commission promulgated thereunder.

                 "Final Memorandum" has the meaning set forth in the Purchase
Agreement.

                 "Holder" and "Holders" have the meanings set forth in the
preamble hereto.

                 "Initial Placement" has the meaning set forth in the preamble
hereto.

                 "Losses" has the meaning set forth in Section 5(d).

                 "Majority Holders" means the Holders of a majority of the
shares of securities registered or to be registered under the Shelf
Registration Statement.

                 "Managing Underwriters" means the investment banker or
investment bankers and manager or managers that shall administer an
underwritten offering of securities under the Shelf Registration Statement.

                 "Prospectus" means the prospectus included in the Shelf
Registration Statement (including, without limitation, a prospectus that
discloses information previously omitted from a prospectus filed as part of an
effective registration statement in reliance upon Rule 430A under the Act), as
<PAGE>   3
                                                                               3

amended or supplemented by any prospectus supplement, with respect to the terms
of the offering of any portion of the securities covered by the Shelf
Registration Statement, and all amendments and supplements to such prospectus,
including post-effective amendments.

                 "Purchaser" has the meaning set forth in the preamble hereto.

                 "Securities" has the meaning set forth in the preamble hereto.

                 "Shelf Registration Period" has the meaning set forth in
Section 2(b).

                 "Shelf Registration Statement" means a "shelf" registration
statement of the Company pursuant to the provisions of Section 2 which covers
the Securities and the Converted Securities, on an appropriate form under Rule
415 under the Act, or any similar rule that may be adopted by the Commission,
all amendments and supplements to such registration statement, including
post-effective amendments, in each case including the Prospectus contained
therein, all exhibits thereto and all material incorporated by reference
therein.

                 "underwriter" means any underwriter of securities in
connection with an offering thereof under the Shelf Registration Statement.

                 2.  Shelf Registration.

                 (a)  The Company shall prepare and, not later than 30 days
following the Closing Date, shall file with the Commission, and thereafter
shall, not later than 90 days following the Closing Date, cause to be declared
effective under the Act a Shelf Registration Statement relating to the offer
and sale by the Holders (subject to the Holders' right to elect, pursuant to
Section 3(a)(2), not to be included as a "selling security holder" in the Shelf
Registration Statement) of the Securities and the Converted Securities from
time to time in accordance with the methods of distribution elected by the
Holders and set forth in the Shelf Registration Statement.

                 (b)  The Company shall keep the Shelf Registration Statement
continuously effective in order to permit the Prospectus forming part thereof
to be usable by the Holders
<PAGE>   4
                                                                               4

for a period of three years from the Closing Date or such shorter period that
will terminate when all the Securities and Converted Securities covered by the
Shelf Registration Statement have been sold pursuant to the Shelf Registration
Statement (in any such case, such period being called the "Shelf Registration
Period").

                 (c)  The Shelf Registration Statement will not be deemed to
have become effective unless it has been declared effective by the Commission;
provided, however, that if, after it has been declared effective, the offering
of Securities and Converted Securities pursuant to the Shelf Registration
Statement is interfered with by any stop order, inunction or other order or
requirement of the Commission or any other governmental agency, authority or
court, the Registration Statement will be deemed not to have been effective
during the period of such interference until the offering of the securities
registered thereunder may legally resume.

                 (d)  The Holders will suffer damages if the Company fails to
fulfill its obligations under this Section 2 and it would not be feasible to
ascertain as of the date of this Agreement the extent of such damages with
precision.  Accordingly, the certificate of designations relating to the
Securities provides for increases in the annual dividend rate for the
Securities if the Company fails to comply its obligations under this Section 2.
The liquidated damages provided for in such certificate of designations
constitute a reasonable estimate of the damages that may be incurred by the
Holders by reason of the failure of the Company to fulfill its obligations
under this Section 2 and such liquidated damages shall be the sole remedy of
you and the Holders for any such failure.

                 3.  Registration Procedures.  In connection with the Shelf
Registration Statement, the following provisions shall apply:

                 (a)  (1)  The Company shall furnish to you and each Holder,
         prior to the filing thereof with the Commission, a copy of the Shelf
         Registration Statement, and each amendment thereof and each amendment
         or supplement, if any, to the Prospectus included therein and shall
         use its best efforts to reflect in each such document, when so filed
         with the Commission, such comments as you or any Holder reasonably may
         propose.
<PAGE>   5
                                                                               5

                 (2)  Each Holder shall have the right to elect, prior to the
         initial filing of the Shelf Registration Statement, not to be included
         in the Shelf Registration as a "selling security holder"; provided,
         that, notwithstanding any such election, any subsequent Holder that is
         a direct or indirect transferee of Securities or Converted Securities
         of such an original Holder so electing not be included as a "selling
         security holder" shall have the right to elect to be included in the
         Shelf Registration Statement as a "selling security holder".  Any
         original Holder so electing not to be included as a "selling security
         holder" shall notify the Company of such election within three
         business days of receipt, pursuant to paragraph (a)(1) of this Section
         3, of the Shelf Registration Statement prior to the filing thereof
         with the Commission.

                 (3)  The Company shall amend and supplement the Shelf
         Registration Statement and the Prospectus forming part thereof if
         requested to do so by any subsequent Holder to the extent necessary to
         list such Holder as a "selling security holder" pursuant to paragraph
         (a)(2) of this Section 3.

                 (b)  The Company shall ensure that (i) the Shelf Registration
         Statement and any amendment thereto and any Prospectus forming part
         thereof and any amendment or supplement thereto complies in all
         material respects with the Act, (ii) the Shelf Registration Statement
         and any amendment thereto does not, when it becomes effective, contain
         an untrue statement of a material fact or omit to state a material
         fact required to be stated therein or necessary to make the statements
         therein not misleading and (iii) any Prospectus forming part of the
         Shelf Registration Statement, and any amendment or supplement to such
         Prospectus, does not include an untrue statement of a material fact or
         omit to state a material fact necessary in order to make the
         statements, in the light of the circumstances under which they were
         made, not misleading.
<PAGE>   6
                                                                               6

                 (c)        (1) The Company shall advise you and the Holders
         and, if requested by you or any Holder, confirm such advice in
         writing:

                            (i) when the Shelf Registration Statement and any
                 amendment thereto has been filed with the Commission and when
                 the Shelf Registration Statement or any post-effective
                 amendment thereto has become effective; and

                           (ii) of any request by the Commission for amendments
                 or supplements to the Shelf Registration Statement or the
                 Prospectus included therein or for additional information.

                 (2)  Promptly upon becoming aware of such events, the Company
         shall advise you and the Holders and, if requested by you or any
         Holder, confirm such advice in writing:

                            (i) of the issuance by the Commission of any stop
                 order suspending the effectiveness of the Shelf Registration
                 Statement or the initiation of any proceedings for that
                 purpose;

                           (ii) of the receipt by the Company of any
                 notification with respect to the suspension of the
                 qualification of the securities included therein for sale in
                 any jurisdiction or the initiation or threatening of any
                 proceeding for such purpose; and

                          (iii) of the happening of any event that requires the
                 making of any changes in the Shelf Registration Statement or
                 the Prospectus so that, as of such date, the statements
                 therein are not misleading and do not omit to state a material
                 fact required to be stated therein or necessary to make the
                 statements therein (in the case of the Prospectus, in light of
                 the circumstances under which they were made) not misleading
                 (which advice shall be accompanied by an instruction to
                 suspend the use of the Prospectus until the requisite changes
                 have been made).

                 (d)  The Company shall use its best efforts to obtain the
         withdrawal of any order suspending the
<PAGE>   7
                                                                               7

         effectiveness of the Shelf Registration Statement at the earliest
         possible time.

                 (e)  The Company shall furnish to each Holder, without charge,
         at least one copy of the Shelf Registration Statement and any
         post-effective amendment thereto, including financial statements and
         schedules, and, if any Holder so requests in writing, all exhibits
         (including those incorporated by reference).

                 (f)  The Company shall, during the Shelf Registration Period,
         deliver to each Holder, without charge, as many copies of the
         Prospectus (including each preliminary Prospectus) included in the
         Shelf Registration Statement and any amendment or supplement thereto
         as the Holder may reasonably request; and the Company consents to the
         use of the Prospectus or any amendment or supplement thereto by each
         of the selling Holders of securities in connection with the offering
         and sale of the securities covered by the Prospectus or any amendment
         or supplement thereto.

                 (g)  Prior to any offering of securities pursuant to the Shelf
         Registration Statement, the Company shall register or qualify or
         cooperate with the Holders of securities included therein and their
         respective counsel in connection with the registration or
         qualification of such securities for offer and sale under the
         securities or blue sky laws of such jurisdictions as any such Holders
         reasonably request in writing and do any and all other acts or things
         necessary or advisable to enable the offer and sale in such
         jurisdictions of the securities covered by the Shelf Registration
         Statement; provided, however, that the Company will not be required to
         qualify generally to do business in any jurisdiction where it is not
         then so qualified or to take any action which would subject it to
         general service of process or to taxation in any such jurisdiction
         where it is not then so subject.

                 (h)  The Company shall cooperate with the Holders to
         facilitate the timely preparation and delivery of Depositary Receipts
         representing Securities and certificates representing Converted
         Securities to be sold pursuant to the Shelf Registration Statement
         free of any restrictive legends and registered in such names as the
         Holders may request in connection with sales of
<PAGE>   8
                                                                               8

         securities pursuant to the Shelf Registration Statement.

                 (i)  Upon the occurrence of any event contemplated by
         paragraph (c)(2)(iii) above, the Company shall promptly prepare a
         post-effective amendment to the Shelf Registration Statement or an
         amendment or supplement to the related Prospectus or file any other
         required document so that, as thereafter delivered to purchasers of
         the securities included therein, the Prospectus will not include an
         untrue statement of a material fact or omit to state any material fact
         necessary to make the statements therein, in the light of the
         circumstances under which they were made, not misleading.

                 (j)  Not later than the effective date of the Shelf
         Registration Statement hereunder, the Company shall identify the
         securities registered under such Shelf Registration Statement, and
         provide the applicable trustee with printed certificates (and
         Depositary Receipts, if applicable) for such securities, in a form, if
         requested by the applicable Holder or Holder's Counsel, eligible for
         deposit with The Depository Trust Company.

                 (k)  The Company shall use its best efforts to comply with all
         applicable rules and regulations of the Commission and shall make
         generally available to its security holders as soon as practicable
         after the effective date of the Shelf Registration Statement an
         earnings statement satisfying the provisions of Section 11(a) of the
         Act.

                 (l)  The Company may require each Holder of securities to be
         sold pursuant to the Shelf Registration Statement to furnish to the
         Company such information regarding such Holder and the distribution of
         such securities as the Company may from time to time reasonably
         require for inclusion in the Shelf Registration Statement.

                 (m)  The Company shall, if requested, promptly incorporate in
         a Prospectus supplement or post-effective amendment to the Shelf
         Registration Statement, such information as the Managing Underwriters
         and Majority Holders reasonably agree should be included therein and
         shall make all required
<PAGE>   9
                                                                               9

         filings of such Prospectus supplement or post-effective amendment as
         soon as notified of the matters to be incorporated in such Prospectus
         supplement or post-effective amendment.

                 (n)  The Company shall enter into such agreements (including
         underwriting agreements) and take all other appropriate actions in
         order to expedite or facilitate the registration or the disposition of
         the Securities and Converted Securities, and in connection therewith,
         if an underwriting agreement is entered into, cause the same to
         contain indemnification provisions and procedures no less favorable
         than those set forth in Section 5 (or such other provisions and
         procedures acceptable to the Majority Holders and the Managing
         Underwriters, if any, with respect to all parties to be indemnified
         pursuant to Section 5 from Holders).

                 (o)  The Company shall (i) make reasonably available for
         inspection by the Holders, any underwriter participating in any
         disposition pursuant to the Shelf Registration Statement and any
         attorney, accountant or other agent retained by the Holders or any
         such underwriter all relevant financial and other records, pertinent
         corporate documents and properties of the Company and its
         subsidiaries; (ii) cause the Company's officers, directors and
         employees to supply all relevant information reasonably requested by
         any such persons in connection with the Shelf Registration Statement
         as is customary for similar due diligence examinations; provided,
         however, that any information that is designated in writing by the
         Company, in good faith, as confidential at the time of delivery of
         such information, including, without limitation, all material
         non-public information, shall be kept confidential by any such
         persons, unless such disclosure is made in connection with a court
         proceeding or required by law, or such information becomes available
         to the public generally or through a third party without an
         accompanying obligation of confidentiality; (iii) make such
         representations and warranties to the Holders and the underwriters, if
         any, in form, substance and scope as are customarily made by issuers
         to underwriters in primary underwritten offerings and covering matters
         including, but not limited to, those set forth in the Purchase
         Agreement; (iv) obtain opinions of counsel to the Company and updates
         thereof (which counsel and opinions (in form,
<PAGE>   10
                                                                              10

         scope and substance) shall be reasonably satisfactory to Holder's
         Counsel and the Managing Underwriters, if any) addressed to each
         selling Holder and the underwriters, if any, covering such matters as
         are customarily covered in opinions requested in underwritten
         offerings and such other matters as may be reasonably requested by the
         Holders and underwriters; (v) obtain "comfort" letters (or, in the
         case of any person that does not satisfy the conditions for receipt of
         a "comfort" letter specified in Statement on Auditing Standards No.
         72, an "agreed upon procedures letter") and updates thereof from the
         independent certified public accountants of the Company (and, if
         necessary, any other independent certified public accountants of any
         subsidiary of the Company or of any business acquired by the Company
         for which financial statements and financial data are, or are required
         to be, included in the Shelf Registration Statement), addressed to
         each selling Holder of securities registered thereunder and the
         underwriters, if any, in customary form and covering matters of the
         type then customarily covered in "cold comfort" letters in connection
         with primary underwritten offerings; and (vi) deliver such other
         documents and certificates as may be reasonably requested by the
         Majority Holders and the Managing Underwriters, if any, including
         those to evidence compliance with Section 3(i) and with any customary
         conditions contained in the underwriting agreement or other agreement
         entered into by the Company.  The foregoing actions set forth in
         clauses (iii), (iv), (v) and (vi) of this paragraph (o) shall be
         performed at (A) the effectiveness of the Shelf Registration Statement
         and each post-effective amendment thereto and (B) each closing under
         any underwriting or similar agreement as and to the extent required
         thereunder.

                 (p) The Holders may enter into, in their sole discretion, one
         or more underwriting arrangements in connection with the offering of
         securities under the Shelf Registration Statement; provided, however,
         that any such underwriting arrangement shall be with respect to
         Securities or Converted Securities having an aggregate public offering
         price of no less than $50 million; provided, further, however, that,
         notwithstanding the foregoing proviso, if, at any time three such
         underwriting arrangements have each resulted in the closing of the
         public offering of Securities or
<PAGE>   11
                                                                              11

         Converted Securities offered thereby, the Holders may enter into one
         underwriting arrangement which may have an aggregate public offering
         price for the Securities or Converted Securities offered thereunder of
         less than $50 million.

                 (q) The Company may offer securities of the Company, other
         than the Securities and the Converted Securities, under the Shelf
         Registration Statement.

                 4.  Registration Expenses.  The Company shall bear all
expenses incurred in connection with the performance of its obligations under
Sections 2 and 3 (other than any discount or commission payable or paid to any
underwriter, which shall be the responsibility of the Holders) and shall
reimburse the Holders for the reasonable fees and disbursements of one firm or
counsel designated by the Majority Holders to act as counsel for the Holders in
connection therewith.

                 5.  Indemnification and Contribution.  (a)  In connection with
the Shelf Registration Statement, the Company agrees to indemnify and hold
harmless each Holder of securities covered thereby (including, without
limitation, the Purchaser), the directors, officers, employees and agents of
each Holder and each person who controls any Holder within the meaning of
either the Act or the Exchange Act against any and all losses, claims, damages
or liabilities, joint or several, to which they or any of them may become
subject under the Act, the Exchange Act or other Federal or state statutory
laws or regulations, at common law or otherwise, insofar as such losses,
claims, damages or liabilities (or actions in respect thereof) arise out of or
are based upon any untrue statement or alleged untrue statement of a material
fact contained in the Shelf Registration Statement as originally filed or in
any amendment thereof, or in any preliminary Prospectus or Prospectus, or in
any amendment thereof or supplement thereto, or arise out of or are based upon
the omission or alleged omission to state therein a material fact required to
be stated therein or necessary to make the statements therein not misleading,
and agrees to reimburse each such indemnified party, as incurred, for any legal
or other expenses reasonably incurred by them in connection with investigating
or defending any such loss, claim, damage, liability or action; provided,
however, that (i) the Company will not be liable in any case to the extent that
any such loss, claim, damage or liability arises out of or is based
<PAGE>   12
                                                                              12

upon any such untrue statement or alleged untrue statement or omission or
alleged omission made therein in reliance upon and in conformity with written
information furnished to the Company by or on behalf of any such Holder or by
the Managing Underwriter specifically for inclusion therein and (ii) such
indemnity with respect to any preliminary prospectus shall not inure to the
benefit of any Holder (or any director, officer, employee or agent of such
Holder or any person controlling such Holder) from whom the person asserting
any such loss, claim, damage or liability purchased the Securities or Converted
Securities, as the case may be, which are the subject thereof if such person
did not receive a copy of the final prospectus (or the final prospectus as
supplemented) excluding documents incorporated therein by reference at or prior
to the confirmation of the sale of Securities or Converted Securities, as the
case may be, to such person in any case where such delivery is required by the
Securities Act and the untrue statement or omission of a material fact
contained in such preliminary prospectus was corrected in such final prospectus
(or final prospectus as supplemented).  This indemnity agreement will be in
addition to any liability which the Company may otherwise have.

                 The Company also agrees to indemnify or contribute to Losses
of, as provided in Section 5(d), any underwriters, their officers and directors
and each person who controls such underwriters on substantially the same basis
as that of the indemnification of the Purchaser and the selling Holders
provided in this Section 5(a) and shall, if requested by any Holder, enter into
an underwriting agreement reflecting such agreement, as provided in Section
3(m).

                 (b)  Each Holder of securities covered by the Shelf
Registration Statement (including, without limitation, the Purchaser) severally
agrees to indemnify and hold harmless (i) the Company, (ii) each of its
directors, (iii) each of its officers who signs the Shelf Registration
Statement and (iv) each person who controls the Company within the meaning of
either the Act or the Exchange Act to the same extent as the foregoing
indemnity from the Company to each Holder, but only with reference to written
information relating to Holder furnished to the Company by or on behalf of such
Holder specifically for inclusion in the documents referred to in the foregoing
indemnity.  This indemnity agreement will be in addition to any liability which
any Holder may otherwise have.
<PAGE>   13
                                                                              13

                 (c)  Promptly after receipt by an indemnified party under this
Section 5 or notice of the commencement of any action, such indemnified party
will, if a claim in respect thereof is to be made against the indemnifying
party under this Section 5, notify the indemnifying party in writing of the
commencement thereof; but the failure so to notify the indemnifying party (i)
will not relieve it from liability under paragraph (a) or (b) above unless and
to the extent it did not otherwise learn of such action and such failure
results in the forfeiture by the indemnifying party of substantial rights and
defenses and (ii) will not, in any event, relieve the indemnifying party from
any obligations to any indemnified party other than the indemnification
obligation provided in paragraph (a) or (b) above.  The indemnifying party
shall be entitled to appoint counsel of the indemnifying party's choice at the
indemnifying party's expense to represent the indemnified party in any action
for which indemnification is sought (in which case the indemnifying party shall
not thereafter be responsible for the fees and expenses of any separate counsel
retained by the indemnified party or parties except as set forth below);
provided, however, that such counsel shall be satisfactory to the indemnified
party.  Notwithstanding the indemnifying party's election to appoint counsel to
represent the indemnified party in an action, the indemnified party shall have
the right to employ separate counsel (including local counsel), and the
indemnifying party shall bear the reasonable fees, costs and expenses of such
separate counsel (and local counsel), if (i) the use of counsel chosen by the
indemnifying party to represent the indemnified party would present such
counsel with a conflict of interest, (ii) the actual or potential defendants
in, or targets of, any such action include both the indemnified party and the
indemnifying party and the indemnified party shall have reasonably concluded
that there may be legal defenses available to it or any other indemnified party
which are different from or additional to those available to the indemnifying
party, (iii) the indemnifying party shall not have employed counsel
satisfactory to the indemnified party to represent the indemnified party within
a reasonable time after notice of the institution of such action or (iv) the
indemnifying party shall authorize the indemnified party to employ separate
counsel at the expense of the indemnifying party.  An indemnifying party will
not, without the prior written consent of the indemnified parties, settle,
compromise or consent to the entry of any judgment with respect to any pending
or threatened claim, action, suit or proceeding in respect of which
indemnification or
<PAGE>   14
                                                                              14

contribution may be sought hereunder (whether or not the indemnified parties
are actual or potential parties to such claim or action) unless such
settlement, compromise or consent includes an unconditional release of each
indemnified party from all liability arising out of such claim, action, suit or
proceeding.

                 (d)  In the event that the indemnity provided in paragraph (a)
or (b) above is unavailable to or insufficient to hold harmless an indemnified
party for any reason, then each applicable indemnifying party, in lieu of
indemnifying such indemnified party, shall have a joint and several obligation
to contribute to the aggregate losses, claims, damages and liabilities
(including legal and other expenses reasonably incurred in connection with
investigating or defending same) (collectively "Losses") to which such
indemnified party may be subject in such proportion as is appropriate to
reflect the relative benefits received by such indemnifying party, on the one
hand, and such indemnified party, on the other hand, from the Initial Placement
and the Shelf Registration Statement; provided, however, that in no case shall
the Purchaser or any other Holder be responsible, in the aggregate, for any
amount in excess of the purchase discount or commission applicable to the
Securities, as set forth on the cover page of the Final Memorandum, nor shall
any underwriter be responsible for any amount in excess of the underwriting
discount or commission applicable to the securities purchased by such
underwriter under the Shelf Registration Statement.  If the allocation provided
by the immediately preceding sentence is unavailable for any reason, the
indemnifying party and the indemnified party shall contribute in such
proportion as is appropriate to reflect not only such relative benefits but
also the relative fault of such indemnifying party, on the one hand, and such
indemnified party, on the other hand, in connection with the statements or
omissions which resulted in such Losses as well as any other relevant equitable
considerations.  Benefits received by the Company shall be deemed to be equal
to the sum of (x) the total net proceeds from the Initial Placement (before
deducting expenses) as set forth on the cover page of the Final Memorandum and
(y) the total amount of additional dividends specified in the certificate of
designations relating to the Securities which the Company would have been
required to pay as a result of not registering the Securities or Converted
Securities.  Benefits received by the Purchaser shall be deemed to be equal to
the purchase discount and commission set forth on the cover page of the Final
Memorandum, and
<PAGE>   15
                                                                              15

benefits received by any other Holders shall be deemed to be equal to the value
of receiving Securities and Converted Securities registered under the Act.
Benefits received by any underwriter shall be deemed to be equal to the
underwriting discount and commission set forth on the cover page of the
Prospectus forming a part of the Shelf Registration Statement.  Relative fault
shall be determined by reference to whether any alleged untrue statement or
omission relates to information provided by the indemnifying party, on the one
hand, or by the indemnified party, on the other hand.  The parties agree that
it would not be just and equitable if contribution were determined by pro rata
allocation or any other method of allocation which does not take account of the
equitable considerations referred to above.  Notwithstanding the provisions of
this paragraph (d), no person guilty of fraudulent misrepresentation (within
the meaning of Section 11(f) of the Act) shall be entitled to contribution from
any person who was not guilty of such fraudulent misrepresentation.  For
purposes of this Section 6, each person who controls a Holder within the
meaning of either the Act or the Exchange Act and each director, officer,
employee and agent of a Holder shall have the same rights to contribution as
such Holder, and each person who controls the Company within the meaning of
either the Act or the Exchange Act, each officer of the Company who shall have
signed the Shelf Registration Statement and each director of the Company shall
have the same rights to contribution as the Company, subject in each case to
the applicable terms and conditions of this paragraph (d).

                 (e)  The provisions of this Section 5 will remain in full
force and effect, regardless of any investigation made by or on behalf of any
Holder or the Company or any of the officers, directors or controlling persons
referred to in this Section 5, and will survive the sale by a Holder of
Securities or Converted Securities.

                 5.  Preferred Stock.  If, for any reason, the Preferred Stock
shall not be represented by the Securities under a depositary agreement, all
rights, benefits and obligations applicable hereunder to the Securities and
Holders thereof shall be automatically deemed applicable to the Preferred Stock
and the holders thereof.

                 6.  Miscellaneous.  (a)  No Inconsistent Agreements.  The
Company has not, as of the date hereof, entered into, nor shall it, on or after
the date hereof,
<PAGE>   16
                                                                              16

enter into, any agreement with respect to its securities that is inconsistent
with the rights granted to the Holders herein or otherwise conflicts with the
provisions hereof.

                 (b)  Amendments and Waivers.  The provisions of this
Agreement, including the provisions of this sentence, may not be amended,
qualified, modified or supplemented, and waivers or consents to departures from
the provisions hereof may not be given, unless the Company has obtained the
written consent of the Majority Holders; provided, that, with respect to any
matter that directly or indirectly affects the rights of the Purchaser
hereunder, the Company shall obtain the written consent of the Purchaser
against which such amendment, qualification, supplement, waiver or consent is
to be effective.  Notwithstanding the foregoing (except the foregoing proviso),
a waiver or consent to departure from the provisions hereof with respect to a
matter that relates exclusively to the rights of Holders whose securities are
being sold pursuant to the Shelf Registration Statement and that does not
directly or indirectly affect the rights of other Holders may be given by the
Majority Holders, determined on the basis of securities being sold rather than
registered under the Shelf Registration Statement.

                 (c)  Notices.  All notices and other communications provided
for or permitted hereunder shall be made in writing by hand-delivery,
first-class mail, telex, telecopier, or air courier guaranteeing overnight
delivery:

                 (i) if to a Holder, at the most current address given by such
         Holder to the Company in accordance with the provisions of this
         Section 6(c), which address initially is, with respect to each Holder,
         the address of such Holder maintained by the registrar for the
         Securities or Converted Securities, as the case may be, with a copy in
         like manner to the Purchaser;

                (ii) if to the Purchaser; initially at its address set forth 
         in the Purchase Agreement; and

               (iii) if to the Company, initially at its address set forth in 
         the Purchase Agreement.

                 All such notices and communications shall be deemed to have
been duly given when received.  The Purchaser or the Company by notice to the
other may designate
<PAGE>   17
                                                                              17

additional or different addresses for subsequent notices or communications.

                 (d)  Successors and Assigns.  This Agreement shall inure to
the benefit of and be binding upon the successors and assigns of each of the
parties hereto, including, without the need for an express assignment or any
consent by the Company thereto, all current and future Holders.  The Company
hereby agrees to extend the benefits of this Agreement to any Holder and any
Holder may specifically enforce the provisions of this Agreement as if an
original party hereto.

                 (e)  Counterparts.  This Agreement may be executed in any
number of counterparts and by the parties hereto in separate counterparts, each
of which when so executed shall be deemed to be an original and all of which
taken together shall constitute one and the same agreement.

                 (f)  Headings.  The headings in this Agreement are for
convenience of reference only and shall not limit or otherwise affect the
meaning hereof.

                 (g)  Governing Law.  This Agreement shall be governed by and
construed in accordance with the laws of the State of New York (without
reference to conflicts of law rules).

                 (h)  Severability.  In the event that any one of more of the
provisions contained herein, or the application thereof in any circumstances,
is held invalid, illegal or unenforceable in any respect for any reason, the
validity, legality and enforceability of any such provision in every other
respect and of the remaining provisions hereof shall not be in any way impaired
or affected thereby, it being intended that all the rights and privileges of
the parties hereto shall be enforceable to the fullest extent permitted by law.

                 (i)  Securities Held by the Company, etc.  Whenever the
consent or approval of the Majority Holders is required hereunder, securities
held by the Company or its Affiliates (other than Holders deemed to be
Affiliates of the Company solely by reason of their holdings of Securities or
Converted Securities) shall not be counted in determining whether such consent
or approval was given by the Majority Holders.
<PAGE>   18
                                                                              18

                 Please confirm that the foregoing correctly sets forth the
agreement between the Company and you by confirming and accepting this
Agreement as set forth below.


                                     Very truly yours,
                                     
                                     UNITED STATES SURGICAL
                                     CORPORATION
                                     
                                     
                                      By:                           
                                         ------------------------
                                         Name:
                                         Title:


The foregoing Agreement is hereby
confirmed and accepted as of the
date first above written.

SALOMON BROTHERS INC

  By:
     -----------------------
     Name:
     Title:

<PAGE>   1
                                                                 EXHIBIT 4(c)



                              DEPOSIT AGREEMENT


                 DEPOSIT AGREEMENT, dated as of March 28, 1994, among United
States Surgical Corporation, a Delaware corporation, First Chicago Trust
Company of New York, a New York trust company, as Depositary, and all holders
from time to time of Depositary Receipts issued hereunder.

                 WHEREAS, it is desired to provide, as hereinafter set forth in
this Deposit Agreement, for the deposit of shares of Series A Convertible
Preferred Stock of the Company with the Depositary for the purposes set forth
in this Deposit Agreement and for the issuance hereunder of the Receipts
evidencing Depositary Shares each representing 1/50th of a share of such
Preferred Stock so deposited; and

                 WHEREAS, the Depositary Receipts are to be substantially in
the form of Exhibit A annexed to this Deposit Agreement, with appropriate
insertions, modifications and omissions, as hereinafter provided in this
Deposit Agreement;

                 NOW, THEREFORE, in consideration of the premises contained
herein, it is agreed by and among the parties hereto as follows:


                               ARTICLE ARTICLE I

                                  DEFINITIONS

The following definitions shall apply to the respective terms (in the singular
and plural forms of such terms) used in this Deposit Agreement and the
Depositary Receipts:

                 SECTION 1.1  The term "Certificate of Designations" shall
mean the Certificate of Designations adopted by the Board of Directors of the
Company or a duly authorized committee thereof establishing and setting forth
the rights, preferences, privileges and limitations of the Preferred Stock.
<PAGE>   2
                 SECTION 1.2  The term "Certificate of Incorporation" shall
mean the Certificate of Incorporation, as amended from time to time, of the
Company.

                 SECTION 1.3  The term "Company" shall mean United States 
Surgical Corporation, a Delaware corporation having its principal office at 150
Glover Avenue, Norwalk, Connecticut, 06856, and its successors.

                 SECTION 1.4  The term "Corporate Office" shall mean the
corporate office of the Depositary at which at any particular time its
depositary receipt business shall be administered.

                 SECTION 1.5  The term "Deposit Agreement" shall mean this
agreement, as the same may be amended, modified or supplemented from time to
time.

                 SECTION 1.6  The term "Depositary" shall mean First Chicago
Trust Company of New York, a New York trust company, having its principal
office at 14 Wall Street, New York, New York 10005, and any successor as
Depositary hereunder.

                 SECTION 1.7  The term "Depositary Shares" shall mean an
interest in one-fiftieth of a share of the Preferred Stock deposited with the
Depositary hereunder and the same proportional interest in any and all other
property received by the Depositary in respect of such share of Preferred Stock
and held under this Depositary Agreement, all as evidenced by the Receipts
executed and delivered hereunder.  Subject to the terms of this Deposit
Agreement, each holder of a Depositary Share is entitled, proportionately, to
all the rights, preferences and privileges of the Preferred Stock represented
by such Depositary Share, including the dividend, voting and liquidation rights
contained in the Certificate of Designations, and to the benefits of all
obligations of the Company under the Certificate of Designations.

                 SECTION 1.8  The term "Depositary's Agent" shall mean an
agent appointed by the Depositary as provided, and for the purposes specified,
in Section 7.5.

                 SECTION 1.9  The term "Preferred Stock" shall mean shares of
the Company's Series A Convertible Pre-




                                      2
<PAGE>   3
ferred Stock, par value $5.00 per share, $1,127.50 liquidation preference per
share.

                 SECTION 1.10  The term "Receipt" shall mean a Depositary
Receipt issued hereunder to evidence one or more Depositary Shares, whether in
definitive or temporary form.

                 SECTION 1.11  The term "record holder" as applied to a
Receipt shall mean the person in whose name a Receipt is registered on the
books maintained by the Depositary for such purpose.

                 SECTION 1.12  The term "Registrar" shall mean any bank or
trust company appointed to register Receipts as herein provided.

                 SECTION 1.13  The term "Securities Act" shall mean the
Securities Act of 1933.


                               ARTICLE ARTICLE II


                          FORM OF RECEIPTS, DEPOSIT OF
                    PREFERRED STOCK, EXECUTION AND DELIVERY,
                 TRANSFER, SURRENDER AND REDEMPTION OF RECEIPTS

                 SECTION 2.1  Form and Transferability of Receipts.
Definitive Receipts shall be engraved or printed or lithographed with
steel-engraved borders and underlying tint and shall be substantially in the
form set forth in Exhibit A annexed to this Deposit Agreement, with appropriate
insertions, modifications and omissions, as hereinafter provided.  Pending the
preparation of definitive receipts, the Depositary shall, upon written order in
accordance with Section 2.2, execute and deliver temporary Receipts which are
printed, lithographed, typewritten, mimeographed or otherwise substantially of
the tenor of definitive Receipts in lieu of which they are issued and with such
appropriate insertions, modifications and omissions as hereinafter provided.
The Company will cause definitive Receipts to be prepared without unreasonable
delay.  After the preparation of definitive Receipts, the temporary Receipts
shall be exchangeable for definitive Receipts upon surrender of the temporary
Receipts, at the Corporate Office, without charge to the holder.  Upon
surrender for cancellation of





                                       3
<PAGE>   4
any one or more temporary Receipts, the Depositary shall execute and deliver in
exchange therefor definitive Receipts representing the same number of
Depositary Shares as represented by the surrendered temporary Receipt or
Receipts.  Such exchange shall be made at the Company's expense and without any
charge to the holder thereof.  Until so exchanged, the temporary Receipts shall
in all respects be entitled to the same benefits under this Deposit Agreement
as definitive Receipts.  Receipts shall be executed by the Depositary by the
manual signature of a duly authorized signatory of the Depositary, provided
that such signature may be a facsimile if a Registrar (other than the
Depositary) shall have countersigned the Receipts by manual signature of a duly
authorized signatory of the Registrar.  No Receipt shall be entitled to any
benefits under this Deposit Agreement or be valid or obligatory for any purpose
unless it shall have been executed as provided in the preceding sentence.  The
Depositary shall record on its books each Receipt executed as provided above
and delivered as hereinafter provided.

                 Receipts shall be in denominations of any number of whole
Depositary Shares.  All Receipts shall be dated the date of their execution.

                 Receipts may be endorsed with or have incorporated in the text
thereof such legends or recitals or changes not inconsistent with the
provisions of this Deposit Agreement as may be required by the Depositary or
required to comply with any applicable law or regulation or with the rules and
regulations of any securities exchange upon which the Preferred Stock, the
Depositary Shares or the Receipts may be listed or to conform with any usage
with respect thereto, or to indicate any special limitations or restrictions to
which any particular Receipts are subject by reason of the date of issuance of
the Preferred Stock or otherwise; provided, however, that for three years
following the date of this agreement, each Receipt shall bear the legend set
forth on Annex I hereto, unless the Depositary shall have received written
notice and an opinion of counsel from the Company that the Depositary Shares
have been registered under the Securities Act; and provided, further, that from
and after receipt of such notice, holders of Receipts shall have the right to
exchange Receipts held for Receipts without the legend set forth on Annex I.





                                       4
<PAGE>   5
                 Title to any Receipt (and to the Depositary Shares evidenced
by such Receipt) that is properly endorsed or accompanied by a properly
executed instrument of transfer or endorsement shall be transferable by
delivery with the same effect as in the case of a negotiable instrument;
provided, however, that until a Receipt shall be transferred on the books of
the Depositary as provided in Section 2.4, the Depositary may, notwithstanding
any notice to the contrary, treat the record holder thereof at such time as the
absolute owner thereof for the purpose of determining the person entitled to
distribution of dividends or other distributions or to any notice provided
for in this Deposit Agreement and for all other purposes.

                 SECTION 2.2  Deposit of Preferred Stock; Execution and
Delivery of Receipts in Respect Thereof.  On each date on which the Preferred
Stock is initially issued by the Company, the Depositary, upon receipt of
written instructions from the Company or the holder to which such Preferred
Stock was issued, and a Certificate or certificates for the Preferred Stock to
be deposited under this Deposit Agreement in accordance with the provisions of
this Section 2.2, shall execute and deliver a Receipt or Receipts for the
number of Depositary Shares representing such deposited Preferred Stock to the
person or persons stated in such instructions.

                 Subject to the terms and conditions of this Deposit Agreement,
any holder of Preferred Stock may deposit such Preferred Stock (including any
fractional share of Preferred Stock) under this Deposit Agreement by delivery
to the Depositary of a certificate or certificates for the Preferred Stock to
be deposited, properly endorsed or accompanied, if required by the Depositary,
by a properly executed instrument of transfer or endorsement in form
satisfactory to the Depositary, together with (i) all such certifications as
may be required by the Depositary in accordance with the provisions of this
Deposit Agreement and (ii) a written order directing the Depositary to execute
and deliver to or upon the written order of the person or persons stated in
such order a Receipt or Receipts for the number of Depositary Shares
representing such deposited Preferred Stock.

                 If required by the Depositary, Preferred Stock presented for
deposit at any time, whether or not the





                                       5
<PAGE>   6
register of stockholders of the Company is closed, shall also be accompanied by
an agreement or assignment, or other instrument satisfactory to the Depositary,
that will provide for the prompt transfer to the Depositary or its nominee of
any dividend or right to subscribe for additional Preferred Stock or to receive
other property that any person in whose name the Preferred Stock is or has been
registered may thereafter receive upon or in respect of such deposited
Preferred Stock, or in lieu thereof such agreement of indemnity or other
agreement as shall be satisfactory to the Depositary.

                 Upon receipt by the Depositary of a certificate or
certificates for Preferred Stock to be deposited hereunder, together with the
other documents specified above, the Depositary shall, as soon as transfer and
registration can be accomplished, present such certificate or certificates to
the registrar and transfer agent of the Preferred Stock for transfer and
registration in the name of the Depositary or its nominee of the Preferred
Stock being deposited.  Deposited Preferred Stock shall be held by the
Depositary in an account to be established by the Depositary at the Corporate
Office or at such other office as the Depositary shall determine.

                 Upon receipt by the Depositary of a certificate or
certificates for Preferred Stock to be deposited hereunder, together with the
other documents specified above, the Depositary, subject to the terms and
conditions of this Deposit Agreement, shall execute and deliver to or upon the
order of the person or persons named in the written order delivered to the
Depositary referred to in the first or second paragraph of this Section 2.2 a
Receipt or Receipts for the number of whole Depositary Shares representing the
Preferred Stock so deposited and registered in such name or names as may be
requested by such person or persons.  The Depositary shall execute and deliver
such Receipt or Receipts at the Corporate Office, except that, at the request,
risk and expense of any person requesting such delivery, such delivery may be
made at such other place which may be designated by such person.  In each case,
delivery will be made only upon payment to the Depositary of all taxes and
other governmental charges and any fees payable in connection with such deposit
and the transfer of the deposited Preferred Stock.  The Company shall deliver
to the Depositary from time to time such quantities of Receipts as the Deposi-





                                       6
<PAGE>   7
tary may request to enable the Depositary to perform its obligations under this
Deposit Agreement.

                 SECTION 2.3  Optional Redemption of Preferred Stock for
Cash.  Whenever the Company shall elect to redeem shares of Preferred Stock in
accordance with the Certificate of Designations it shall (unless otherwise
agreed in writing with the Depositary) give the Depositary in its capacity as
Depositary notice of the date of such proposed redemption of the Preferred
Stock, which notice shall be given not less than 5 Business Days prior to the
date the Depositary is to mail notice of the redemption to the record holders
of Receipts, in the case of a redemption of all outstanding Depositary Shares,
and not less than 10 days prior to the date the Depositary is to mail notice of
the redemption to the record holders of Receipts evidencing the Depositary
Shares to be redeemed, in the case of a partial redemption of outstanding
Depositary Shares, and be accompanied by a certificate from the Company stating
that such redemption of the Preferred Stock is in accordance with the
provisions of the Certificate of Designations.  Such notice shall be in
addition to the notice required to be given by the Company for redemption
pursuant to the Certificate of Designations.  On the date of any such
redemption of Preferred Stock, provided that the Company shall then have
deposited with the Depositary the shares of Common Stock as required pursuant
to the Certificate of Designations to be delivered in exchange for the
Preferred Stock to be redeemed, the Depositary shall redeem (using the shares
of Common Stock and any cash deposited with it) the number of Depositary Shares
representing such redeemed Preferred Stock.  The Depositary shall mail, first
class postage prepaid, notice of the redemption of Preferred Stock and the
proposed simultaneous redemption of the Depositary Shares representing the
Preferred Stock to be redeemed, not less than 15 and not more than 60 days
prior to the date fixed for redemption of such Preferred Stock and Depositary
Shares (the "Redemption Date"), to the record holders of the Receipts
evidencing the Depositary Shares to be so redeemed, at the addresses of such
holders as they appear on the records of the Depositary; but neither failure to
mail any such notice to one or more such holders nor any defect in any notice
to one or more such holders shall affect the sufficiency of the proceedings for
redemption as to other holders.  Each such notice shall state:  (i) the
Redemption Date; (ii) the number of





                                       7
<PAGE>   8
Depositary Shares to be redeemed and, if less than all the Depositary Shares
held by any such holder are to be redeemed, the number of such Depositary
Shares held by such holder to be so redeemed; (iii) the DECS Call Price (as
defined in the Certificate of Designations); (iv) the number of shares of
Common Stock deliverable upon redemption of each share of Preferred Stock to be
redeemed, and the Current Market Price (as defined in the Certificate of
Designations) used to calculate such number of shares of Common Stock; (v) the
place or places where Receipts evidencing Depositary Shares are to be
surrendered for payment of the redemption price; and (vi) that dividends in
respect of the shares of Preferred Stock represented by the Depositary Shares
to be redeemed will cease to accumulate on such Redemption Date.  Notices shall
be mailed and published by the Company pursuant to Section 3 of the Certificate
of Designations.  In case fewer than all the outstanding Depositary Shares are
to be redeemed, the Depositary Shares to be redeemed shall be selected by lot
or pro rata (as nearly as may be) or by any other equitable method determined
by the Depositary to be consistent with the method determined by the Board of
Directors of the Company with respect to the Preferred Stock.

                 Notice having been mailed and published as aforesaid, from and
after the Redemption Date (unless the Company shall have failed to redeem the
shares of Preferred Stock to be redeemed by it, as set forth in the Company's
notice provided for in the preceding paragraph), the Depositary Shares called
for redemption shall be deemed no longer to be outstanding and all rights of
the holders of Receipts evidencing such Depositary Shares (except the right to
receive the shares of Common Stock upon redemption and cash for any fractional
share amount) shall, to the extent of such Depositary Shares, cease and
terminate.  Upon surrender in accordance with said notice of the Receipts
evidencing such Depositary Shares (properly endorsed or assigned for transfer,
as the Depositary shall so require), such Depositary Shares shall be redeemed
for shares of Common Stock and cash for any fractional share amount at a rate
per Depositary Share equal to one-fiftieth of the number of shares of Common
Stock (including fractional amounts) delivered upon redemption of a share of
Preferred Stock pursuant to the Certificate of Designations.





                                       8
<PAGE>   9
                 If fewer than all the Depositary Shares evidenced by a Receipt
are called for redemption, the Depositary will deliver to the holder of such
Receipt upon its surrender to the Depositary, together with the shares of
Common Stock for the Depositary Shares called for redemption, a new Receipt
evidencing the Depositary Shares evidenced by such prior Receipt and not called
for redemption.

                 To the extent that Depositary Shares are redeemed for shares
of Common Stock and all such shares of Common Stock cannot be distributed to
the record holders of Receipts without creating fractional interests in such
shares, the Depositary may, with the consent of the Company, adopt such method
as it deems equitable and practicable for the purpose of effecting such
distribution, including the sale (at public or private sale) of such shares of
Common Stock at such place or places and upon such terms as it may deem proper,
and the net proceeds of any such sale shall, subject to Section 3.2, be
distributed or made available for distribution to such record holders that
would otherwise receive fractional interests in such shares of Common Stock.

                 Except with respect to a conversion of Depositary Shares which
may occur pursuant to Section 3 of the Certificate of Designations, the
Depositary shall not be required (a) to execute and deliver, transfer or
exchange any Receipts for a period beginning 15 days next preceding any
selection of Depositary Shares and Preferred Stock to be redeemed and ending at
the close of business on the day of the mailing of notice or redemption of
Depositary Shares or (b) to transfer or exchange for another Receipt any
Receipt evidencing Depositary Shares called or being called for redemption in
whole or in part, except as provided in the third paragraph of this Section
2.3.

                 SECTION 2.4  Transfer of Receipts.  Subject to the terms and
conditions of this Deposit Agreement, the Depositary shall make transfers on
its books from time to time of Receipts upon any surrender thereof at the
Corporate Office or such other office as the Depositary may designate by the
holder in person or by a duly authorized attorney, properly endorsed or
accompanied by a properly executed instrument of transfer or endorsement, or
other instrument satisfactory to the Depositary, together with





                                       9
<PAGE>   10
evidence of the payment of any transfer taxes as may be required by law.  Upon
such surrender, the Depositary shall execute a new Receipt or Receipts and
deliver the same to or upon the order of the person or persons entitled thereto
evidencing the same aggregate number of Depositary Shares evidenced by the
Receipt or Receipts surrendered.

                 SECTION 2.5  Combinations and Split-ups of Receipts.  Upon
surrender of a Receipt or Receipts at the Corporate Office or such other office
as the Depositary may designate for the purpose of effecting a split-up or
combination of Receipts, subject to the terms and conditions of this Deposit
Agreement, the Depositary shall issue a new Receipt or Receipts in the
authorized denominations requested evidencing the same aggregate number of
Depositary Shares evidenced by the Receipt or Receipts surrendered; provided,
however, that the Depositary shall not issue any Receipt evidencing a
fractional Depositary Share.

                 SECTION 2.6  Surrender of Receipts and Withdrawal of
Preferred Stock.  Any holder of a Receipt or Receipts may withdraw any or all
of the Preferred Stock (but only in whole shares of Preferred Stock)
represented by the Depositary Shares evidenced by such Receipts and all money
and other property, if any, represented by such Depositary Shares by
surrendering such Receipt or Receipts at the Corporate Office or at such other
office as the Depositary may designate for such withdrawals.  After such
surrender, without unreasonable delay, the Depositary shall deliver to such
holder, or to the person or persons designated by such holder as hereinafter
provided, certificates for the whole number of shares of Preferred Stock and
all such money and other property, if any, represented by the Depositary Shares
evidenced by the Receipt or Receipts so surrendered for withdrawal.  If the
Receipt or Receipts delivered by the holder to the Depositary in connection
with such withdrawal shall evidence a number of Depositary Shares in excess of
the number of whole Depositary Shares representing the number of shares of
Preferred Stock to be withdrawn, the Depositary shall at the same time, in
addition to such whole number of shares of Preferred Stock and such money and
other property, if any, to be withdrawn, deliver to such holder, or (subject to
Section 2.4) upon his order, a new Receipt or Receipts evidencing such excess
number of





                                       10
<PAGE>   11
whole Depositary Shares.  Delivery of the Preferred Stock and such money and
other property being withdrawn may be made by the delivery of such
certificates, documents of title and other instruments as the Depositary may
deem appropriate, which, as required by the Depositary, shall be properly
endorsed or accompanied by proper instruments of transfer.

                 If the Preferred Stock and the money and other property being
withdrawn are to be delivered to a person or persons other than the record
holder of the Receipt or Receipts being surrendered for withdrawal of Preferred
Stock, such holder shall execute and deliver to the Depositary a written order
so directing the Depositary and the Depositary may require that the Receipt or
Receipts surrendered by such holder for withdrawal of such shares of Preferred
Stock be properly endorsed in blank or accompanied by a properly executed
instrument of transfer or endorsement in blank.

                 The Depositary shall deliver the Preferred Stock and the money
and other property, if any, represented by the Depositary Shares evidenced by
Receipts surrendered for withdrawal at the Corporate Office, except that, at
the request, risk and expense of the holder surrendering such Receipt or
Receipts and for the account of the holder thereof, such delivery may be made
at such other place as may be designated by such holder.

                 SECTION 2.7  Limitations on Execution and Delivery, Transfer, 
Split-up, Combination, Redemption, Surrender and Exchange of Receipts.  As a
condition precedent to the execution and delivery, transfer, split-up,
combination, redemption, surrender or exchange of any Receipt or the exercise
of any conversion right referred to in Section 2.10, the Depositary, any of the
Depositary's Agents or the Company may require any or all of the following: (i)
payment to it of a sum sufficient for the payment (or, in the event that the
Depositary or the Company shall have made such payment, the reimbursement to
it) of any tax (including applicable interest, penalties or additions) or other
governmental charge with respect thereto (including any such tax or charge with
respect to the Preferred Stock being deposited or withdrawn or with respect to
the Common Stock (as defined in Section 2.10) or other securities or property
of the Company being issued upon conversion or redemption); (ii)





                                       11
<PAGE>   12
the production of proof satisfactory to it as to the identity and genuineness
of any signature; and (iii) compliance with such regulations, if any, as the
Depositary or the Company may establish consistent with the provisions of this
Deposit Agreement.

                 The deposit of Preferred Stock may be refused, the delivery of
Receipts against Preferred Stock may be suspended, the transfer of Receipts may
be refused, and the transfer, split-up, combination, surrender or exchange of
outstanding Receipts may be suspended (i) during any period when the register
of stockholders of the Company is closed, (ii) if any such action is deemed
necessary or advisable by the Depositary, any of the Depositary's Agents or the
Company at any time or from time to time because of any requirement of law or
of any government or governmental body or commission, or under any provision of
this Deposit Agreement, or (iii) with the approval of the Company, for any
other reason.

                 SECTION 2.8  Lost Receipts, etc.  In case any Receipt shall
be mutilated or destroyed or lost or stolen, the Depositary in its discretion
may execute and deliver a Receipt of like form and tenor in exchange and
substitution for such mutilated Receipt or in lieu of and in substitution for
such destroyed, lost or stolen Receipt; provided that the holder thereof
provides the Depositary with (i) evidence satisfactory to the Depositary of
such destruction, loss or theft of such Receipt, of the authenticity thereof
and of his ownership thereof, (ii) reasonable indemnification satisfactory to
the Depositary and (iii) payment of any expense (including fees, charges and
expenses of the Depositary) in connection with such execution and delivery.

                 SECTION 2.9  Cancellation and Destruction of Surrendered
Receipts.  All Receipts surrendered to the Depositary or any Depositary's Agent
shall be cancelled by the Depositary and returned to the Company.  Except as
prohibited by applicable law or regulation, at any time after six years from
the date of issuance of any Receipt the Company may destroy such Receipts so
cancelled.

                 SECTION 2.10  Optional Conversion of Preferred Stock into
Common Stock.  Receipts may be surrendered with written instructions to the
Depositary to instruct the Company to cause the conversion of any specified





                                       12
<PAGE>   13
number of whole shares of Preferred Stock represented by whole Depositary
Shares evidenced by such Receipts into whole shares of Common Stock, par value
$0.10 per share, of the Company ("Common Stock"), and cash for any fractional
share amount at the conversion price then in effect for the Preferred Stock
pursuant to the Certificate of Designations as such conversion price may be
adjusted by the Company from time to time as provided in the Certificate of
Designations.  Subject to the terms and conditions of this Deposit Agreement
and the Certificate of Designations, a holder of a Receipt or Receipts
evidencing Depositary Shares representing whole or fractional shares of
Preferred Stock may surrender such Receipt or Receipts at the Corporate Office
or at such office or to such Depositary's Agents as the Depositary may
designate for such purpose, together with a notice of conversion duly completed
and executed, thereby directing the Depositary to instruct the Company to cause
the conversion of the number of whole shares of underlying Preferred Stock
specified in such notice of conversion into shares of Common Stock, and an
assignment of such Receipt or Receipts to the Company or in blank, duly
completed and executed (or, if applicable, payable in cash in an amount equal
to the dividend attributable to the current quarterly dividend period payable
on such Depositary Shares).  To the extent that a holder delivers to the
Depositary for conversion a Receipt or Receipts which in the aggregate are
convertible into less than one whole share of Common Stock, the holder shall
receive payment in cash in lieu of such fractional share of Common Stock
otherwise issuable.  If more than one Receipt shall be delivered for conversion
at one time by the same holder, the number of whole shares of Common Stock
issuable upon conversion thereof shall be computed on the basis of the
aggregate number of Depositary Shares represented by the Receipts so delivered.

                 Upon receipt by the Depositary of a Receipt or Receipts,
together with notice of conversion, duly completed and executed, directing the
Depositary to instruct the Company to cause the conversion of a specified
number of shares of Preferred Stock, and an assignment of such Receipt or
Receipts to the Company or in blank, duly completed and executed (or, if
applicable, payable in cash in an amount equal to the dividend attributable to
the current quarterly dividend period payable on such Depositary Shares), the
Depositary shall instruct the





                                       13
<PAGE>   14
Company (i) to cause the conversion of the number of whole shares of Preferred
Stock represented by the Depositary Shares evidenced by the receipts so
surrendered for conversion as specified in the written notice to the Depositary
and (ii) to cause the delivery to the holders of such Receipts of a certificate
or certificates evidencing the number of whole shares of Common Stock and the
amount of money, if any, to be delivered to the holders of Receipts surrendered
for conversion in lieu of fractional shares of Common Stock otherwise issuable.
The Company shall as promptly as practicable after receipt thereof cause the
delivery of (i) a certificate or certificates evidencing the number of whole
shares of Common Stock into which the Preferred Stock represented by the
Depositary Shares evidenced by such Receipt or Receipts has been converted, and
(ii) any money or other property to which the holder is entitled by reason of
such conversion.  Upon such conversion, the Depositary (i) shall deliver to the
holder a Receipt evidencing the number of Depositary Shares evidenced by the
surrendered Receipt over the number of Depositary Shares evidenced by such
Receipt that has been so converted, (ii) shall cancel the Depositary Shares
evidenced by Receipts surrendered for conversion and (iii) shall deliver to the
Company or its transfer agent for the Preferred Stock for cancellation the
shares of Preferred Stock represented by the Depositary Shares evidenced by the
Receipts so surrendered and so converted.  Upon the delivery of the shares of
Preferred Stock to be cancelled due to such conversion by the Depositary to the
Company, the Company shall deliver to the Depositary a certificate or
certificates evidencing the number of shares of Preferred Stock, if any, that
equals the excess of the number of shares of Preferred Stock evidenced by the
surrendered certificate over the number of shares of Preferred Stock evidenced
by that certificate that has been so converted.

                 If Preferred Stock shall be called by the Company for
redemption, the Depositary Shares representing such Stock may be converted into
Common Stock as provided in this Deposit Agreement until but not after the
close of business on the Redemption Date unless the Company shall fail to
deposit with the Depositary the shares of Common Stock and cash for any
fractional share amounts required to redeem the Preferred Stock held by the
Depositary, in which case the Depositary Shares representing such Preferred
Stock may continue to be





                                       14
<PAGE>   15
converted into Common Stock until, but not after, the close of business on the
date on which the Company deposits with the Depositary such shares of Common
Stock and cash for any fractional share amounts as are required by the
Certificate of Designations to make full payment of the amounts payable upon
such redemption.

                 The record holder of Depositary Shares on any dividend payment
record date established by the Depositary shall be entitled to receive the
dividend payable with respect to such Depositary Shares on the corresponding
dividend payment date notwithstanding the conversion subsequent to such record
date of the shares of Preferred Stock to which such Depositary Shares relate.
However, if a share of Preferred Stock is converted between the record date
with respect to any dividend payment on the Preferred Stock and the
corresponding dividend payment date, any holder of Receipts surrendered with
instructions to the Depositary for conversion of the underlying Preferred Stock
shall pay to the Depositary an amount equal to the dividend attributable to the
current quarterly dividend period payable on such dividend payment date on the
Depositary Shares represented by the Receipts being surrendered for conversion
(except for Depositary Shares redeemed on a redemption date between such record
date and dividend payment date).  Any holder of Receipts on a dividend payment
record date who (or whose transferee) surrenders the Receipts with instructions
to the Depositary for conversion of the underlying Preferred Stock on the
corresponding dividend payment date will receive the dividend payable with
respect to the Depositary Shares underlying such Receipts and will not be
required to include payment of the amount of such dividend upon surrender of
the Receipts for conversion.

                 Upon the conversion of any share of Preferred Stock for which
a request for conversion has been made by the holder of Depositary Shares
representing such share, all dividends in respect of such Depositary Shares
shall cease to accrue, such Depositary Shares shall be deemed no longer
outstanding, all rights of the holder of the Receipt with respect to such
Depositary Shares (except the right to receive the Common Stock, any cash
payable with respect to any fractional shares of Common Stock as provided
herein and any cash payable on account of accrued dividends as provided herein
and any Receipts evidencing Depositary Shares no so converted) shall





                                       15
<PAGE>   16
terminate, and the Receipt evidencing such Depositary Shares shall be cancelled
in accordance with Section 2.9 hereof.

                 No fractional shares of Common Stock shall be issuable upon
conversion of Preferred Stock underlying the Depositary Shares.  If any holder
of Receipts surrendered with instructions to the Depositary for conversion of
the underlying Preferred Stock would be entitled to a fractional share of
Common Stock upon such conversion, the Company shall cause to be delivered to
such holder an amount in cash for such fractional share as provided in the
Certificate of Designations.

                 SECTION 2.11  Mandatory Conversion of Preferred Stock into 
Common Stock.  The following provisions shall apply to any Preferred Stock on
deposit with the Depositary as to which the Company has not exercised its right
to redeem and the record holder has not exercised its right of optional
conversion on the date fixed for mandatory conversion of such Preferred Stock
and Depositary Shares (the "Mandatory Conversion Date").

                 On the Mandatory Conversion Date, all then outstanding shares
of Preferred Stock shall mandatorily convert into shares of Common Stock, cash
for any fractional share amounts and the right to receive amounts in cash equal
to all accrued and unpaid dividends on such shares of Preferred Stock to the
Mandatory Conversion Date (other than previously declared dividends payable to
a holder of record as of a prior date), all as provided in and subject to
Section 3 of the Certificate of Designations.

                 From and after the Mandatory Conversion Date, the Depositary
Shares representing the shares of Preferred Stock mandatorily converted shall
be deemed no longer to be outstanding and all rights of the record holders of
Receipts evidencing such Depositary Shares (except the right to receive the
shares of Common Stock, any cash for accrued and unpaid dividends (other than
previously declared dividends payable to a holder of record as of a prior date)
and any fractional share amount deliverable or payable upon mandatory
conversion or in connection therewith) shall, to the extent of such Depositary
Shares, cease and terminate.  Upon surrender, in accordance with said notice,
of the Receipts evidenc-





                                       16
<PAGE>   17
ing such Depositary Shares (properly endorsed or assigned for transfer, as the
Depositary shall so require), such Depositary Shares shall be exchanged for
shares of Common Stock and cash for any fractional share amount (and the right
to receive cash for any accrued and unpaid dividends payable in connection
therewith) at a rate per Depositary Share equal to one-fiftieth of the number
(including fractional shares) of shares of Common Stock (and one-fiftieth of
the right to receive cash for any accrued and unpaid dividends) exchanged for
each share of Preferred Stock pursuant to the Certificate of Designations.  The
foregoing shall be subject further to the terms and conditions of the
Certificate of Designations.

                 On or prior to the Mandatory Conversion Date, the Company
shall deposit with the Depositary certificates for the shares of Common Stock
and the cash for any fractional share amounts into which the shares of
Preferred Stock held by the Depositary shall mandatorily convert on the
Mandatory Conversion Date, plus, subject to the Certificate of Designations, an
amount in cash equal to all accrued and unpaid dividends on such shares of
Preferred Stock (other than previously declared dividends payable to a holder
of record as of a prior date) to the Mandatory Conversion Date.  Using such
shares of Common Stock and cash, the Depositary shall deliver certificates for
the appropriate number of shares of Common Stock and the appropriate amount of
cash, without interest, to record holders who properly deliver their Receipts
to the Depositary.

                 No fractional shares of Common Stock shall be issuable upon
mandatory conversion of Preferred Stock underlying the Depositary Shares.  If
any holder of Receipts surrendered to the Depositary for mandatory conversion
of the underlying Preferred Stock would be entitled to a fractional share of
Common Stock upon such mandatory conversion, the Company shall cause to be
delivered to such holder an amount in cash for such fractional share as
provided in the Certificate of Designations.  To the extent that Depositary
Shares are mandatorily converted into shares of Common Stock and all such
shares of Common Stock cannot be distributed to the record holders of Receipts
without creating fractional interest in such shares, the Depositary may, with
the consent of the Company, adopt such method as it deemed equitable and
practicable for the purpose of effecting





                                       17
<PAGE>   18
such distribution, including the sale (at public or private sale) of such
shares of Common Stock at such place or places and upon such terms as it may
deem proper, and the net proceeds of any such sale shall, subject to Section
3.2, without interest, be distributed or made available for distribution to
such record holders that would otherwise receive fractional interests in such
shares of Common Stock.


                              ARTICLE ARTICLE III

                         CERTAIN OBLIGATIONS OF HOLDERS
                          OF RECEIPTS AND THE COMPANY

                 SECTION 3.1  Filing Proofs, Certificates and Other Information.
Any person presenting Preferred Stock for deposit or any holder of a Receipt
may be required from time to time to file such proof of residence or other
information, to execute such certificates and to make such representations and
warranties as the Depositary or the Company may reasonably deem necessary or
proper.  The Depositary or the Company may withhold or delay the delivery of
any Receipt, the transfer, redemption or exchange of any Receipt, the
withdrawal of the Preferred Stock represented by the Depositary Shares
evidenced by any Receipt, the distribution of any dividend or other
distribution, the sale of any rights or of the proceeds thereof, the exercise
of any conversion right referred to in Section 2.10 and 2.11 or the delivery of
any Common Stock upon such conversion until such proof or other information is
filed, such certificates are executed or such representations and warranties
are made.

                 SECTION 3.2  Payment of Taxes or Other Governmental Charges.
If any tax (including applicable interest, penalties or additions) or other
governmental charge shall become payable by or on behalf of the Depositary with
respect to any Receipt, the Depositary Shares evidenced by such Receipt, the
Preferred Stock (or any fractional interest therein) represented by such
Depositary Shares, the exercise of any conversion right referred to in Section
2.10 or any transaction referred to in Section 4.6 with respect to a Receipt or
the Preferred Stock represented by such Receipt, such tax (including transfer,
issuance or acquisition taxes, if any) or





                                       18
<PAGE>   19
governmental charge shall be payable by the holder of such Receipt.  Until such
payment is made, transfer of any Receipt or any withdrawal of the Preferred
Stock or money or other property, if any, represented by the Depositary Shares
evidenced by such Receipt may be refused, any dividend or other distribution
may be withheld, such conversion right may be refused and any part or all of
the Preferred Stock or other property represented by the Depositary Shares
evidenced by such Receipt may be sold for the account of the holder thereof
(after attempting by reasonable means to notify such holder prior to such
sale).  Any dividend or other distribution so withheld and the proceeds of any
such sale may be applied to any payment of such tax or other governmental
charge, the holder of such Receipt remaining liable for any deficiency.  In the
event the Depositary is required to pay any such amounts, the Company shall
reimburse the Depositary for payment thereof upon the request of the Depositary
and the Depositary shall, upon the Company's request and as instructed by the
Company, pursue its rights against such holder at the Company's expense.

                 SECTION 3.3  Representations and Warranties as to Preferred
Stock.  Each person (including, without limitation, the Company) depositing
Preferred Stock under this Deposit Agreement shall be deemed thereby to
represent and warrant that such Preferred Stock and each certificate therefor
are valid, fully paid and nonassessable shares and that the person making such
deposit is duly authorized to do so.  Such representations and warranties shall
survive the deposit of the Preferred Stock and the issuance of Receipts.


                               ARTICLE ARTICLE IV

                          THE PREFERRED STOCK NOTICES

                 SECTION 4.1  Cash Distributions.  Whenever the Depositary
shall receive any cash dividend or other cash distribution on the Preferred
Stock, the Depositary shall, subject to Section 3.2, distribute to record
holders of Receipts on the record date fixed pursuant to Section 4.4 such
amounts of such sum as are, as nearly as practicable, attributable to the
respective numbers of Depositary Shares evidenced by the Receipts held by such
holders; provided, however, that in case the Company or





                                       19
<PAGE>   20
the Depositary shall be required to withhold and does withhold from any cash
dividend or other cash distributed in respect of the Preferred Stock an amount
on account of taxes, the amount made available for distribution or distributed
in respect of Depositary Shares shall be reduced accordingly.  The Depositary
shall distribute or make available for distribution, as the case may be, only
such amount, however, as can be distributed without attributing to any owner of
Depositary Shares a fraction of one cent and any balance not so distributable
shall be rounded to the next highest whole cent and, upon request of the
Depositary, the Company shall pay the additional amount to the Depositary for
distribution.

                 SECTION 4.2  Distributions Other Than Cash. Whenever the 
Depositary shall receive any distribution other than cash on the Preferred
Stock, the Depositary shall, subject to Section 3.2, distribute to record
holders of Receipts on the record date fixed pursuant to Section 4.4 such
amounts of the securities or property received by it as are, as nearly as
practicable, in proportion to the respective numbers of Depositary Shares
evidenced by the Receipts held by such holders, in any manner that the
Depositary and the Company may deem equitable and practicable for accomplishing
such distribution.  If, in the opinion of the Company after consultation with
the Depositary, such distribution cannot be made proportionately among such
record holders, or if for any other reason (including any requirement that the
Company or the Depositary withhold an amount on account of taxes or as
otherwise required by law, regulation, or court process), the Depositary deems,
after consultation with the Company, such distribution not to be feasible, the
Depositary may, with the approval of the Company, adopt such method as it deems
equitable and practicable for the purpose of effecting such distribution,
including the sale (a public or private sale) of the securities or property
thus received, or any part thereof, at such place or places and upon such terms
as it may deem proper.  The net proceeds of any such sale shall, subject to
Section 3.2, be distributed or made available for distribution, as the case may
be, by the Depositary to record holders of Receipts as provided by Section 4.1
in the case of a distribution received in cash.

                 SECTION 4.3  Subscription Rights, Preferences or Privileges.
If the Company shall at any time offer or





                                       20
<PAGE>   21
cause to be offered to the persons in whose names Preferred Stock is registered
on the books of the Company any rights, preferences or privileges to subscribe
for or to purchase any securities or any rights, preferences or privileges of
any other nature, such rights, preferences or privileges shall, in each such
instance be made available by the Depositary to the record holders of Receipts
if the Company so directs in such manner as the Company shall instruct
(including by the issuance to such record holders of warrants representing such
rights, preferences or privileges); provided, however, that (a) if at the time
of issue or offer of any such rights, preferences or privileges the Company
determines that it is not lawful or feasible to make such rights, preferences
or privileges available to some or all holders of Receipts (by the issue of
warrants or otherwise) or (b) if and to the extent instructed by holders of
Receipts who do not desire to exercise such rights, preferences or privileges,
the Depositary shall then, if so instructed by the Company, and if applicable
laws or the terms of such rights, preferences or privileges so permit, sell
such rights, preferences or privileges of such holders at public or private
sale, at such place or places and upon such terms as it may deem proper.  The
net proceeds of any such sale shall be distributed by the Depositary to the
record holders of Receipts entitled thereto as provided by Section 4.1 in the
case of a distribution received in cash.

                 If registration under the Securities Act of the securities to
which any rights, preferences or privileges relate is required in order for
holders of Receipts to be offered or sold the securities to which such rights,
preferences or privileges relate, the Company will promptly file a registration
statement pursuant to the Securities Act with respect to such rights,
preferences or privileges and securities and use its best efforts and take all
steps available to it to cause such registration statement to become effective
sufficiently in advance of the expiration of such rights, preferences or
privileges to enable such holders to exercise such rights, preferences or
privileges.  In no event shall the Depositary make available to the holders of
Receipts any right, preference or privilege to subscribe for or to purchase any
securities unless and until the Depositary receives written notice and an
opinion of counsel from the Company that a registration statement shall have
become effective





                                       21
<PAGE>   22
or the offering and sale of such securities to such holders are exempt from
registration under the provisions of the Securities Act.

                 If any other action under the law of any jurisdiction or any
governmental or administrative authorization, consent or permit is required in
order for such rights, preferences or privileges to be made available to
holders of Receipts, the Company will use its best efforts to take such action
or obtain such authorization, consent or permit sufficiently in advance of the
expiration of such rights, preferences or privileges to enable such holders to
exercise such rights, preferences or privileges.

                 SECTION 4.4  Notice of Dividends, Fixing of Record Date for
Holders of Receipts.  Whenever any cash dividend or other cash distribution
shall become payable, any distribution other than cash shall be made, or any
rights, preferences or privileges shall at any time be offered, with respect to
the Preferred Stock or the Depositary shall receive notice of (i) any meeting
at which holders of Preferred Stock are entitled to vote or of which holders of
Preferred Stock are entitled to notice or (ii) any election on the part of the
Company to redeem any shares of Preferred Stock, the Depositary shall in each
such instance fix a record date (which shall be the same date as the record
date fixed by the Company in respect of the Preferred Stock) for the
determination of the holders of Receipts who shall be entitled to receive such
dividend, distribution, rights, preferences or privileges or the net proceeds
of the sale thereof, to give instructions for the exercise of voting rights at
any such meeting or to receive notice of such meeting or whose Depositary
Shares are to be so redeemed.

                 SECTION 4.5  Voting Rights.  Upon receipt of notice of any
meeting at which the holders of Preferred Stock are entitled to vote, the
Depositary shall, as soon as practicable thereafter, mail to the record holders
of Receipts a notice, which shall be provided by the Company and which shall
contain (i) such information as is contained in such notice of meeting, (ii) a
statement that the holders of Receipts at the close of business on a specified
record date fixed pursuant to Section 4.4 will be entitled, subject to any
applicable provision of law, the Certificate of Incorporation or the
Certificate of





                                       22
<PAGE>   23
Designations, to instruct the Depositary as to the exercise of the voting
rights pertaining to the amount of Preferred Stock represented by their
respective Depositary Shares and (iii) a brief statement as to the manner in
which such instructions may be given.  Upon the written request of a holder of
a Receipt on such record date, the Depositary shall endeavor insofar as
practicable to vote or cause to be voted the number of shares of Preferred
Stock represented by the Depositary Shares evidenced by such Receipt in
accordance with the instructions set forth in such request.  The Company hereby
agrees to take all reasonable action that may be deemed necessary by the
Depositary in order to enable the Depositary to vote such shares of Preferred
Stock or cause such shares of Preferred Stock to be voted.  In the absence of
specific instructions from the holder of a Receipt, the Depositary will abstain
from voting to the extent of the Preferred Stock represented by the Depositary
Shares evidenced by such Receipt.  After aggregating all voting Depositary
Shares, the Depositary will disregard for voting purposes any fractional share
of Preferred Stock remaining.

                 SECTION 4.6  Changes Affecting Preferred Stock and 
Reclassifications, Recapitalizations, etc.  Upon any split-up, consolidation or
any other reclassification of Preferred Stock, or upon any recapitalization,
reorganization, merger, amalgamation or consolidation affecting the Company or
to which it is a party or sale of all or substantially all of the Company's
assets, the Depositary shall, upon the instructions of the Company, treat any
shares of stock or other securities or property (including cash) that shall be
received by the Depositary in exchange for or upon conversion of or in respect
of the Preferred Stock as new deposited property under this Deposit Agreement,
and Receipts then outstanding shall thenceforth represent the proportionate
interests of holders thereof in the new deposited property so received in
exchange for or upon conversion or in respect of such Preferred Stock.  In any
such case the Depositary may, in its discretion, with the approval of the
Company, execute and deliver additional Receipts, or may call for the surrender
of all outstanding Receipts to be exchanged for new Receipts specifically
describing such new deposited property.





                                       23
<PAGE>   24
                               ARTICLE ARTICLE V

                         THE DEPOSITARY AND THE COMPANY

                 SECTION 5.1  Maintenance of Offices, Agencies, Transfer
Books by the Depositary; the Registrar.  Upon execution of this Deposit
Agreement in accordance with its terms, the Depositary shall maintain at the
Corporate Office facilities for the execution and delivery, transfer, surrender
and exchange, split-up, combination and redemption of Receipts and deposit and
withdrawal of Preferred Stock and at the offices of the Depositary's Agents, if
any, facilities for the delivery, transfer, surrender and exchange, split-up,
combination, conversion and redemption of Receipts and deposit and withdrawal
of Preferred Stock, all in accordance with the provisions of this Deposit
Agreement.

                 The Depositary shall keep books at the Corporate Office for
the registration and transfer of Receipts, which books at all reasonable times
and during normal business hours shall be open for inspection by the record
holders of Receipts as provided by applicable law; provided, that any such
holder requesting to exercise such right shall certify to the Depositary that
such inspection shall be for a proper purpose reasonably related to such
person's interest as an owner of Depositary Shares evidenced by the Receipts.
The Depositary shall consult with the Company upon receipt of any request for
inspection and shall not permit such inspection unless authorized by the
Company in writing.  The Depositary may close such books, at any time or from
time to time, when deemed expedient by it in connection with the performance of
its duties hereunder.

                 The Depositary shall make available for inspection by holders
of Receipts at the Corporate Office and at such other places as it may from
time to time deem advisable during normal business hours any reports and
communications received from the Company that are both received by the
Depositary as the holder of Preferred Stock and made generally available to the
holders of Preferred Stock.

                 Promptly upon request from time to time by the Company, the
Depositary shall, at the Company's sole expense, furnish to it a list, as of a
recent date, of





                                       24
<PAGE>   25
the names, addresses and holdings of Depositary Shares of all persons in whose
names Receipts are registered on the books of the Depositary.

                 If the Receipts or the Depositary Shares evidenced thereby or
the Preferred Stock represented by such Depositary Shares shall be listed on
The New York Stock Exchange, Inc., the Depositary may, with the approval of the
Company, appoint a Registrar for registry of such Receipts or Depositary Shares
in accordance with the requirements of such Exchange.  Such Registrar (which
may be the Depositary if so permitted by the requirements of such Exchange) may
be removed and a substitute registrar appointed by the Depositary upon the
request or with the approval of the Company.  If the Receipts, such Depositary
Shares or the Preferred Stock is listed on one or more other stock exchanges,
the Depositary will, at the request of the Company, arrange such facilities for
the delivery, transfer, surrender and exchange of such Receipts, such
Depositary Shares or such Preferred Stock as may be required by law or
applicable stock exchange regulations.

                 SECTION 5.2  Prevention or Delay in Performance by the
Depositary, the Depositary's Agents or the Company.  Neither the Depositary nor
any Depositary's Agent nor the Company shall incur any liability to any holder
of any Receipt, if by reason of any provision of any present or future law or
regulation thereunder of the United States of America or of any other
governmental authority or, in the case of the Depositary or the Depositary's
Agent, by reason of any provision, present or future, of the Certificate of
Incorporation or the Certificate of Designations or, in the case of the
Company, the Depositary or the Depositary's Agent, by reason of any act of God
or war or other circumstance beyond the control of the relevant party, the
Depositary, any Depositary's Agent or the Company shall be prevented or
forbidden from doing or performing any act or thing that the terms of this
Deposit Agreement provide shall be done or performed; nor shall the Depositary,
any Depositary's Agent or the Company incur any liability to any holder of a
Receipt by reason of any nonperformance or delay, caused as aforesaid, in the
performance of any act or thing that the terms of this Deposit Agreement
provide shall or may be done or performed, or by reason of any





                                       25
<PAGE>   26
exercise of, or failure to exercise, any discretion provided for in this
Deposit Agreement.

                 SECTION 5.3  Obligations of the Depositary, the Depositary's
Agents and the Company.  Neither the Depositary, the Registrar, any
Depositary's Agent nor the Company assumes any obligation or shall be subject
to any liability under this Deposit Agreement or any Receipt to holders of
Receipts other than for their negligence (including the failure to meet
customary trade practice) or willful misconduct and that each of them agrees to
act in good faith in the performance of such duties as are specifically set
forth in this Deposit Agreement.

                 Neither the Depositary, the Registrar nor any Depositary's
Agent nor the Company shall be under any obligation to appear in, prosecute or
defend any action, suit or other proceeding with respect to the Preferred
Stock, Depositary Shares, Receipts or Common Stock that in its opinion may
involve it in expense or liability, unless indemnity satisfactory to it against
all expense and liability be furnished as often as may be required.

                 Neither the Depositary, the Registrar, any Depositary's Agent
nor the Company shall be liable for any action or any failure to act by it in
reliance upon the advice of or information from legal counsel, accountants, any
person presenting Preferred Stock for deposit, any holder of a Receipt or any
other person believed by it in good faith to be competent to give such advice
or information.  The Depositary, any Depositary's Agent and the Company may
each rely and shall each be protected in acting upon any written notice,
request, direction or other document believed by it to be genuine and to have
been signed or presented by the proper party or parties.

                 The Depositary, its parent, affiliate, or subsidiaries, the
Registrar and any Depositary's Agent may own, buy, sell or deal in any class of
securities of the Company and its affiliates and in Receipts or Depositary
Shares or become pecuniarily interested in any transaction in which the Company
and its affiliates may be interested or contract with or lend money to or
otherwise act as fully or as freely as if the Depositary, the Registrar or the
Depositary's Agent, as the case may be, was not the Depositary, the Registrar
or the Depositary's Agent hereunder.  The Depositary may also act as transfer





                                       26
<PAGE>   27
agent or registrar of any of the securities of the Company and its affiliates.

                 It is intended that neither the Depositary nor any
Depositary's Agent shall be deemed to be an "issuer" of the securities under
the federal securities laws or applicable state securities laws, it being
expressly understood and agreed that the Depositary and any Depositary's Agent
are acting only in a ministerial capacity as Depositary for the Preferred
Stock.  The Depositary agrees to comply with all information reporting and
withholding requirements applicable to it under law or this Deposit Agreement
in its capacity as Depositary.

                 Neither the Depositary (or its officers, directors, employees
or agents) nor any Depositary's Agent makes any representation or has any
responsibility as to the validity of the Preferred Stock, the Depositary Shares
or the Receipts (except for its counter-signatures thereon) or any instruments
referred to therein or herein, or as to the correctness of any statement made
therein or herein.

                 The Depositary assumes no responsibility for the correctness
of the description that appears in the Receipts, which can be taken as a
statement of the Company summarizing certain provisions of this Deposit
Agreement.  Notwithstanding any other provision herein or in the Receipts, the
Depositary makes no warranties or representations as to the validity,
genuineness or sufficiency of any Preferred Stock at any time deposited with
the Depositary hereunder or of the Depositary Shares, as to the validity or
sufficiency of this Deposit Agreement, as to the value of the Depositary Shares
or as to any right, title or interest of the record holders of Receipts in and
to the Depositary Shares.  The Depositary shall not be accountable for the use
or application by the Company of the proceeds of the Depositary Shares or the
Preferred Stock.

                 The Depositary shall act as the withholding agent for any
payments, distributions, and exchanges made with respect to the Depositary
Shares and Receipts, and the Preferred Stock, Common Stock or other securities
or assets represented thereby (collectively, the "Securities").  The Depositary
shall be responsible with respect





                                       27
<PAGE>   28
to the Securities for the timely (i) collection and deposit of any required
withholding or backup withholding tax, and (ii) filing of any information
returns or other documents with Federal taxing authorities.

                 SECTION 5.4  Resignation and Removal of the Depositary,
Appointment of Successor Depositary.  The Depositary may at any time resign as
Depositary hereunder by notice of its election to do so delivered to the
Company, such resignation to take effect upon the appointment of a successor
depositary and its acceptance of such appointment as hereinafter provided.

                 The Depositary may at any time be removed by the Company by
notice of such removal delivered to the Depositary, such removal to take effect
upon the appointment of a successor depositary and its acceptance of such
appointment as hereinafter provided.

                 In case at any time the Depositary acting hereunder shall
resign or be removed, the Company shall, within 45 days after the delivery of
the notice of resignation or removal, as the case may be, appoint a successor
depositary, which shall be a bank or trust company having its principal office
in the United States of America and having a combined capital and surplus of at
least $50,000,000.  If a successor depositary shall not have been appointed in
45 days, the resigning Depositary may petition a court of competent
jurisdiction to appoint a successor depositary.  Every successor depositary
shall execute and deliver to its predecessor and to the Company an instrument
in writing accepting its appointment hereunder, and thereupon such successor
depositary, without any further act or deed, shall become fully vested with all
the rights, powers, duties and obligations of its predecessor and for all
purposes shall be the Depositary under this Deposit Agreement, and such
predecessor, upon payment of all sums due it and on the written request of the
Company, shall promptly execute and deliver an instrument transferring to such
successor all rights and powers of such predecessor hereunder, shall duly
assign, transfer and deliver all rights, title and interest in the Preferred
Stock and any moneys or property held hereunder to such successor and shall
deliver to such successor a list of the record holders of all outstanding
Receipts and such other records respecting the Receipts, the Depositary Shares
and the Preferred Stock as the





                                       28
<PAGE>   29
successor shall require in order to perform its duties.  Any successor
depositary shall promptly mail notice of its appointment to the record holders
of Receipts.

                 Any corporation into or with which the Depositary may be
merged, consolidated or converted shall be the successor of such Depositary
without the execution or filing of any document or any further act.  Such
successor depositary may execute the Receipts either in the name of the
predecessor depositary or in the name of the successor depositary.

                 SECTION 5.5  Corporate Notices and Reports.  The Company
agrees that it will deliver to the Depositary, and the Depositary will,
promptly after receipt thereof, transmit to the record holders of Receipts, in
each case at the address recorded in the Depositary's books, copies of all
notices and reports (including financial statements) required by law, by the
rules of any national securities exchange upon which the Preferred Stock, the
Depositary Shares or the Receipts are listed or by the Certificate of
Incorporation and the Certificate of Designations to be furnished by the
Company to holders of Preferred Stock.  Such transmission will be at the
Company's expense and the Company will provide the Depositary with such number
of copies of such documents as the Depositary may reasonably request.  In
addition, the Depositary will transmit to the record holders of Receipts at the
Company's expense such other documents as may be requested by the Company.

                 SECTION 5.6  Deposit of Preferred Stock by the Company.  The
Company agrees with the Depositary that neither the Company nor any company
controlled by the Company will at any time deposit any Preferred Stock if such
Preferred Stock is required to be registered under the provisions of the
Securities Act and no registration statement is at such time in effect as to
such Preferred Stock.

                 SECTION 5.7  Indemnification by the Company.  The Company
agrees to indemnify the Depositary, any Depositary's Agent and any Registrar
against, and hold each of them harmless from, any liability, costs and expenses
(including the reasonable fees and expenses of counsel) that may arise out of
or in connection with its acting as Depositary, Depositary's Agent or
Registrar,





                                       29
<PAGE>   30
respectively, under this Deposit Agreement and the Receipts, except for any
liability arising out of negligence or bad faith on the part of any such person
or persons.

                 SECTION 5.8  Fees, Charges and Expenses.  No fees, charges
and expenses of the Depositary or any Depositary's Agent hereunder or of any
Registrar shall be payable by any person other than the Company, except for any
taxes (including transfer taxes, if any) and other governmental charges and
except as provided in this Deposit Agreement.  If the Depositary incurs fees,
charges or expenses for which it is not otherwise liable hereunder due to any
action or inaction of a holder of a Receipt or other person, such holder or
other person will be liable for such fees, charges and expenses.  All other
fees, charges and expenses of the Depositary and any Depositary's Agent
hereunder and of any Registrar (including, in each case, the reasonable fees
and expenses of counsel) incident to the performance of their respective
obligations hereunder will be paid upon consultation and agreement between the
Depositary and the Company as to the amount and nature of such fees, charges
and expenses.  The Depositary shall present its statement for fees, charges and
expenses to the Company once every month or at such other intervals as the
Company and the Depositary may agree.


                               ARTICLE ARTICLE VI

                           AMENDMENT AND TERMINATION

                 SECTION 6.1  Amendment.  The form of the Receipts and any
provision of this Deposit Agreement may at any time and from time to time be
amended by agreement between the Company and the Depositary in any respect that
they may deem necessary or desirable.  Any amendment that shall impose any
fees, taxes or charges (other than taxes and other governmental charges, fees
and expenses provided for herein or in the Receipts), or that shall otherwise
prejudice any substantial existing right of holders of Receipts, shall not
become effective as to outstanding Receipts until the expiration of 90 days
after notice of such amendment shall have been given to the record holders of
outstanding Receipts.  Every holder of an outstanding Receipt at the time any
such amendment





                                       30
<PAGE>   31
becomes effective shall be deemed, by continuing to hold such Receipt, to
consent and agree to such amendment and to be bound by this Deposit Agreement
as amended thereby.  In no event shall any amendment impair the right, subject
to the provisions of Sections 2.3, 2.4, 2.6, 2.7, 2.10 and 2.11 and Article
III, of any owner of any Depositary Shares to surrender the Receipt evidencing
such Depositary Shares with instructions to the Depositary to deliver to the
holder the Preferred Stock or to cause the conversion of the underlying
Preferred Stock into Common Stock and cash for fractional shares and, in each
case, all money and other property, if any, represented thereby, except in
order to comply with mandatory provisions of applicable law.

                 SECTION 6.2  Termination.  Whenever so directed by the
Company, the Depositary will terminate this Deposit Agreement by mailing notice
of such termination to the record holders of all Receipts then outstanding at
least 30 days prior to the date fixed in such notice for such termination.  The
Depositary may likewise terminate this Deposit Agreement if at any time 45 days
shall have expired after the Depositary shall have delivered to the Company a
written notice of its election to resign and a successor depositary shall not
have been appointed and accepted its appointment as provided in Section 5.4.
If any Receipts remain outstanding after the date of termination, the
Depositary thereafter will discontinue the transfer of Receipts, will suspend
the distribution of dividends to the holders thereof, and will not give any
further notices (other than notice of such termination) or perform any further
acts under this Deposit Agreement except as provided below and except that the
Depositary will continue (i) to collect dividends on the Preferred Stock and
any other distributions with respect thereto and (ii) to deliver Preferred
Stock together with such dividends and distributions and the net proceeds of
any sales of rights, preferences, privileges or other property, without
liability for interest thereon, in exchange for Receipts surrendered.  At any
time after the expiration of two years from the date of termination, the
Depositary may sell the Preferred Stock then held by it at public or private
sales, at such place or places and upon such terms as it deems proper and may
thereafter hold the net proceeds of any such sale, together with any money and
other property then held by it, without liability for interest thereon, for the
pro rata benefit of the





                                       31
<PAGE>   32
holders of Receipts which have not been surrendered.  In the event this Deposit
Agreement is terminated and a sufficient number of shares of Preferred Stock
remain outstanding, the Company will use its best efforts to list the shares of
Preferred Stock on the New York Stock Exchange (unless the holders of a
majority of the outstanding shares of Preferred Stock shall consent to the
Company not effecting such listing).  Upon termination, the Company and the
Depositary shall be discharged from all obligations under this Deposit
Agreement, except from the Company's obligations to the Depositary, any
Depositary's Agent or any Registrar under Sections 5.7 and 5.8.


                              ARTICLE ARTICLE VII

                                 MISCELLANEOUS

                 SECTION 7.1  Counterparts.  This Deposit Agreement may be
executed by the Company and the Depositary in separate counterparts, each of
which counterparts, when so executed an delivered, shall be deemed an original,
but all such counterparts taken together shall constitute one and the same
instrument.  Delivery of an executed counterpart of a signature page to this
Deposit Agreement by telecopier shall be effective as delivery of a manually
executed counterpart of this Deposit Agreement.  Copies of this Deposit
Agreement shall be filed with the Depositary and the Depositary's Agent at the
Corporate Office and the respective offices of the Depositary's Agents, if any,
by any holder of a Receipt.

                 SECTION 7.2  Exclusive Benefits of Parties.  This Deposit
Agreement is for the exclusive benefit of the parties hereto, and their
respective successors hereunder, and shall not be deemed to give any legal or
equitable right, remedy or claim to any other person whatsoever.

                 SECTION 7.3  Invalidity of Provisions.  In case any one or
more of the provisions contained in this Deposit Agreement or in the Receipts
should be or become invalid, illegal or unenforceable in any respect, the
validity, legality and enforceability of the remaining provisions contained
herein or therein shall in no way be affected, prejudiced or disturbed thereby.





                                       32
<PAGE>   33
                 SECTION 7.4  Notices.  Any notices to be given to the Company 
hereunder or under the Receipts shall be in writing and shall be deemed to have
been duly given if personally delivered or sent by overnight, registered or
certified mail, or by telegram or telex confirmed by letter, addressed to the
Company at 150 Glover Avenue, Norwalk, Connecticut 06856; Attention: Chief
Financial Officer, or at such other address as shall be specified by the
Company by like notice.  Any notices to be given to the Depositary hereunder or
under the Receipts shall be in writing and shall be deemed to have been duly
given if personally delivered or sent by overnight, registered or certified
mail, or by telegram or telex confirmed by letter, addressed to the Depositary
at 14 Wall Street, Suite 4680, New York, New York, 10005, Attention: Account
Manager Officer, or at such other address as shall be specified by the
Depositary by like notice.

                 Any notices given to any record holder of a Receipt hereunder
or under the Receipts shall be in writing and shall be deemed to have been duly
given if personally delivered or sent by mail, or by telegram or telex
confirmed by letter, addressed to such record holder at the address of such
record holder as it appears on the books of the Depositary or, if such holder
shall have filed with the Depositary a written request that notices intended
for such holder be mailed to some other address, at the address designated in
such request.

                 Delivery of a notice sent by mail, or by telegram or telex
shall be deemed to be effected at the time when a duly addressed letter
containing the same (or a duly addressed letter confirming an earlier notice in
the case of a telegram or telex message) is deposited, postage prepaid, in a
post office letter box.  The Depositary or the Company may, however, act upon
any telegram or telex message received by it from the other or from any holder
of a Receipt, notwithstanding that such telegram or telex message shall not
subsequently be confirmed by letter as aforesaid.

                 SECTION 7.5  Depositary's Agents.  The Depositary may from
time to time appoint Depositary's Agents to act in any respect for the
Depositary for the purposes of this Deposit Agreement and may at any time
appoint additional Depositary's Agents and vary or terminate the





                                       33
<PAGE>   34
appointment of such Depositary's Agents.  The Depositary will notify the
Company of any such action.

                 SECTION 7.6  Holders of Receipts Are Parties.  The holders of 
Receipts from time to time shall be deemed to be parties to this Deposit
Agreement and shall be bound by all of the terms and conditions hereof and of
the Receipts by acceptance of delivery thereof.

                 SECTION 7.7  Governing Law.  This Deposit Agreement and the
Receipts and all rights hereunder and thereunder and provisions hereof and
thereof shall be governed by, and construed in accordance with, the laws of the
State of New York, without regard to conflict of laws rules.

                 SECTION 7.8  Headings.  The headings of articles and sections 
in this Deposit Agreement and in the form of the Receipt set forth in Exhibit A
hereto have been inserted for convenience only and are not to be regarded as a
part of this Deposit Agreement or the Receipts or to have any bearing upon the
meaning or interpretation of any provision contained herein or in the Receipts.





                                       34
<PAGE>   35

                 IN WITNESS WHEREOF, the Company and the Depositary have duly
executed this agreement as of the day and year first above set forth and all
holders of Receipts shall become parties hereto by and upon acceptance by them
of delivery of Receipts issued in accordance with the terms hereof.


                                     U.S. SURGICAL CORPORATION


Attest:                              By: 
        ----------------                 -----------------------
                                        Name:
                                        Title:


                                     FIRST CHICAGO TRUST COMPANY OF
                                       NEW YORK


Attest:                              By: 
        ----------------                 -----------------------
                                        Name:
                                        Title:





                                       35

<PAGE>   1
                                                                   EXHIBIT 4(d)

                       United States Surgical Corporation
                      SERIES A CONVERTIBLE PREFERRED STOCK
 
                                                SEE REVERSE FOR CERTAIN
     INCORPORATED UNDER THE LAWS         DEFINITIONS AND TRANSFER RESTRICTIONS
      OF THE STATE OF DELAWARE                     CUSIP 912707 30 4
 
   THIS CERTIFIES THAT



   is the owner of
 
FULLY PAID AND NON-ASSESSABLE SHARES OF SERIES A CONVERTIBLE PREFERRED STOCK OF
                         THE PAR VALUE OF $5.00 EACH OF
    -------------------UNITED STATES SURGICAL CORPORATION--------------------- 
 
transferable on the books of the Corporation by the holder hereof in person or
by duly authorized attorney upon surrender of the certificate properly endorsed.
This certificate and the shares represented hereby are issued and shall be
subject to all the provisions of the Certificate of Incorporation of the
Corporation, as in effect from time to time, to all of which the holder hereof
by acceptance hereof assents. This Certificate is not valid unless countersigned
by the Transfer Agent and registered by the Registrar.
 
     WITNESS the facsimile seal of the Corporation and the facsimile signatures
of its duly authorized officers.
<TABLE>
<S>                                      <C>                    <C>
Dated:
By:                                                             By:                                                   
           [signature]                    [corporate seal]                  [signature]                        
                      SECRETARY                                                          CHAIRMAN, PRESIDENT AND 
                                                                                         CHIEF EXECUTIVE OFFICER 
</TABLE>

COUNTERSIGNED AND REGISTERED:
                 FIRST CHICAGO TRUST COMPANY
                       OF NEW YORK                  TRANSFER AGENT
BY                                                   AND REGISTRAR


                                              AUTHORIZED SIGNATURE



<PAGE>   2
 
                       UNITED STATES SURGICAL CORPORATION
 
   THE SECURITY (OR ITS PREDECESSOR) EVIDENCED HEREBY HAS NOT BEEN REGISTERED
UNDER THE U.S. SECURITIES ACT OF 1933 (THE "SECURITIES ACT"), AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR
BENEFIT OF, U.S. PERSONS EXCEPT AS SET FORTH IN THE FOLLOWING SENTENCE. BY ITS
ACQUISITION HEREOF, THE HOLDER (1) REPRESENTS THAT (A) IT IS A "QUALIFIED
INSTITUTIONAL BUYER" (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT) OR (B)
IT IS AN INSTITUTIONAL "ACCREDITED INVESTOR" (AS DEFINED IN RULE 501(a)(1), (2),
(3) OR (7) UNDER THE SECURITIES ACT) ("INSTITUTIONAL ACCREDITED INVESTOR") OR
(C) IT IS NOT A U.S. PERSON AND IS ACQUIRING THE SECURITY EVIDENCED HEREBY IN AN
OFFSHORE TRANSACTION, (2) AGREES THAT IT WILL NOT WITHIN THREE YEARS AFTER THE
ORIGINAL ISSUANCE OF THE SECURITY EVIDENCED HEREBY RESELL OR OTHERWISE TRANSFER
THE SECURITY EVIDENCED HEREBY EXCEPT (A) TO UNITED STATES SURGICAL CORPORATION
OR ANY SUBSIDIARY THEREOF, (B) INSIDE THE UNITED STATES TO A QUALIFIED
INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, (C)
INSIDE THE UNITED STATES TO AN INSTITUTIONAL ACCREDITED INVESTOR THAT, PRIOR TO
SUCH TRANSFER, FURNISHES TO FIRST CHICAGO TRUST COMPANY OF NEW YORK, AS TRANSFER
AGENT, A SIGNED LETTER CONTAINING CERTAIN REPRESENTATIONS AND AGREEMENTS
RELATING TO THE RESTRICTIONS ON TRANSFER OF THE SECURITY EVIDENCED HEREBY (THE
FORM OF WHICH LETTER CAN BE OBTAINED FROM SUCH TRANSFER AGENT), (D) OUTSIDE THE
UNITED STATES IN COMPLIANCE WITH RULE 904 UNDER THE SECURITIES ACT, (E) PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR (F) PURSUANT
TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144,
IF APPLICABLE, UNDER THE SECURITIES ACT AND (3) AGREES THAT IT WILL DELIVER TO
EACH PERSON TO WHOM THE SECURITY EVIDENCED HEREBY IS TRANSFERRED A NOTICE
SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND. IN CONNECTION WITH ANY TRANSFER OF
THE SECURITY EVIDENCED HEREBY IN CERTIFICATED FORM WITHIN THREE YEARS AFTER THE
ORIGINAL ISSUANCE OF SUCH SECURITY, THE HOLDER MUST CHECK THE APPROPRIATE BOX
SET FORTH BELOW RELATING TO THE MANNER OF SUCH TRANSFER AND SUBMIT THIS
CERTIFICATE TO FIRST CHICAGO TRUST COMPANY OF NEW YORK, AS TRANSFER AGENT. IF
THE PROPOSED TRANSFEREE IS AN INSTITUTIONAL ACCREDITED INVESTOR, THE HOLDER
MUST, PRIOR TO SUCH TRANSFER, FURNISH TO FIRST CHICAGO TRUST COMPANY OF NEW
YORK, AS TRANSFER AGENT, SUCH CERTIFICATIONS, LEGAL OPINIONS OR OTHER
INFORMATION AS IT MAY REASONABLY REQUIRE TO CONFIRM THAT SUCH TRANSFER IS BEING
MADE PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. THIS LEGEND WILL BE REMOVED
AFTER THE EXPIRATION OF THREE YEARS FROM THE ORIGINAL ISSUANCE OF THE SECURITY
EVIDENCED HEREBY, AS USED HEREIN, THE TERMS "OFFSHORE TRANSACTION", "UNITED
STATES" AND "U.S. PERSON" HAVE THE MEANINGS GIVEN TO THEM BY REGULATION S UNDER
THE SECURITIES ACT.
  In connection with any transfer of any of the shares of Series A Preferred
Stock evidenced by this certificate (or any issuance of shares of Common Stock
upon conversion or redemption of the shares of Series A Preferred Stock
represented hereby) occurring prior to the third anniversary of the date of
original issuance of this certificate, the undersigned states that such shares
of Series A Preferred Stock (or such shares of Common Stock, as the case may be)
are being transferred:
 
   / / inside the United States to a qualified institutional buyer pursuant to
       and in compliance with Rule 144A under the Securities Act of 1933, as
       amended;
 
       or
 
   / / outside the United States pursuant to and in compliance with Rule 904
       under the Securities Act of 1933, as amended;
 
       or
 
   / / to an institutional accredited investor pursuant to and in compliance
       with Rule 144A under the Securities Act of 1933, as amended;
 
       or
 
   / / pursuant to and in compliance with Rule 144 under the Securities Act of
       1933, as amended (if available).
 
  Unless one of the boxes above is checked, the Depositary will refuse to
register any of the shares of Series A Preferred Stock evidenced by this
certificate (or such shares of Common Stock, as the case may be) in the name of
any person other than the registered holder hereof; provided, however, that the
Depositary will, in its sole discretion, register the transfer of such shares of
Series A Preferred Stock or Common Stock, as the case may be, if it has received
such certifications, legal opinions and/or other information as it has
reasonably requested stating that such transfer is being made pursuant to an
exemption from, or in a transaction not subject to, the registration
requirements of the Securities Act of 1933, as amended.
 
  In addition, if the transferee is an institutional accredited investor, the
holder must furnish to the Depositary (i) a signed letter containing certain
representations and agreements relating to the restrictions on transfer of the
security evidenced hereby, and (ii) such other certifications, legal opinions or
other information as it may reasonably require stating that such transfer is
being made pursuant to an exemption from, or in a transaction not subject to,
the registration requirements of the Securities Act of 1933, as amended.
 
   The following abbreviations, when used in the inscription on the face of this
certificate, shall be construed as though they were written out in full
according to applicable laws or regulations:
 
<TABLE>
    <S>           <C>                                  <C>                  <C>                            
    TEN COM --    as tenants in common                 UNIF GIFT MIN ACT --  ........ Custodian  ........  
    TEN ENT --    as tenants by the entireties                                (Cust)             (Minor)      
    JT TEN  --    as joint tenants with right of                            under Uniform Gifts to Minors  
                  survivorship and not as tenants                           Act..........................  
                  in common                                                             (State)                        
</TABLE>
 

    Additional abbreviations may also be used though not in the above list.
 
For value received, ------------- hereby sell, assign and transfer unto
 
  PLEASE INSERT SOCIAL SECURITY OR OTHER
   IDENTIFYING NUMBER OF ASSIGNEE
- ----------------------------------------

- ----------------------------------------  -----------------------------------

 
- -----------------------------------------------------------------------------
   (PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING POSTAL ZIP CODE, OF
                                   ASSIGNEE)
 
- -----------------------------------------------------------------------------

- -----------------------------------------------------------------------------

- ----------------------------------------------------------------------shares
of the preferred stock represented by the within Certificate, and do hereby
irrevocably constitute and appoint

- --------------------------------------------------------------------Attorney
to transfer the said stock on the books of the within named Corporation with
full power of substitution in the premises.
 
Dated _________________________________
 
<TABLE>
<S>            <C>   <C>
               NOTICE: THE SIGNATURE TO THIS
                     ASSIGNMENT MUST CORRESPOND
                     WITH THE NAME AS WRITTEN UPON
                     THE FACE OF
                     THE CERTIFICATE IN EVERY
                     PARTICULAR, WITHOUT ALTERATION
                     OR ENLARGEMENT OR ANY CHANGE
                     WHATEVER.
</TABLE>
 
THE CORPORATION WILL FURNISH THE STOCKHOLDER A FULL STATEMENT OF THE
DESIGNATIONS, RELATIVE RIGHTS, PREFERENCES AND LIMITATIONS APPLICABLE TO EACH
CLASS OF ITS SHARES AND THE VARIATIONS IN RIGHTS, PREFERENCES, AND LIMITATIONS
DETERMINED FOR EACH SERIES ON REQUEST AND WITHOUT CHARGE.
 
THIS CERTIFICATE IS SUBJECT TO THE INTERESTS OF DEPOSITARY RECEIPTS PURSUANT TO
A DEPOSIT AGREEMENT, A COPY OF WHICH IS ON FILE WITH THE CORPORATION.

<PAGE>   1
                                                                    EXHIBIT 4(e)

 
THE SECURITY (OR ITS PREDECESSOR) EVIDENCED HEREBY HAS NOT BEEN REGISTERED UNDER
THE U.S. SECURITIES ACT OF 1933 (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY
NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR
BENEFIT OF, U.S. PERSONS EXCEPT AS SET FORTH IN THE FOLLOWING SENTENCE. BY ITS
ACQUISITION HEREOF, THE HOLDER (1) REPRESENTS THAT (A) IT IS A "QUALIFIED
INSTITUTIONAL BUYER" (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT) OR (B)
IT IS AN INSTITUTIONAL "ACCREDITED INVESTOR" (AS DEFINED IN RULE 501(A)(1), (2),
(3) OR (7) UNDER THE SECURITIES ACT) ("INSTITUTIONAL ACCREDITED INVESTOR") OR
(C) IT IS NOT A U.S. PERSON AND IS ACQUIRING THE SECURITY EVIDENCED HEREBY IN AN
OFFSHORE TRANSACTION, (2) AGREES THAT IT WILL NOT WITHIN THREE YEARS AFTER THE
ORIGINAL ISSUANCE OF THE SECURITY EVIDENCED HEREBY RESELL OR OTHERWISE TRANSFER
THE SECURITY EVIDENCED HEREBY EXCEPT (A) TO UNITED STATES SURGICAL CORPORATION
OR ANY SUBSIDIARY THEREOF, (B) INSIDE THE UNITED STATES TO A QUALIFIED
INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, (C)
INSIDE THE UNITED STATES TO AN INSTITUTIONAL ACCREDITED INVESTOR THAT, PRIOR TO
SUCH TRANSFER, FURNISHES TO FIRST CHICAGO TRUST COMPANY OF NEW YORK, AS TRANSFER
AGENT, A SIGNED LETTER CONTAINING CERTAIN REPRESENTATIONS AND AGREEMENTS
RELATING TO THE RESTRICTIONS ON TRANSFER OF THE SECURITY EVIDENCED HEREBY (THE
FORM OF WHICH LETTER CAN BE OBTAINED FROM SUCH TRANSFER AGENT), (D) OUTSIDE THE
UNITED STATES IN COMPLIANCE WITH RULE 904 UNDER THE SECURITIES ACT, (E) PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR (F) PURSUANT
TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144,
IF APPLICABLE, UNDER THE SECURITIES ACT AND (3) AGREES THAT IT WILL DELIVER TO
EACH PERSON TO WHOM THE SECURITY EVIDENCED HEREBY IS TRANSFERRED A NOTICE
SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND. IN CONNECTION WITH ANY TRANSFER OF
THE SECURITY EVIDENCED HEREBY IN CERTIFICATED FORM WITHIN THREE YEARS AFTER THE
ORIGINAL ISSUANCE OF SUCH SECURITY, THE HOLDER MUST CHECK THE APPROPRIATE BOX
SET FORTH ON THE REVERSE OF THIS CERTIFICATE RELATING TO THE MANNER OF SUCH
TRANSFER AND SUBMIT THIS CERTIFICATE TO FIRST CHICAGO TRUST COMPANY OF NEW YORK,
AS TRANSFER AGENT. IF THE PROPOSED TRANSFEREE IS AN INSTITUTIONAL ACCREDITED
INVESTOR, THE HOLDER MUST, PRIOR TO SUCH TRANSFER, FURNISH TO FIRST CHICAGO
TRUST COMPANY OF NEW YORK, AS TRANSFER AGENT, SUCH CERTIFICATIONS, LEGAL
OPINIONS OR OTHER INFORMATION AS IT MAY REASONABLY REQUIRE TO CONFIRM THAT SUCH
TRANSFER IS BEING MADE PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT
SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. THIS LEGEND
WILL BE REMOVED AFTER THE EXPIRATION OF THREE YEARS FROM THE ORIGINAL ISSUANCE
OF THE SECURITY EVIDENCED HEREBY. AS USED HEREIN, THE TERMS "OFFSHORE
TRANSACTION," "UNITED STATES" AND "U.S. PERSON" HAVE THE MEANINGS GIVEN TO THEM
BY REGULATION S UNDER THE SECURITIES ACT.
 
                   DEPOSITARY RECEIPT FOR DEPOSITARY SHARES,
                  EACH REPRESENTING ONE-FIFTIETH OF A SHARE OF
                     SERIES A CONVERTIBLE PREFERRED STOCK,
                           PAR VALUE $5 PER SHARE OF                           
                                                     -------------------------
                                                         DEPOSITARY SHARES
                     
                       UNITED STATES SURGICAL CORPORATION
             (INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE)
 
DR
                                                               CUSIP 912707 20 5
 
   FIRST CHICAGO TRUST COMPANY OF NEW YORK, as Depositary (the "Depositary"),
   hereby certifies that
 


   is the registered owner of                               DEPOSITARY SHARES
 
(the "Depositary Shares"), each Depositary Share representing one-fiftieth of a
share of Series A Convertible Preferred Stock, par value $5 per share (the
"Series A Preferred Stock"), of United States Surgical Corporation, a
corporation duly organized and existing under the laws of the State of Delaware
(the "Company"), and the same proportionate interest in any and all other
property received by the Depositary in respect of such shares of Series A
Preferred Stock and held by the Depositary under the Deposit Agreement (as
defined below). Subject to the terms of the Deposit Agreement, each owner of a
Depositary Share is entitled, proportionately, to all the rights, preferences
and privileges of the Series A Preferred Stock represented thereby, including
the dividend, voting, conversion, liquidation and other rights contained in the
Certificate of Designations of the Series A Convertible Preferred Stock, par
value $5 per share, establishing the rights, preferences, privileges and
limitations of the Series A Preferred Stock (the "Certificate of Designations"),
copies of which are on file at the office of the Depositary at which at any
particular time its business in respect of matters governed by the Deposit
Agreement shall be administered, which at the time of the execution of the
Deposit Agreement is located at the corporate office of the Depositary at which
at any time its depositary receipt business shall be administered (the
"Corporate Office").
   THE DEPOSITARY IS NOT RESPONSIBLE FOR THE VALIDITY OF ANY DEPOSITED STOCK.
THE DEPOSITARY ASSUMES NO RESPONSIBILITY FOR THE CORRECTNESS OF THE DESCRIPTION
SET FORTH IN THIS RECEIPT, WHICH CAN BE TAKEN AS A STATEMENT OF THE COMPANY
SUMMARIZING CERTAIN PROVISIONS OF THE DEPOSIT AGREEMENT. UNLESS EXPRESSLY SET
FORTH IN THE DEPOSIT AGREEMENT, THE DEPOSITARY MAKES NO WARRANTIES OR
REPRESENTATIONS AS TO THE VALIDITY, GENUINENESS OR SUFFICIENCY OF ANY STOCK AT
ANY TIME DEPOSITED WITH THE DEPOSITARY UNDER THE DEPOSIT AGREEMENT OR OF THE
DEPOSITARY SHARES OR RECEIPTS (EXCEPT FOR ITS COUNTERSIGNATURES THEREON), AS TO
THE VALIDITY OR SUFFICIENCY OF THE DEPOSIT AGREEMENT, AS TO THE VALUE OF
DEPOSITARY SHARES OR AS TO ANY RIGHT, TITLE OR INTEREST OF THE RECORD HOLDERS OF
THE RECEIPTS IN AND TO THE DEPOSITARY SHARES.
   The Company will furnish to any holder of a Receipt, without charge, upon
request addressed to its executive office or the office of its transfer agent, a
statement or summary of the powers, designations, preferences and relative,
participating, optional or other special rights of each authorized class of
capital stock of the Company, and of each series of preferred stock of the
Company authorized to be issued, so far as the same may have been fixed, and of
the qualifications, limitations or restrictions of such preferences and/or
rights.
   This Depositary Receipt (the "Receipt") is continued on the reverse hereof
and the additional provisions therein set forth for all purposes have the same
effect as if set forth at this place.
   This Receipt shall not be entitled to any benefits under the Deposit
Agreement or be valid or obligatory for any purpose, unless this Receipt shall
have been executed manually by the Depositary or, if a Registrar for the
Receipts (other than the Depositary) shall have been appointed, by facsimile of
the Depositary, by the signature of a duly authorized officer and, if executed
by facsimile signature of the Depositary, shall have been countersigned manually
by such Registrar by the signature of a duly authorized officer.
 

Dated:
                                                    FIRST CHICAGO TRUST COMPANY
                                                           OF NEW YORK
                                                      Depositary and Registrar
                                                    By:
                                                       
                                                        [SIGNATURE]      

                                                    Authorized Officer
<PAGE>   2
 
                       UNITED STATES SURGICAL CORPORATION
 
   1. THE DEPOSIT AGREEMENT. Depositary Receipts (the "Receipts"), of which this
Receipt is one, are made available upon the terms and conditions set forth in
the Deposit Agreement, dated as of March 28, 1994 (the "Deposit Agreement")
among the Company, the Depositary and all holders from time to time of Receipts.
The Deposit Agreement (copies of which are on file at the Corporate Office and
at the office of any Agent of the Depositary) sets forth the rights of holders
of Receipts and the rights and duties of the Depositary. The statements made on
the face and the reverse of this Receipt are summaries of certain provisions of
the Deposit Agreement and are subject to the detailed provisions thereof, to
which reference is hereby made. In the event of any conflict between the
provisions of this Receipt and the provisions of the Deposit Agreement, the
provisions of the Deposit Agreement will govern.
   2. DEFINITIONS. Unless otherwise expressly herein provided, all defined terms
used herein shall have the meanings ascribed thereto in the Deposit Agreement.
   3. REDEMPTION OF SERIES A PREFERRED STOCK. Whenever the Company shall elect
to redeem shares of Series A Preferred Stock for shares of its Common Stock, par
value $.10 per share ("Common Stock"), in accordance with the Certificate of
Designations, it shall (unless otherwise agreed in writing with the Depositary)
give the Depositary in its capacity as Depositary the notice required by the
Deposit Agreement. The Depositary shall mail, first class postage prepaid,
notice of such redemption and the proposed simultaneous redemption of the number
of Depositary Shares representing the Series A Preferred Stock to be redeemed,
not less than 15 and not more than 60 days prior to the date fixed for
redemption of such Series A Preferred Stock and Depositary Shares (the
"Redemption Date"), to the record holders of the Receipts evidencing the
Depositary Shares to be so redeemed, at the addresses of such holders as they
appear on the records of the Depositary; but neither failure to mail any such
notice to one or more such holders nor any defect in any notice to one or more
such holders shall affect the sufficiency of the proceedings for redemption as
to other holders. Each such notice shall state: (i) the Redemption Date; (ii)
the number of Depositary Shares to be redeemed and, if less than all the
Depositary Shares held by any such holder are to be redeemed, the number of such
Depositary Shares held by such holder to be so redeemed; (iii) the DECS Call
Price (as defined in the Certificate of Designations); (iv) the number of shares
of Common Stock deliverable upon redemption of each share of Series A Preferred
Stock to be redeemed, and the Current Market Price (as defined in the
Certificate of Designations) used to calculate such number of shares of Common
Stock; (v) the place or places where Receipts evidencing Depositary Shares are
to be surrendered for payment of the redemption price; and (vi) that dividends
in respect of the shares of Series A Preferred Stock represented by the
Depositary Shares to be redeemed will cease to accumulate on such Redemption
Date. Notices shall be mailed and published by the Company pursuant to Section 3
of the Certificate of Designations. In case fewer than all the outstanding
Depositary Shares are to be redeemed, the Depositary Shares to be redeemed shall
be selected by lot or pro rata (as nearly as may be) or by any other equitable
method determined by the Depositary to be consistent with the method determined
by the Board of Directors of the Company with respect to the Series A Preferred
Stock.
   Notice having been mailed and published as aforesaid, from and after the
Redemption Date (unless the Company shall have failed to redeem the shares of
Series A Preferred Stock to be redeemed by it, as set forth in the Company's
notice provided for above), the Depositary Shares called for redemption shall be
deemed no longer to be outstanding and all rights of the holders of Receipts
evidencing such Depositary Shares (except the right to receive the shares of
Common Stock upon redemption and cash for any fractional share amount) shall, to
the extent of such Depositary Shares, cease and terminate. Upon surrender in
accordance with said notice of the Receipts evidencing such Depositary Shares
(properly endorsed or assigned for transfer, as the Depositary shall so
require), such Depositary Shares shall be redeemed for shares of Common Stock
and cash for any fractional share amount at a rate per Depositary Share equal to
one-fiftieth of the number of shares of Common Stock (including fractional
amounts) delivered upon redemption of a share of Series A Preferred Stock
pursuant to the Certificate of Designations.
   If fewer than all the Depositary Shares evidenced by this Receipt are called
for redemption, the Depositary will deliver to the holder of this Receipt upon
its surrender to the Depositary, together with shares of Common Stock for the
Depositary Shares called for redemption, a new Receipt evidencing the Depositary
Shares evidenced by such prior Receipt and not called for redemption.
   4. SURRENDER OF RECEIPTS AND WITHDRAWAL OF SERIES A PREFERRED STOCK. Upon
surrender of this Receipt to the Depositary at the Corporate Office or such
other offices as the Depositary may designate, and subject to the provisions of
the Deposit Agreement, the holder hereof is entitled to withdraw, and to obtain
delivery of, to or upon the order of such holder, any or all of the Series A
Preferred Stock (but only in whole shares of Series A Preferred Stock) and any
or all money and other property, if any, at the time represented by the
Depositary Shares evidenced by this Receipt; provided, however, that, in the
event this Receipt shall evidence a number of Depositary Shares in excess of the
number of Depositary Shares representing the whole number of shares of Series A
Preferred Stock to be withdrawn, the Depositary shall, in addition to such whole
number of shares of Series A Preferred Stock and such money and other property,
if any, to be withdrawn, deliver, to or upon the order of such holder, a new
Receipt or Receipts evidencing such excess number of whole Depositary Shares.
   5. OPTIONAL CONVERSION OF SERIES A PREFERRED STOCK INTO COMMON STOCK. Subject
to the terms and conditions of the Deposit Agreement and the Certificate of
Designations, this Receipt may be surrendered with written instructions to the
Depositary to instruct the Company to cause the conversion of any specified
number of whole shares of Series A Preferred Stock represented by whole
Depositary Shares evidenced hereby into whole shares of Common Stock and cash
for any fractional share amount at the conversion price then in effect for the
Series A Preferred Stock pursuant to the Certificate of Designations as such
conversion price may be adjusted by the Company from time to time as provided in
the Certificate of Designations. Subject to the terms and conditions of the
Deposit Agreement and the Certificate of Designations, a holder of a Receipt or
Receipts evidencing Depositary Shares representing whole or fractional shares of
Series A Preferred Stock may surrender such Receipt or Receipts at the
Depositary's Office or at such office or to such Depositary's Agents as the
Depositary may designate for such purpose, together with a notice of conversion
duly completed and executed, thereby directing the Depositary to instruct the
Company to cause the conversion of the number of whole shares of underlying
Series A Preferred Stock specified in such notice of conversion into shares of
Common Stock, and an assignment of such Receipt or Receipts to the Company or in
blank, duly completed and executed. To the extent that a holder delivers to the
Depositary for conversion a Receipt or Receipts which in the aggregate are
convertible into less than one whole share of Common Stock, the holder shall
receive payment in cash in lieu of such fractional share of Common Stock
otherwise issuable. If more than one Receipt shall be delivered for conversion
at one time by the same holder, the number of whole shares of Common Stock
issuable upon conversion thereof shall be computed on the basis of the aggregate
number of Depositary Shares represented by the Receipts so delivered.
   If Series A Preferred Stock shall be called by the Company for redemption,
the Depositary Shares representing such Series A Preferred Stock may be
converted into Common Stock as provided in the Deposit Agreement until, but not
after, the close of business on the Redemption Date unless the Company shall
fail to deposit with the Depositary the shares of Common Stock and cash for any
fractional share amounts required to redeem the Series A Preferred Stock, in
which case the Depositary Shares representing such Series A Preferred Stock may
continue to be converted into Common Stock until, but not after, the close of
business on the date on which the Company deposits with the Depositary such
shares of Common Stock and cash for any fractional share amounts as are required
by the Certificate of Designations to make full payment of the amounts payable
upon such redemption. Upon receipt by the Depositary of a Receipt or Receipts,
together with a properly completed and executed notice of conversion,
representing any Series A Preferred Stock called for redemption, the shares of
Series A Preferred Stock held by the Depositary represented by such Depositary
Shares for which conversion is requested shall be deemed to have been received
by the Company for conversion as of immediately prior to the close of business
on the date of such receipt by the Depositary.

<PAGE>   3

   6. MANDATORY CONVERSION OF SERIES A PREFERRED STOCK INTO COMMON STOCK. The
following provisions shall apply to any Series A Preferred Stock on deposit with
the Depositary as to which the Company has not exercised its right to redeem and
the record holder has not exercised its right of optional conversion on the date
fixed for mandatory conversion of such Series A Preferred Stock and Depositary
Shares (the "Mandatory Conversion Date"):
   On the Mandatory Conversion Date, all then outstanding shares of Series A
Preferred Stock shall mandatorily convert into shares of Common Stock, cash for
any fractional share amounts and the right to receive amounts in cash equal to
all accrued and unpaid dividends on such shares of Series A Preferred Stock to
the Mandatory Conversion Date (other than previously declared dividends payable
to a holder of record as of a prior date), all as provided in and subject to
paragraph 3 of the Certificate of Designations.
   From and after the Mandatory Conversion Date, the Depositary Shares
representing the shares of Series A Preferred Stock mandatorily converted shall
be deemed no longer to be outstanding and all rights of the record holders of
Receipts evidencing such Depositary Shares (except the right to receive the
shares of Common Stock, any cash for accrued and unpaid dividends (other than
previously declared dividends payable to a holder of record as of a prior date)
and any fractional share amount deliverable or payable upon mandatory conversion
or in connection therewith) shall, to the extent of such Depositary Shares,
cease and terminate. Upon surrender, in accordance with said notice, of the
Receipts evidencing such Depositary Shares (properly endorsed or assigned for
transfer, as the Depositary shall so require), such Depositary Shares shall be
exchanged for shares of Common Stock and cash for any fractional share amount
(and the right to receive cash for any accrued and unpaid dividends payable in
connection therewith) at a rate per Depositary Share equal to one-fiftieth of
the number (including fractional amounts) of shares of Common Stock (and
one-fiftieth of the right to receive cash for any accrued and unpaid dividends)
exchanged for each share of Series A Preferred Stock pursuant to the Certificate
of Designations. The foregoing shall be subject further to the terms and
conditions of the Certificate of Designations and the Deposit Agreement.
   On or prior to the Mandatory Conversion Date, the Company shall deposit with
the Depositary certificates for the shares of Common Stock and the cash for any
fractional share amounts into which the shares of Series A Preferred Stock held
by the Depositary shall mandatorily convert on the Mandatory Conversion Date,
plus, subject to the Certificate of Designations, an amount in cash equal to all
accrued and unpaid dividends on such shares of Series A Preferred Stock (other
than previously declared dividends payable to a holder of record as of a prior
date) to the Mandatory Conversion Date. Using such shares of Common Stock and
cash, the Depositary shall deliver certificates for the appropriate number of
shares of Common Stock and the appropriate amount of cash, without interest, to
record holders who properly deliver their Receipts to the Depositary.
   7. TRANSFERS, SPLIT-UPS, COMBINATIONS. Subject to Paragraphs 8, 9 and 10
below, this Receipt is transferable on the books of the Depositary upon
surrender of this Receipt to the Depositary at the Corporate Office or such
other offices as the Depositary may designate, properly endorsed or accompanied
by a properly executed instrument of transfer or endorsement, or other
instrument satisfactory to the Depositary, and upon such transfer the Depositary
shall issue a Receipt to or upon the order of the person entitled thereto, all
as provided in and subject to the Deposit Agreement. This Receipt may be split
into other Receipts or combined with other Receipts into one Receipt evidencing
the same aggregate number of Depositary Shares evidenced by the Receipt or
Receipts surrendered; provided, however, that the Depositary shall not execute
and deliver any Receipt evidencing a fractional Depositary Share.
   8. CONDITIONS TO SIGNING AND DELIVERY, TRANSFER, ETC., OF RECEIPTS. Prior to
the execution and delivery, transfer, split-up, combination, surrender or
exchange of this Receipt, the Depositary, any of the Depositary's Agents or the
Company may require any or all of the following: (i) payment to it of a sum
sufficient for the payment (or, in the event that the Depositary or the Company
shall have made such payment, the reimbursement to it) of any tax or other
governmental charge with respect thereto (including any such tax or charge with
respect to Series A Preferred Stock being deposited or withdrawn or with respect
to Common Stock or other securities or property of the Company being issued upon
conversion or redemption); (ii) the production of proof satisfactory to it as to
the identity and genuineness of any signature; and (iii) compliance with such
regulations, if any, as the Depositary or the Company may establish not
inconsistent with the Deposit Agreement. Any person presenting Series A
Preferred Stock for deposit, or any holder of this Receipt, may be required to
file such proof of information, to execute such certificates and to make such
representations and warranties as the Depositary or the Company may reasonably
deem necessary or proper. The Depositary or the Company may withhold or delay
the delivery of any Receipt, the transfer, redemption, conversion or exchange of
any Receipt, the withdrawal of the Series A Preferred Stock or money or other
property, if any, represented by the Depositary Shares evidenced by this Receipt
or the distribution of any dividend or other distribution until such proof or
other information is filed, such certificates are executed or such
representations and warranties are made.
   9. SUSPENSION OF DELIVERY, TRANSFER, ETC. The deposit of Series A Preferred
Stock may be refused, the delivery of this Receipt against Series A Preferred
Stock may be suspended, and the transfer, split-up, combination, surrender or
exchange of this Receipt may be suspended (i) during any period when the
register of holders of Receipts is closed, (ii) if any such action is deemed
necessary or advisable by the Depositary, any of the Depositary's Agents or the
Company at any time or from time to time because of any requirement of law or of
any government or governmental body or commission, or under any provision of the
Deposit Agreement, or (iii) with the approval of the Company, for any other
reason. Except with respect to a conversion of Depositary Shares which may occur
pursuant to paragraph 3 of the Certificate of Designations, the Depositary shall
not be required (a) to execute and deliver, transfer or exchange any Receipts
for a period beginning at the opening of business 15 days next preceding any
selection of Depositary Shares and Series A Preferred Stock to be redeemed and
ending at the close of business on the day of the mailing of notice of
redemption of Depositary Shares or (b) to transfer or exchange for another
Receipt any Receipt evidencing Depositary Shares called or being called for
redemption, in whole or in part, except as provided in the second to last
paragraph of Paragraph 3 above.
   10. PAYMENT OF TAXES OR OTHER GOVERNMENTAL CHARGES. If any tax or other
governmental charge shall become payable by or on behalf of the Depositary with
respect to this Receipt, the Depositary Shares evidenced by this Receipt, the
Series A Preferred Stock (or any fractional interest therein) represented by
such Depositary Shares or any transaction referred to in Section 4.6 of the
Deposit Agreement, such tax (including transfer, issuance or acquisition taxes,
if any) or governmental charge shall be payable by the holder hereof. Until such
payment is made, transfer, redemption, conversion or exchange of this Receipt or
any withdrawal of the Series A Preferred Stock or money and other property, if
any, represented by the Depositary Shares evidenced by this Receipt may be
refused, any dividend or other distribution may be withheld and any part or all
of the Series A Preferred Stock or other property represented by the Depositary
Shares evidenced by this Receipt may be sold for the account of the holder
hereof (after attempting by reasonable means to notify such holder prior to such
sale). Any dividend or other distribution so withheld and the proceeds of any
such sale may be applied to any payment of such tax or other governmental
charge, the holder of this Receipt remaining liable for any deficiency. The
Depositary shall act as the withholding agent for any payments, distributions,
and exchanges made with respect to the Depositary Shares and Receipts, and the
Preferred Stock, Common Stock or other securities or assets represented thereby
(collectively, the "Securities"). The Depositary shall be responsible with
respect to the Securities for the timely (i) collection and deposit of any
required withholding or backup withholding tax, and (ii) filing of any
information returns or other documents with federal (and other applicable)
taxing authorities. In the event the Depositary is required to pay any such
amounts, the Company shall reimburse the Depositary for payment thereof upon the
request of the Depositary and the Depositary shall, upon the Company's request
and as instructed by the Company, pursue its rights against such holder at the
Company's expense.

<PAGE>   4

   11. AMENDMENT. The form of the Receipts and any provision of the Deposit
Agreement may at any time and from time to time be amended by agreement between
the Company and the Depositary in any respect that they may deem necessary or
desirable. Any amendment that shall impose any fees, taxes or charges payable by
holders of Receipts (other than taxes and other governmental charges, fees and
other expenses provided for herein or in the Deposit Agreement), or that shall
otherwise prejudice any substantial existing right of holders of Receipts, shall
not become effective as to outstanding Receipts until the expiration of 90 days
after notice of such amendment shall have been given to the record holders of
outstanding Receipts. The holder of this Receipt at the time any such amendment
becomes effective shall be deemed, by continuing to hold this Receipt, to
consent and agree to such amendment and to be bound by the Deposit Agreement as
amended thereby. In no event shall any amendment impair the right, subject to
the provisions of Paragraphs 3, 4, 5, 6, 7, 8, 9 and 10 hereof and of Sections
2.3, 2.4, 2.6, 2.7, 2.10 and 2.11 and Article III of the Deposit Agreement, of
the owner of the Depositary Shares evidenced by this Receipt to surrender this
Receipt with instructions to the Depositary to deliver to the holder the Series
A Preferred Stock and all money and other property, if any, represented hereby,
or to cause the conversion of the underlying Series A Preferred Stock into
Common Stock and cash for any fractional share amount, except in order to comply
with mandatory provisions of applicable law.
   12. FEES, CHARGES AND EXPENSES. The Company will pay all fees, charges and
expenses of the Depositary, except for taxes (including transfer taxes, if any)
and other governmental charges and such charges as are expressly provided in the
Deposit Agreement to be at the expense of persons depositing Series A Preferred
Stock, holders of Receipts or other persons.
   13. TITLE TO RECEIPTS. It is a condition of this Receipt, and every
successive holder hereof by accepting or holding the same consents and agrees,
that title to this Receipt (and to the Depositary Shares evidenced hereby) when
properly endorsed or accompanied by a properly executed instrument of transfer
or endorsement, is transferable by delivery; provided, however, that until this
Receipt shall be transferred on the books of the Depositary as provided in
Section 2.04 of the Deposit Agreement, the Depositary may, notwithstanding any
notice to the contrary, treat the record holder hereof at such time as the
absolute owner hereof for the purpose of determining the person entitled to
distribution of dividends or other distributions or to any notice provided for
in the Deposit Agreement and for all other purposes.
   14. DIVIDENDS AND DISTRIBUTIONS. Whenever the Depositary receives any cash
dividend or other cash distribution on the Series A Preferred Stock, the
Depositary will, subject to the provisions of the Deposit Agreement, distribute
such portions of such sum to record holders of Receipts as are, as nearly as
practicable, proportionate to the respective numbers of Depositary Shares
evidenced by the Receipts held by such holders; provided, however, that in case
the Company or the Depositary shall be required to withhold and does withhold
from any cash dividend or other cash distribution in respect of the Series A
Preferred Stock an amount on account of taxes or as otherwise required by law,
regulation or court order, the amount made available for distribution or
distributed in respect of Depositary Shares shall be reduced accordingly. The
Depositary shall distribute or make available for distribution, as the case may
be, only such amount, however, as can be distributed without attributing to any
owner of Depositary Shares a fraction of one cent and any balance not so
distributable shall be rounded to the next highest whole cent and, upon request
of the Depositary, the Company shall pay the additional amount to the Depositary
for distribution.
   15. SUBSCRIPTION RIGHTS, PREFERENCES OR PRIVILEGES. If the Company shall at
any time offer or cause to be offered to the persons in whose names Series A
Preferred Stock is registered on the books of the Company any rights,
preferences or privileges to subscribe for or to purchase any securities or any
rights, preferences or privileges of any other nature, such rights, preferences
or privileges shall in each such instance, subject to the provisions of the
Deposit Agreement, be made available by the Depositary to the record holders of
Receipts if the Company so directs in such manner as the Company shall instruct.

<PAGE>   5

   16. NOTICE OF DIVIDENDS, FIXING OF RECORD DATE. Whenever any cash dividend or
other cash distribution shall become payable, any distribution other than cash
shall be made, or any rights, preferences or privileges shall at any time be
offered, with respect to the Series A Preferred Stock, or the Depositary shall
receive notice of (i) any meeting at which holders of Series A Preferred Stock
are entitled to vote or of which holders of Series A Preferred Stock are
entitled to notice or (ii) any election on the part of the Company to call for
redemption of any shares of Series A Preferred Stock, the Depositary shall in
each such instance fix a record date (which shall be the same date as the record
date fixed by the Company with respect to the Series A Preferred Stock) for the
determination of the holders of Receipts (i) who shall be entitled to receive
such dividend, distribution, rights, preferences or privileges or the net
proceeds of the sale thereof, or to give instructions for the exercise of voting
rights at any such meeting or to receive notice of such meeting or (ii) whose
Depositary Shares are to be so redeemed.
   17. VOTING RIGHTS. Upon issuance of notice of any meeting at which the
holders of Series A Preferred Stock are entitled to vote, the Company shall
direct the Depositary, as soon as practicable thereafter, to mail to the record
holders of Receipts a notice, which shall contain (i) such information as is
contained in such notice of meeting, (ii) a statement that the holders of
Receipts at the close of business on a specified record date determined as
provided in Paragraph 16 will be entitled, subject to any applicable provision
of law, the Certificate of Incorporation or the Certificate of Designations, to
instruct the Depositary as to the exercise of the voting rights pertaining to
the amount of Series A Preferred Stock represented by their respective
Depositary Shares, and (iii) a brief statement as to the manner in which such
instructions may be given. Upon the written request of a holder of a Receipt on
such record date, the Depositary shall endeavor insofar as practicable to vote
or cause to be voted an amount of Series A Preferred Stock represented by the
Depositary Shares evidenced by such Receipt in accordance with the instructions
set forth in such request. The Company has agreed to take all reasonable action
that may be deemed necessary by the Depositary in order to enable the Depositary
to vote such Series A Preferred Stock or cause such Series A Preferred Stock to
be voted. In the absence of specific instructions from the holder of a Receipt,
the Depositary will abstain from voting to the extent of the Series A Preferred
Stock represented by the Depositary Shares evidenced by such Receipt. After
aggregating all voting Depositary Shares, the Depositary will disregard for
voting purposes any fractional share of Series A Preferred Stock remaining.
   18. REPORTS, INSPECTION OF TRANSFER BOOKS. The Depositary shall make
available for inspection by holders of Receipts at the Corporate Office and at
such other places as it may from time to time deem advisable during normal
business hours any reports and communications received from the Company that are
both received by the Depositary as the holder of Series A Preferred Stock and
made generally available to the holders of Series A Preferred Stock by the
Company. The Depositary shall keep books at the Corporate Office for the
registration and transfer of Receipts, which books during normal business hours
will be open for inspection by the record holders of Receipts as provided by
applicable law.
   19. LIABILITY OF THE DEPOSITARY, THE DEPOSITARY'S AGENTS AND THE COMPANY.
Neither the Depositary nor any Depositary's Agent nor the Company shall incur
any liability to any holder of any Receipt, if by reason of any provision of any
present or future law or regulation of any governmental authority or, in the
case of the Depositary or the Depositary's Agent, by reason of any provision,
present or future, of the Certificate of Incorporation or the Certificate of
Designations or, in the case of the Company, the Depositary or the Depositary's
Agent, by reason of any act of God or war or other circumstance beyond the
control of the relevant party, the Depositary, any Depositary's Agent or the
Company shall be prevented or forbidden from doing or performing any act or
thing that the terms of the Deposit Agreement provide shall be done or
performed; nor shall the Depositary, any Depositary's Agent or the Company incur
any liability to any holder of a Receipt by reason of any nonperformance or
delay, caused as aforesaid, in the performance of any act or thing that the
terms of the Deposit Agreement provide shall or may be done or performed or by
reason of any exercise of, or failure to exercise, any discretion provided for
in the Deposit Agreement.
   20. OBLIGATIONS OF THE DEPOSITARY, THE DEPOSITARY'S AGENTS AND THE COMPANY.
Neither the Depositary, the Registrar, any Depositary's Agent nor the Company
assumes any obligation or shall be subject to any liability hereunder or under
the Deposit Agreement to holders of Receipts other than for their negligence
(including the failure to comply with customary trade practice) or willful
misconduct and each of them agrees to use good faith in the performance of such
duties as are specifically set forth in the Deposit Agreement.
   Neither the Depositary, the Registrar, any Depositary's Agent nor the Company
shall be under any obligation to appear in, prosecute or defend any action, suit
or other proceeding with respect to Series A Preferred Stock, Depositary Shares,
Receipts or Common Stock that in its opinion may involve it in expense or
liability, unless indemnity satisfactory to it against all expense and liability
be furnished as often as may be required.
   Neither the Depositary, the Registrar, any Depositary's Agent nor the Company
will be liable for any action or failure to act by it in reliance upon the
advice of or information from legal counsel, accountants, any person presenting
Series A Preferred Stock for deposit, any holder of a Receipt or any other
person believed by it in good faith to be competent to give such advice or
information.

<PAGE>   6

   21. TERMINATION OF DEPOSIT AGREEMENT. Whenever so directed by the Company,
the Depositary will terminate the Deposit Agreement, provided, that notice of
such termination has been given by mailing notice of such termination to the
record holders of all Receipts then outstanding at least 30 days prior to the
date fixed in such notice for such termination. The Depositary may likewise
terminate the Deposit Agreement if at any time 45 days shall have expired after
the Depositary shall have delivered to the Company a written notice of its
election to resign and a successor depositary shall not have been appointed and
accepted its appointment as provided in Section 5.4 of the Deposit Agreement.
Upon the termination of the Deposit Agreement, the Company shall be discharged
from all obligations thereunder except for its obligations to the Depositary,
any Depositary's Agent and any Registrar under Sections 5.7 and 5.8 of the
Deposit Agreement.
   If any Receipts remain outstanding after the date of termination, the
Depositary thereafter shall discontinue all functions and be discharged from all
obligations as provided in the Deposit Agreement, except as specifically
provided therein.
   22. GOVERNING LAW. The Deposit Agreement and this Receipt and all rights
thereunder and hereunder and provisions thereof and hereof shall be governed by,
and construed in accordance with, the law of the State of New York without
giving effect to principles of conflict of laws.
 

<PAGE>   7

                              NOTICE OF CONVERSION
 
   The undersigned holder of this Receipt for Depositary Shares hereby
irrevocably exercises the option to convert that number of whole shares of
Series A Convertible Preferred Stock of the Company represented by [         ]
Depositary Shares into shares of Common Stock of the Company and cash for any
fractional share amount in accordance with the terms of and subject to the
conditions of the Series A Preferred Stock, including the Certificate of
Designations in respect thereof, and the Deposit Agreement, and directs the
Depositary to instruct the Company that the shares of Common Stock deliverable
upon such conversion be registered in the name of, and delivered together with a
check in payment for any fractional shares of Common Stock to, the undersigned
unless a different name has been indicated below. If the shares of Common Stock
are to be registered in the name of a person other than the undersigned, the
undersigned will pay all transfer and similar taxes payable with respect
thereto. If the number of whole shares of Series A Preferred Stock represented
by the number of Depositary Shares set forth above is less than the number of
shares of Series A Preferred Stock on deposit in respect of this Receipt, the
undersigned directs that the Depositary execute and deliver to the undersigned,
unless a different name is indicated below, a new Receipt evidencing Depositary
Shares for the balance of such Series A Preferred Stock not to be converted.
 
Dated: _________________________________________________________________________
 
       Signature: ______________________________________________________________
       NOTE: The signature on this notice of conversion must correspond with the
       name as written upon the face of this Receipt in every particular without
       alteration or enlargement or any change whatsoever, and must be
       guaranteed by a commercial bank, trust company, securities broker or
       dealer, credit union, savings association or other eligible guarantor
       institution which is a member of or participant in a signature guarantee
       program acceptable to the Depositary.
 
Name: __________________________________________________________________________
 
Address: _______________________________________________________________________
                (Please print names and address of Registered Holder)
 
Name: __________________________________________________________________________
 
Address: _______________________________________________________________________
            (Please indicate other delivery instructions, if applicable)
 
   In connection with any transfer of any of the Depositary Shares evidenced by
this Receipt (or any issuance of shares of Common Stock upon conversion or
redemption of the Series A Preferred Stock represented by such Depositary
Shares) occurring prior to the third anniversary of the date of original
issuance of this Receipt, unless and until a registration statement is effective
with respect to the Depositary Shares, Series A Preferred Stock, or Common
Stock, as the case may be, the undersigned states that such Depositary Shares
(or such shares of Common Stock, as the case may be) are being transferred:
 
 / / inside the United States to a qualified institutional buyer pursuant to and
     in compliance with Rule 144A under the Securities Act of 1933, as amended;
     or
 / / outside the United States pursuant to and in compliance with Rule 904 under
     the Securities Act of 1933, as amended;
     or
 / / to an institutional accredited investor pursuant to and in compliance with
     the Securities Act of 1933, as amended;
     or
 / / pursuant to and in compliance with Rule 144 under the Securities Act of
     1933, as amended (if available).
   Unless one of the boxes above is checked, unless and until a registration
statement is effective with respect to the Depositary Shares, Series A Preferred
Stock, or Common Stock, as the case may be, the Depositary will refuse to
register any of the Depositary Shares evidenced by this Receipt (or such shares
of Common Stock, as the case may be) in the name of any person other than the
registered holder hereof; provided, however, that the Depositary will, in its
sole discretion, register the transfer of such Depositary Shares or Common
Stock, as the case may be, if it has received such certifications, legal
opinions and/or other information as it has reasonably requested stating that
such transfer is being made pursuant to an exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act of 1933, as
amended.
   In addition, if the transferee is an institutional accredited investor, the
holder must furnish to the Depositary (i) a signed letter containing certain
representations and agreements relating to the restrictions on transfer of the
security evidenced hereby, and (ii) such other certifications, legal opinions or
other information as it may reasonably require stating that such transfer is
being made pursuant to an exemption from, or in a transaction not subject to,
the registration requirements of the Securities Act of 1933, as amended.
 
Dated: ----------------------------------------------------------------------
Signature Guarantee:

Signature: ------------------------------------------------------------------
NOTE: The signature to this Agreement must correspond with the name
as written upon the face of this Receipt in every particular, without
alteration or enlargement, or any change whatsoever.


<PAGE>   8

                                ASSIGNMENT

FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers
unto

  PLEASE INSERT SOCIAL SECURITY OR
OTHER IDENTIFYING NUMBER OF ASSIGNEE
- ------------------------------------

- --------------------------------------------------------------------------------
           (Print or type assignee's name, address and zip code)

- --------------------------------------------------------------------------------
the within Receipt and all rights and interests represented by the Depositary
Shares evidenced thereby, and hereby irrevocably constitutes and 
appoints

- -----------------------------------------------------------------  his attorney,
to transfer the same on the books of the within-named Depositary, with full
power of substitution in the premises.


Dated: ------------------------------------------------------------------------

Signature: --------------------------------------------------------------------
NOTE: The signature on this assignment must correspond with the name
as written upon the face of this Receipt in every particular, without
alteration or enlargement, or any change whatsoever, and must be guaranteed by
a commercial bank, trust company, securities broker or dealer, credit union,
savings association or other eligible guarantor institution which is a member
of or participant in a signature guarantee program acceptable to the
Depositary.

<PAGE>   1
 
                                                                       EXHIBIT 5
 
                                                                  April 27, 1994
 
United States Surgical Corporation
150 Glover Avenue
Norwalk, Connecticut 06856
 
Dear Sirs:
 
     I refer to the Registration Statement on Form S-3 (the "Registration
Statement") to be filed by United States Surgical Corporation, a Delaware
corporation (the "Company"), on or about the date hereof with the Securities and
Exchange Commission in connection with the registration under the Securities Act
of 1933, as amended, of 8,870,000 Depositary Shares, each representing a one-
fiftieth interest in a share of the Company's Series A Convertible Preferred
Stock, $5.00 par value (the "Series A Preferred Stock") of 177,400 shares of the
Series A Preferred Stock, and of 8,870,000 shares of the Company's common stock,
par value $.10 per share (the "Common Stock"), issuable on conversion or
redemption of the Series A Preferred Stock.
 
     I am familiar with the Certificate of Incorporation and By-laws of the
Company and have examined originals or copies, certified or otherwise identified
to my satisfaction, of such documents, evidence of corporate action,
certificates and other instruments, and have made such other investigations of
law and fact, as I have deemed necessary or appropriate for the purposes of this
opinion.
 
     Based upon the foregoing, it is my opinion that the 177,400 shares of the
Series A Preferred Stock, and the 8,870,000 shares of the Common Stock, issuable
on conversion or redemption of the Series A Preferred Stock, have been duly
authorized and are or, when issued will be, validly issued, fully paid and
nonassessable.
 
     I hereby consent to the filing of this opinion in the Registration
Statement referred to above.
 
                                          Very truly yours,
 
                                      /s/ Donald F. Crane, Jr.

                                          Donald F. Crane, Jr.
                                          Senior SEC Counsel

<PAGE>   1
                                                                   EXHIBIT 12

                       UNITED STATES SURGICAL CORPORATION
 STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND
                           PREFERRED STOCK DIVIDENDS

<TABLE>
<CAPTION>
                                                                    PRO-FORMA
                                                                    YEAR ENDED
                                                                   DECEMBER 31,
                                                                       1993     
                                                                   ------------ 
<S>                                                                 <C>
Determination of earnings:
  Income before provision for Income taxes                          ($ 127,200)
  Fixed charges                                                         19,700
                                                                   ------------ 
       Total earnings as defined                                      (107,500)
                                                                   ------------ 
Fixed charges and other:
  Interest expense                                                       8,300 (1)
  Interest portion of rent expense                                      11,400
                                                                   ------------ 
       Fixed charges                                                    19,700

  Capitalized Interest                                                   9,500
                                                                   ------------ 
       Total fixed charges and capitalized interest                     29,200

  Preferred stock dividends (2)                                         30,000
                                                                   ------------ 
Combined fixed charges and preferred stock dividends                $   59,200
                                                                   ============ 
Ratio of Earnings to Fixed Charges

Ratio of Earnings to Combined Fixed Charges
  and Preferred Stock Dividends                                         N.M.(4)
</TABLE>





<TABLE>
<CAPTION>
                                                                                   YEARS ENDED DECEMBER 31                     
                                                         -----------------------------------------------------------------------
                                                             1993            1992            1991          1990          1989
                                                         -----------       ---------       ---------      ---------     -------- 
<S>                                                      <C>               <C>             <C>            <C>           <C>
Determination of earnings:
  Income before provision for Income taxes               ($ 137,400)       $192,900        $130,300       $ 66,200      $43,700
  Fixed charges                                              29,900          22,600          16,900         12,800       10,000
                                                         -----------       ---------       ---------      ---------     -------- 
       Total earnings as defined                           (107,500)        215,500         147,200         79,000       53,700
                                                         -----------       ---------       ---------      ---------     -------- 
Fixed charges and other:
  Interest expense                                           18,500          14,700          12,000          9,800        7,800
  Interest portion of rent expense                           11,400           7,900           4,900          3,000        2,200
                                                         -----------       ---------       ---------      ---------     -------- 
       Fixed charges                                         29,900          22,600          16,900         12,800       10,000

  Capitalized Interest                                        9,500           6,400           2,700          1,400        1,700
                                                         -----------       ---------       ---------      ---------     -------- 
       Total fixed charges and capitalized interest       $  39,400        $ 29,000        $ 19,600       $ 14,200      $11,700
                                                         ===========       =========       =========      =========     ======== 
  Preferred stock dividends (2)

Combined fixed charges and preferred stock dividends

Ratio of Earnings to Fixed Charges                           N.M.(3)            7.4             7.5            5.6          4.6

Ratio of Earnings to Combined Fixed Charges
  and Preferred Stock Dividends
</TABLE>


The ratio of earnings to fixed charges and to combined fixed charges and
preferred stock dividends is computed by dividing the sum of earnings before
provision for income taxes and fixed charges (excluding capitalized interest)
by total fixed charges and capitalized interest, or by the sum of total fixed
charges and capitalized interest and preferred stock dividends.  Total fixed
charges and capitalized interest includes all interest (including capitalized
interest) and the interest factor of all rentals, assumed to be one-third of
consolidated rent expense.

(1)  Pro-forma interest expense assumes that the net proceeds form the
                          issuance of preferred stock of $192 million were
                          received on January 1, 1993 and were used to repay
                          bank loans with an average interest rate of 5.3%.

(2)  Using the same assumptions in (1) above, preferred stock dividends have
                          been increased to an amount representing the pretax
                          earnings which would be required to cover such
                          dividend requirements, assuming a statutory tax rate
                          of 35%.

(3)  Earnings are inadequate to cover fixed charges.  The dollar amount of the
                          deficiency at 12/31/93 is $146.9 million.  If the
                          restructuring charges of $137.6 million were excluded
                          from the calculation, the dollar amount of the
                          deficiency would have been  $9.3 million.

(4)  Earnings are inadequate to cover combined fixed charges and preferred
                          stock dividends.  The dollar amount of the
                          pro-forma deficiency at December 31, 1993 was $166.7
                          million.  If the restructuring charges of $137.6
                          million were excluded from the calculation, the
                          dollar amount of the pro-forma deficiency would have
                          been $29.1 million.

<PAGE>   1
 
                                                                   EXHIBIT 23(A)
 
                         INDEPENDENT AUDITORS' CONSENT
 
     We consent to the incorporation by reference in this Registration Statement
of United States Surgical Corporation on Form S-3 of our report dated February
1, 1994 except as to notes H, K and L as to which the date is March 28, 1994,
appearing in the Annual Report on Form 10-K of United States Surgical
Corporation for the year ended December 31, 1993 and to the reference to us
under the heading "Experts" in the Prospectus, which is part of this
Registration Statement.
 
/s/ Deloitte & Touche

Deloitte & Touche
 
New York, New York
April 26, 1994

<PAGE>   1
 
                                                                      EXHIBIT 24
 
                               POWER OF ATTORNEY
 
     KNOWN ALL MEN BY THESE PRESENTS, that each of the undersigned officers and
directors of UNITED STATES SURGICAL CORPORATION, a Delaware corporation (the
"Corporation"), in connection with the filing with the Securities and Exchange
Commission, Washington, D.C., under the provisions of the Securities Act of
1933, as amended (the "Act") a Registration Statement on Form S-3 with respect
to the registration under the Act of 8,870,000 Depositary Shares, each
representing a one-fiftieth interest in a share of the Company's Series A
Convertible Preferred Stock, $5,00 par value, of 177,400 shares of the Series A
Preferred Stock, and of 8,870,000 shares of the Company's common stock, par
value $.10 per share, issuable on conversion or redemption of the Series A
Preferred Stock, hereby constitutes and appoints Thomas R. Bremer and Howard M.
Rosenkrantz such undersigned's true and lawful attorneys-in-fact and agents, and
each of them with full power to act without the other as such undersigned's true
and lawful attorney-in-fact and agent, for and in the name, place and stead of
such undersigned, in any and all capacities, to sign said Registration Statement
and any and all future amendments thereto and to file said Registration
Statement and each such future amendment, with all exhibits thereto, and any and
all other documents in connection therewith, with the Securities and Exchange
Commission, hereby granting unto said attorneys-in-fact and agents, and each of
them, full power and authority to do and perform any and all acts and things
requisite and necessary to be done in and about the premises, as fully to all
intents and purposes as such undersigned might or could do in person, hereby
ratifying and confirming all the said attorneys-in-fact and agents, or either of
them, may lawfully do or cause to be done by virtue hereof.
<PAGE>   2
 
     IN WITNESS WHEREOF, the undersigned have hereunto set their hands and seals
this 26th day of April, 1994.
 
<TABLE>
<S>                                           <C>
/s/  LEON C. HIRSCH                           /s/  DOUGLAS L. KING
- ------------------------------------------    ------------------------------------------
Leon C. Hirsch                                Douglas L. King
Chairman of the Board, President,             Director
Chief Executive Officer and Director
(Principal Executive Officer)

/s/  BRUCE S. LUSTMAN                         /s/  WILLIAM F. MAY
- ------------------------------------------    ------------------------------------------
Bruce S. Lustman                              William F. May
Director                                      Director

/s/  TURI JOSEFSEN                            /s/  MARIANNE SCIPIONE
- ------------------------------------------    ------------------------------------------
Turi Josefsen                                 Marianne Scipione
Director                                      Director

/s/  JOHN A. BOGARDUS, JR.                    /s/  DOUGLAS T. TANSILL
- ------------------------------------------    ------------------------------------------
John A. Bogardus, Jr.                         Douglas T. Tansill
Director                                      Director

/s/  THOMAS R. BREMER                         /s/  HOWARD M. ROSENKRANTZ
- ------------------------------------------    ------------------------------------------
Thomas R. Bremer                              Howard M. Rosenkrantz
Director                                      Senior Vice President, Finance,
                                              Chief Financial Officer
                                              (Principal Financial Officer)
</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission